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SUMMARY
The coordinate temporal control of the HSV-1 
transcriptional programme involves three main phases of gene 
expression; immediate-early (IE), early (E), and late (L). 
The features which distinguish IE genes are well defined.
IE genes are transcribed in the absence of de novo protein 
synthesis. Their transcription is stimulated by a component 
of the virus particle, Vmw65, and this requires the presence 
of a "far-upstream region" which includes one or more copies 
of the consensus sequence, 5'-TAATGARATTC-3'. IE gene 
products are required for the activation of the later 
classes of viral genes, whose expression in the absence of 
DNA replication is either maximal (E genes), sub-maximal (EL 
genes) or very poor (L genes). The organization of the 
promoter sequences of IE and E genes resembles that of many 
other eukaryotic (non-"housekeeping") genes, characterized 
by (i) a proximal element bearing a TATA box homology, and
(ii) distal elements which are recognized by cellular 
transcription factors such as Spl and CTF. E genes do not 
possess far-upstream regulatory elements. Until recently, 
very little was known about late gene expression; What 
distinguishes a late promoter from an early promoter; why 
is efficient late gene expression dependent on DNA 
replication?
The work in this thesis has been directed at the 
control of expression of an HSV-1 late gene, USll. It was 
shown that the USll gene was regulated in the virus with 
"true-late" kinetics, in terms of the time-course of 
appearance of USll RNA and the sensitivity of USll gene 
expression to inhibition of DNA replication. Under 
conditions of DNA replication inhibition, the accumulation 
of USll RNA was reduced by 50 to 100-fold. In contrast, the 
accumulation of RNA from an EL gene, glycoprotein D (gD), 
was reduced by only 5 to 10-fold. Thus there is a clear 
difference between the regulation of transcription of gD, an 
EL gene, and USll, a "true-late" gene.
A plasmid system was developed in order to study the 
regulation of the USll promoter. Plasmid DNA was introduced 
into tissue culture cells by a short-term transfection 
procedure, followed by infection with virus to provide the 
necessary factors for activation of USll. The USll promoter 
was therefore linked to the coding portion of the rabbit 
-globin gene, in order to distinguish between transcripts 
derived from the plasmid and those from the virus. The 
activity of the plasmid-borne USll promoter in constructs 
containing or lacking a functional HSV-1 origin of DNA 
replication (ORIg) was analysed by quantitative SI mapping 
of correctly initiated hybrid transcripts. Following HSV-1 
infection of transfected HeLa cells, the USll promoter in 
ORI+ plasmids was expressed with similar kinetics to its 
viral counterpart. USll promoter activity was first 
detected at the same time as the onset of DNA template 
replication. Expression of USll RNA was detectable from 
non-replicating ORI” plasmids, although transcript 
accumulation was reduced by greater than 90%. Sequences 
containing the IE gene 5 promoter (a 3' co-terminal gene 
whose transcription starts 5' of USll) also played a 
positive role in achieving normal USll gene expression, 
which suggested that both replication and through- 
transcription may act by inducing structural changes to the 
late promoter DNA.
The DNA sequence requirements for USll gene expression 
were investigated using plasmids which contain ORIg. The 
sequences necessary for fully efficient regulated expression 
of USll lie within the region -31 to +39 relative to the RNA 
start sites. It appeared that a late promoter might consist 
only of a proximal TATA box-cap site region. This 
hypothesis was tested by removing the distal upstream region 
of the gD promoter (which is required for its normal 
regulation as an EL promoter) and linking this truncated 
promoter to ORIg. The result was the conversion of gD 
promoter regulation to late gene kinetics during virus 
super infection. It therefore seems unlikely that late 
promoters are distinguished by late promoter-specific
sequences.
Co-transfection of the USll promoter with plasmids 
bearing HSV-1 IE genes showed that USll could be activated 
by Vmwl75 and VmwllO and most efficiently, by the two in 
combination. This suggests that the target sequence for 
trans-activation by HSV IE gene products may be in the TATA 
box region. These results are discussed in terms of the 
possible mechanisms of regulation of late genes, and of 
transactivation of transcription in general, and also in 
comparison with late gene regulation in other viral systems
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]INTRODUCTION
The subject of this thesis is the control of HSV-1 late 
gene transcription. The aims of the Introduction are to -
(i) provide a brief background to the biology of herpes 
simplex virus (HSV) (Section A); (ii) highlight the 
important developments that have occurred in recent years in 
our understanding of HSV processes at a molecular biological 
level (Section B); (iii) review selectively eukaryotic 
transcription (Sections C and D), with the aim of putting 
into context - (iv) a detailed account of HSV-1 
transcription (Section E).
SECTION A ; THE HERPESVIRUSES
la. Classification of herpesviruses
The family Herpetoviridae comprises of at least eighty 
different members, isolated from hosts as diverse as fish 
and man. Membership of this family is based on four 
morphological features:
(i) an electron-dense core, containing the 
double-stranded viral DNA genome (Epstein, 1962).
(ii) an icosahedral capsid, lOOnm in diameter comprising 
162 capsomeres (Wildy et a l ., 1960).
(iii) a tegument, consisting of a largely undefined layer 
of proteinaceous material between the capsid and envelope 
(Roizman and Furlong, 1974).
(iv) an envelope, which surrounds the capsid and 
tegument, and is derived by budding through the inner 
nuclear membrane. The envelope contains numerous virally 
encoded glycoprotein spikes (Wildy et a l ., 1960; Spear and 
Roizman, 1972).
The herpesviruses have undergone considerable 
diversification with respect to virion antigenic and 
biological properties. One property common to many 
herpesviruses is the ability to persist in a latent state.
Herpesvirus genomes show considerable variation in base 
composition, size and arrangement of their DNA. Sul)division 
according to biological properties has been proposed by 
Roizman et a l . (1981): The three sub-families alpha-, beta-
and gammaherpesvirinae are based on criteria of host-range, 
duration of the reproductive cycle, cytopathology and 
location of the viral genome during latent infection (see 
below). The herpesviruses have also been grouped on the 
basis of their genome structure, depending on the 
arrangement of reiterated sequences (Roizman et a l ., 1981; 
Roizman and Batterson, 1985).
lb. Pathogenicity of human herpesviruses
There are at least five members of the Herpetoviridae 
family which infect man, including representatives from each 
of the three subfamilies. These pathogens are listed here, 
along with a brief mention of the diseases they cause or are 
associated with, and features of the subfamily to which they 
belong :
(i) Alphaherpesvirinae; Members of this subfamily may 
have a wide or narrow host range. The reproductive cycle is 
short (less than 24h), and in cell culture causes mass 
destruction of susceptible cells. Latent infection usually 
occurs in ganglia.
Herpes simplex virus types 1 and 2 (HSV-1, HSV-2):
Varicella-zoster virus (VZV): Vesicular lesions of the lips
and mouth, known as 'cold sores' are often caused by HSV-1. 
The primary agent of genital herpes is HSV-2. These two 
viruses are closely related and there is some overlap in 
their clinical manifestations (reviewed by Whitley, 1985). 
Following primary infection the virus often establishes 
latency, during which it lies dormant in nerve ganglia 
(reviewed by Hill, 1985). Recurrent lesions may then 
periodically occur at the same or other peripheral sites 
upon virus reactivation. HSV-1 is widespread in the human 
population, and although infection is usually mild or 
asymptomatic, it can give rise to systemic illness and 
encephalitis, particularly in immunosuppressed individuals.
The diseases caused by VZV are chickenpox (varicella) arici 
shingles (herpes zoster). Varicella represents a primary 
infection and is seen predominantly in childhood. Herpes 
zoster appears to be a consequence of reactivation of VZV 
that has remained dormant since an earlier attack of 
varicella (reviewed by Gelb, 1985).
(ii) Betaherpesvirinae; Members of this subfamily have a 
narrow host range, frequently restricted to the species or 
genus to which the host belongs. The reproductive cycle is 
relatively long (greater than 24h), and results in slowly 
progressing lytic foci in cell culture; infected cells 
become enlarged both in vivo and in vitro. Latent infection 
may occur in secretory glands, lympho-reticular cells, 
kidneys and other tissues.
Human cytomegalovirus (HCMV): HCMV infects the
majority of the human population. Infection is most serious 
in neonates, but usually HCMV infections are subclinical.
CMV characteristically produces cell enlargement with 
intranuclear inclusions similar to those produced by HSV.
One of the main problems caused by CMV is infection in 
immunosuppressed patients, particularly in transplant 
therapy, and more recently, in patients with acquired 
immunodeficiency syndrome (AIDS). HCMV DNA has been found 
in a small proportion of biopsies taken from patients with 
cervical intraepithélial neoplasia (pre-ma1ignant cancer), 
suggesting that like HSV-2 (see below), HCMV may sometimes 
play a role in the development of cervical cancer (Fletcher 
et a l ., 1986; reviewed by Alford and Britt, 1985).
(iii) Gammaherpesvirinae; Host range is usually 
restricted to the same family or order as the natural host, 
although in vitro all members of this subfamily can 
replicate in lymphoblastoid cells. Lytic infection may 
occur to a lesser extent in epithelioid cells and 
fibroblasts, but the cytopathology is variable. Latent 
infection frequently occurs in lymphoid tissue.
Epstein Barr Virus (EBV): EBV is a lymphotropic virus
that infects human B-cells. It is the causative agent of
infectious mononucleosis and is strongly associated with 
Burkitt's lymphoma and nasopharangea1 carcinoma. EBV is 
also capable of immortalizing lymphocytes (reviewed by 
Miller, 1985).
2. Herpes Virus - Host Interactions
a . HSV and latency
The ability to establish a latent infection following 
primary infection of the host is an important property of 
HSV. The latent state is characterized by the prolonged 
association of the viral genome with its host, during which 
no infectious virus can be isolated (Hill, 1985). It is 
believed that the virus is transported intra-axonally from 
infected skin sensory nerve cells to the neurons of the 
sensory ganglia, where it is found in a latent state in both 
mouse model systems (Stevens and Cook, 1971; Cook et a l ., 
1974; McLennan and Darby, 1980) and in man (Baringer and 
Swoveland, 1973). Reactivation of latent virus may occur in 
response to diverse stimuli, and in particular trauma and 
nerve damage (Hill, 1985).
Examination of DNA extracted from latently infected 
mouse brainstem and human trigeminal tissue has shown HSV 
DNA (which is linear in virions) to be present in an 
'endless' form (Rock and Fraser, 1983, 1985; Efst athiou ej^
a l . , 1986). It is not clear whether this is due to 
integration of the HSV genome into cellular DNA, or if the 
viral genome is maintained extrachromosomally in circular or 
concatemeric form. Whether the HSV genome is silent in its 
latent state, or is capable of expressing some functions is 
also unknown.
In vitro latency systems have been developed in order 
to improve understanding of the molecular processes involved 
in the establishment and maintenance of HSV latent 
infections. A non-productive infection can be established 
in the absence of drugs that inhibit virus multiplication at 
a low moi (0.003 pfu/cell) by incubating infected cells at 
42oc, a supraoptimal temperature (Russell and Preston,
19Bb). Virus replication can be rejjressed and latency 
establislied at a li i gVi iiioi (Ü. 1- 1.0 pfu/cell) by incubating 
infected cells in the presence of BVdR and interferon before 
transfer to an elevated temperature of 40.5Oc (Wigdahl ejt 
al., 1982, 1984; Vonka et a l ., 1986). Virus reactivation
can be induced by a variety of agents in one or both 
systems. These agents include super infect ion with 
heterotypic virus, HSV mutants, HCMV or SV40 (but not 
adenovirus of types 2 and 5), and incubation in increased 
serum concentrations. Since Wigdahl et a l . (1984) noted
that the predominant form of HSV DNA in their latency system 
was nonintegrated and linear, which is at variance with the 
in vivo situation (Efst athiou et a l ., 1986), caution should 
be observed in extrapolating results obtained in vitro.
The in vitro latency system of Russell and Preston 
(1986) has demonstrated that HSV-1 tsK, but not 
uv-inactivated virus, is effective in reactivating latent 
HSV-2 at the non-permissive temperature (NPT). The tsK
virus has a temperature sensitive lesion in Vmwl75, an
immediate-early polypeptide (the product of IE gene 3) which
is essential for activation of early and late HSV
transcription (Marsden et a l ., 1976; Preston, 1979). The 
virion component that stimulates IE transcription (see 
Section E(2b)) is probably not directly involved in 
reactivation, since it can be supplied efficiently by 
uv-irradiated t sK (Preston,C et a l ., 1984). These results 
raise the possibility that one or more of the four remaining 
HSV IE gene products is involved in reactivation of latent 
virus. A role for VmwllO (IE gene 1 product) has recently 
been implicated since ^1403, a mutant virus containing a 
large deletion in IE gene 1, is unable to reactivate latent 
HSV-2 in vitro (Russell, Stow and Preston, personal 
communication). Both tsK and ^ 1 4 0 3  are able to establish 
latency suggesting that little or no viral gene expression 
is required for this step in the in vitro latency system 
used (Russell, Stow and Preston, personal communication).
6b . HSV and cervical cancer
An association between HSV and cervical cancer bas long 
been recognised (Naib et a l ., 1966; Rawls et a l ., 1969; 
Nahmias et a l ., 1970). However, difficulties have been 
experienced in establishing whether or not there is a causal 
relationship, since the risk factors associated with 
developing cervical cancer are similar to those for becoming 
infected with HSV-2. It is also very likely that more than 
one factor is involved in the development of cervical 
cancer. Human papillomavirus DNA has been frequently 
detected in cervical disease (Durst et a l ., 1983; Boshart 
et a l ., 1984) and it has been suggested that HSV-2 may act 
as a co-carcinogen along with such other agents (zur Hausen, 
1982). Evidence supporting the suggestion that HSV-2 may be 
involved in cervical neoplastic disease came from finding 
HSV gene products and DNA in some tumours (reviewed by 
Galloway and McDougall, 1983). The mechanism(s) by which 
HSV-2 may act as a carcinogen has been a field of intense 
investigation. It is generally accepted that HSV-2 does not 
carry a viral oncogene analogous to the oncogenes of 
retroviruses or the small DNA tumour viruses. It also seems 
clear that the retention of HSV DNA is not required to 
maintain the transformed phenotype, suggesting that the 
detection of HSV gene expression in cervical neoplasia may 
be fortuitous (Galloway and McDougall, 1983; Cameron e^
^ . ,  1985).
Galloway and McDougall (1983) favour a 'hit-and-run' 
hypothesis for the oncogenic potential of HSV. This could 
occur through a transient or lasting disruption of normal 
cellular gene regulation or function as a result of HSV 
infection, which, in cooperation with other steps in the 
'oncogenic process', might occasionally produce a malignant 
cell. There is much apparently conflicting evidence on the 
oncogenic nature of HSV. It may be relevant that all the 
experiments briefly reviewed below used various cell-types 
in culture, and therefore the significance of the 
conclusions in relation to the situation in vivo remains to 
be established. Two types of mechanism whereby HSV may 
affect cellular processes, which are not necessarily
7m u t u a l l y  e x c l u s i v e ,  a r e  as f o l l o w s :
(i) Gene regulation; Infection by HSV-1 or HSV-2 
causes an increased level of some cellular polypeptides 
(Macnab et a l ., 1985; Kennedy et a l ., 1985; Patel,R. e^ 
al., 1986). Some of these polypeptides also accumulate to
higher levels in transformed cells than in controls (Macnab 
et al ., 1985). This might result from transcriptional 
activation by HSV gene products, which have the potential to 
trans-activate cellular promoters (Everett, 1985).
Disruption of the normal regulation of cellular genes may 
also occur by rather more indirect means, such as 
HSV-induced mutagenesis or chromosomal rearrangements (see 
below).
(ii) Mutagenesis; HSV-2 has been shown to act as a 
mutagen, increasing the natural mutation rate of a cellular 
hypoxanthine phosphoribosyl transferase (HPRT) gene by up to 
ten-fold (Pilon et a l ., 1986). It is conceivable that the 
mutagenic activity may be caused by HSV-encoded enzymes 
involved in DNA biosynthesis. For instance, the disruption 
of normal nucleotide pool regulation by these enzymes could 
lead to an increased error rate during cellular DNA 
replication (Huszar and Bacchetti, 1983). Fragments of 
HSV-2 DNA containing transcribed regions encoding the large 
(Bglllc) and small (Bgllln) subunits of the ribonucleotide 
reductase (RR) gene have been shown to have transforming 
activity in independent assay systems (Jariwalla et a l ., 
1983; Galloway and MacDougall, 1983; Cameron et a l .,
1985), initially lending support to this hypothesis.
Jariwalla et a l . (1986) have subsequently suggested
that the Bglllc fragment of HSV-2 contains two independent 
transforming and immortalising functions. They mapped a 
transforming function to a 480bp fragment (Pstlc/Sallb) 
which lies within the coding sequences of the large RR 
subunit, and yet lacks the promoter/regulatory sequences of 
this gene. Expression of at least some of the large RR 
subunit has been detected only in a minority of cell lines 
transformed with the 480bp fragment (Jariwalla et a l .,
1986), and it is now considered that the potential of 
sequences within the 480bp fragment to adopt stem/loop
Bstructures may be involved in the activation and
rear rangement of cellular genes (reviewed by Mac nab, 1987 ).
It has been reported by Galloway et a 1 . (1984) that a
737bp region of Bgllln (termed the 'morphological 
transforming region' (MTR)II) is responsible for 
transformation, and this subfragment lies completely outside 
the coding sequences of both large and small RR genes. The 
transforming ability of the MTRII sequence has also been 
attributed to its apparent potential to adopt a stem/loop 
structure bounded by direct repeats, which bears a 
resemblance to the structure of insertion-like sequences 
(Galloway et a l ., 1984). It has been postulated that 
insertion of the MTRII into the cellular genome may cause 
activation of cellular genes through enhancer-like activity 
(Galloway et a l ., 1984). However, since such stem/loop 
structures frequently occur in DNA, the MTR must harbour 
some other definitive feature. Transformation by the MTR or 
other HSV fragments occurs at very low frequencies and 
certainly not by a one step mechanism (Macnab, 1987), which 
can create difficulties in the valid interpretation of 
transformation assay results. The mechanisms of HSV-induced 
mutagenesis and alteration of normal cellular gene 
regulation are evidently not straightforward; a detailed 
review of these and other possible mechanisms for the 
oncogenic potential of HSV is given in Macnab (1987).
c . Effects of HSV infection on host-cell metabolism
The infection of permissive cells with HSV-1 or HSV-2 
is characterized by alterations in host functions and 
macromolecular synthesis. Mitosis ceases (Wildy et a l ., 
1961), DNA synthesis is inhibited (Roizman and Roane, 1964), 
and there is a rapid shut-off of most host polypeptide 
synthesis (Sydiskis and Roizman, 1966, 1967), accompanied by
a degradation of cellular mRNAs (Nishioka and Silverstein, 
1977, 1978; Schek and Bachenheimer, 1985). Host
polyribosomes are disaggregated following infection 
(Sydiskis and Roizman, 1966, 1967), and the polyribosomes
which reform contain predominantly virus-encoded mRNAs 
(Stringer et a l ., 1977). In contrast to the general
reduction in levels of host RNA and protein synthesis, the 
expression of some cellular genes (notably heat-shock) is 
stimulated early in infection (Notarianni and Preston, 1982; 
LaThangue et a l ., 1984; Patel,R. et a l ., 1986). HSV 
infection can activate cellular promoters integrated into 
the genome of biochemically transformed cells (Everett, 
1985), and increase the expression of certain cellular 
proteins which are also found at higher levels in 
HSV-transformed cells (Macnab et a l ., 1985). Alterations in 
host macromolecular synthesis early in viral infection could 
play a role in determining the ultimate outcome of infection 
(for example, lysis, latency or transformation). Host 
shut-off of polypeptide synthesis is considered in more 
detail below.
Infection with HSV-2 typically results in a more rapid 
inhibition of host protein synthesis compared to HSV-1 
(Powell and Courtney, 1975; Pereira et a l ., 1977; Fenwick 
et a l ., 1979; Schek and Bachenheimer, 1985). The control 
of host shut-off is poorly understood and it is not clear 
how many mechanisms mediate this process. In most 
cell-types infected with uv-irradiated virus (Fenwick and 
Walker, 1979), or infected in the presence of actinomycin D 
(Sydikis and Roizman, 1967; Fenwick et a l ., 1979; Schek 
and Bachenheimer, 1985), there is a rapid shut-off of host
polypeptide synthesis and a concomitant degradation of 
cellular mRNAs. This process is probably mediated by a 
virion function. Mutants have been isolated from HSV-1 
which are defective in virion-associated host shut-off (vhs 
mutants) (Read and Frenkel, 1983). The vhs mutants which 
have been described are not conditionally lethal indicating 
that this mechanism of host shut-off is not essential for 
lytic growth. Interestingly, at least one of these mutants, 
vhs-1, overproduces virus IE polypeptides due to a failure 
in the post-transcriptional shut-off of IE viral gene 
expression (Read and Frenkel, 1983).
Full shut-off of host polypeptide synthesis may require 
viral gene expression in addition to the virion function, at 
least in HSV-1. Nishioka and Silverstein (1978) reported 
that infection of Friend Erythroleukaemia cells (which can
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be inducfid to express large amounts of globin gene products) 
with uv-irrad 1 ated HSV-1 resulted in an inhibition of globin 
synthesis. However, further shut-off, characterized by the 
(non-specific) degradation of globin mRNA, required viral 
gene expression, suggesting that there is a secondary 
shut-off event distinct from the virion associated event 
(Nishioka and Silverstein, 1978). Other investigators have 
suggested that expression of an early or late viral protein 
is needed to fully inhibit host polypeptide synthesis 
(Honess and Roizman, 1974; Marsden et a l ., 1976; Stenberg 
and Pizer, 1982), but the existence of a protein species 
involved in shut-off in addition to the virion-associated 
function(s) has not been demonstrated. Since the vhs 
mutants of Read and Frenkel (1983) are not defective in 
secondary shut-off of host polypeptide synthesis, the 
virion-associated and secondary shut-off events might be 
mediated by distinct viral gene products.
Schek and Bachenheimer (1985) have shown that the 
degradation of four common cellular mRNAs (encoding actin, 
&-tubulin, and histones H3 and H4) in HSV-1 and HSV-2 
infected Vero cells was not dependent on viral gene 
expression. Furthermore, the vhs-1 mutant defective in 
virion-associated shut-off of host polypeptide synthesis was 
also apparently defective in cellular mRNA degradation.
Their results imply that the virion function is responsible 
for both host polyribosome disaggregation and cellular mRNA 
degradation, and seem inconsistent with a secondary shut-off 
event. However, it is possible that the rate of shut-off is 
dependent on variable factors such as the abundance and 
species of the mRNA in question, and that the speed of 
cellular mRNA degradation reported by Schek and Bachenheimer 
(1985), may not be fast enough to account for early shut-off 
of host protein synthesis.
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SECTION B : HERPES VIRUS DNA
The structure and functions of HSV DNA are discussed in 
this section with particular reference to HSV-1, which is 
the best characterized of the alphaherpesviruses and the 
most relevant to the work described in this thesis. Viral 
gene products are mentioned only insofar as their 
interaction with the genome is concerned, while the 
regulation of viral gene transcription is discussed 
extensively in Section E.
1. Structure
The HSV-1 genome is a linear duplex DNA molecule of 
about 155,000 base-pairs with a base composition of 67% G+C 
(Becker et a l ., 1967; Kieff et a l ., 1971). HSV DNA can be 
fragmented by treatment with alkali or formamide, suggesting 
that it contains single-stranded nicks (Kieff et a l ., 1971; 
Wilkie, 1973; Gorden et a l ., 1973). Early electron 
microscopy studies showed that the termini of intact single 
strands of HSV DNA self anneal to internal inverted 
sequences, and that double-stranded HSV DNA which has been 
treated with processive 5'- or 3 '-exonuclease is able to 
circularise, indicating the presence of terminal redundancy 
(Sheldrick and Berthelot, 1974; Grafstrom et a l ., 1974). 
These observations led Sheldrick and Berthelot (1974) to 
propose a model for the structure of HSV DNA which has since 
proved substantially correct (Wadsworth et a l ., 1975;
Wilkie, 1976) The genome is divided into two unique 
segments, Ul (long) and Ug (short), each of which is 
bracketed by inverted repeats, Rl and Rg respectively 
(Figure 1). Flanking each end of the genome is a direct 
repeat, the a sequence, which varies in size from 280 to 550 
bp among HSV strains (Davison and Wilkie, 1981). Multiple 
copies of the a sequence are often present at the L terminus 
and at least one inverted copy of the a sequence separates 
the L and S components, while a single copy is present at 
the S terminus (Wagner and Summers, 1978). The organization 
of the HSV genome can thus be represented as
^nb-UL~b ' a ' '-Ug-ca, as shown in Figure 1. The HSV-1 and
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Figure 1. Organization of the HSV-1 genome
The HSV-1 genome is shown to scale in prototype (P) 
orientation. The long unique (U^) and short unique (Ug) 
regions (single lines) are flanked by terminal (TR) and 
internal (IR) repeats (double lines). The a sequences (a) 
at the termini of the L and S components are represented by 
heavy vertical lines, and may be duplicated "n" or "m" times 
(a' = inverse orientation). The remainder of the long and 
short repeats are referred to as "b" and "c" respectively, 
or in their inverted forms as "b'" and "o'". Below the 
genome are mapped (i) the IE mRNAs (spliced regions are 
raised); (ii) E and L transcripts which specify the best 
known virus-encoded proteins; and (iii) the three HSV-1 
origins of DNA replication (ORI). The four possible isomers 
of the HSV-1 genome are depicted below, where the L and S 
components may be inverted (I) relative to the P orientation 
as indicated.
Abréviations and key references (mainly for HSV-1 strain 
17+), are as follows:
IE immediated-early - (IE 1, Perry et a l ., 1986; IE
2, Whitton et a l ., 1983; IE 3, Rixon et a l .,
1982; lEs 4 and 5, Rixon and Clements, 1982).
AE alkaline exonuclease (Costa et a l ., 1983).
VP5 major capsid protein (Costa et a l ., 1984).
tk thymidine kinase (McKnight, 1980).
gB glycoprotein B (Bzik et a l ., 1984).
MDBP major DMA binding protein (Quinn and McGeoch,
1985).
Pol DMA polymerase (Quinn and McGeoch, 1985).
RR ribonucleotide reductase (Frink et a l ., 1981;
McLauchlan and Clements, 1983). 
gC glycoprotein C (Frink et a l ., 1983).
Vmw65 IE stimulatory protein (Hall et a l ., 1982;
Dalrymple et a l ., 1985). 
dUTPase (Hall et a l ., 1982; Preston and Fisher, 1984). 
gG, gD, g E ; glycoproteins G , D and E (Rixon and McGeoch, 
1985; McGeoch et a l ., 1985, 1987).
21K USll gene product (Rixon and McGeoch, 1984;
Johnson et a l ., 1986).
ORIg (Stow and McMonagle, 1983).
ORIl (Quinn and McGeoch, 1985).
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HSV-2 genomes are essentially col inear, with viral genes 
mapping at equivalent positions (Timbury and Subak-Sharpe, 
1973; Esparza et a l ., 1976; Marsden et a l ., 1978;
Schaffer et a l ., 1978; Davison and Wilkie, 1983a), and show 
40-50% sequence homology as judged by solution hybridization 
(Kieff et a l ., 1972).
2. DNA Replication
a ) Template signals
Linear DNA molecules circularize soon after infection 
(Jacob and Roizman, 1977), probably by direct ligation of 
the termini (Davison and Wilkie, 1983a). Newly replicated 
DNA molecules consist of large head-to-tail concatemers, 
which probably arise by rolling-circle replication 
(Ben-Porat and Tokazewski, 1977; Jacob and Roizman, 1977; 
Jacob et a l ., 1979). The large concatemers are subsequently 
cleaved within a sequences, situated at the junctions 
between adjacent viral genomes (Davison and Wilkie, 1981).
The initiation of replication of HSV DNA can occur at 
multiple widely separated loci, as deduced by electron 
microscopy (Friedmann et a l ., 1977). The approximate 
locations of three HSV origins of DNA replication were found 
by characterization of two classes of defective genomes 
which accumulate in virus stocks passaged at high 
multiplicities of infection. Class I defective genomes 
contain an origin of replication from TRg or IRg, termed 
ORIg; Class II defectives possess an origin of replication 
from Ul , GRIp (Vlazny and Frenkel, 1981; Spaete and 
Frenkel, 1982). A functional copy of ORIg is located in 
each of the short repeats, TRg and IRg, in the 
non-transcribed region between IE mRNAs 3 and 4/5 (Stow,
1982; see Figure 1). Stow and McMonagle (1983) subsequently 
identified a 90bp fragment which sufficed for origin 
function, and consists of a 45bp palindromic sequence 
featuring 18 centrally located A or T residues flanked by 
G+C-rich sequences. ORI^ i s located between the 5 ' termini 
of mRNAs encoding the DNA polymerase and major DNA binding 
protein (Figure 1). It has proved difficult to produce a
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s t a b l e  c l o u e  of t i n s  i e g i o n  in b a c t e r i a .  H o w e v e r ,  c l o n i n g  
in yeast and direct sequencing of viral DNA sliowed that ORI^ 
contained a 72b p  palindrome and revealed a high degree of 
homology (85% identical residues) to the ORIg palindrome 
(Weller et a l ., 1985; Quinn and McGeoch, 1985). The HSV-2 
ORIp sequence (determined by cloning in E.coli recBC sbcB, 
under minimal growth conditions) is highly homologous to its 
HSV-1 counterpart, and is active in the presence of HSV-1 
replication functions (Lockshon and Galloway, 1986).
The presence of an A+T-rich region in a eukaryotic 
origin of DNA replication may be significant in influencing 
origin configuration or facilitating the access of proteins 
required for replication (Stow, 1985). The A+T-rich region 
is sensitive to nuclease SI digestion when ORIg is located 
in supercoiled plasmid DNA; this allowed substitution of the 
central 23bp by an 8bp synthetic oligonucleotide linker 
molecule, a manipulation which abolished replicative ability 
(Stow, 1985). The observation that both GRIp, and ORIg are 
flanked by divergently transcribed mRNAs is of unknown 
significance, as is the importance of having three origins 
on the standard genome.
b) Virus-encoded replication functions
Since helper virus is needed to replicate defective 
genomes or plasmids which contain an HSV origin of 
replication (Vlazny and Frenkel, 1981; Stow, 1982), the 
induction of virus-specific replicative functions by HSV can 
be inferred. The HSV DNA polymerase (Keir and Gold, 1963; 
Keir et al ., 1966; Purifoy et a l ., 1977; Chartrand et a l ., 
1980), the major DNA binding protein (Bayliss et a l ., 1975; 
Powell et a l ., 1981; Quinlan and Knipe, 1985a ), and the 
alkaline exonuclease (Keir and Gold, 1963; Preston and 
Cordingley, 1982; Banks et a l ., 1983; Moss, 1986)^ are all 
essential functions for DNA replication. The HSV DNA 
polymerase differs from most cellular eukaryotic polymerases 
by virtue of its 3' to 5' (proof-reading) exonuclease 
activity (Knopf, 1979). In addition, the HSV enzyme is 
sensitive to phosphonoacetic acid (PAA), a pyrophosphate 
analogue (Leinbach et a l ., 1976). Properties of the major
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DNA biiidiny protein ( MDHl’) i lie 1 ude its preferential tiinding 
to single-stranded DNA (Bayliss et a l ., 1975; Knipe et a l ., 
1982) and ability to lower the melting temperature of poly 
A/T helices in vitro (Powell et a l ., 1981). Prior to viral 
DNA replication in infected cells, MDBP is localized to 
specific sites in the nucleus. When viral DNA replication 
occurs, MDBP is then found localised in large globular 
'replication compartments' (Quinlan et a l ., 1984), where it 
is bound to progeny or replicating DNA (Leinbach and Castro, 
1983; Lee and Knipe, 1983). It is postulated that MDBP 
acts in a replication complex with polymerase and alkaline 
exonuclease, since lesions in purified MDBP impair the 
function of these two enzymes at NPT in vitro (Littler ejt 
al. , 1983). The role of MDBP in viral gene regulation is 
discussed in Section E. Recently, an unidentified
virus-induced protein has been shown to specifically bind
joe
ORIg, and can/isolated from ORIg DNA in association with 
polymerase andMDBP (Elias et a l ., 1986).
The HSV-encoded ribonucleotide reductase (RR) is 
essential for virus growth and is also involved in DNA 
metabolism; the activity of DNA polymerase correlates with 
the functioning of RR (Cohen, 1972; Ponce de Leon et a l ., 
1977, Dutia, 1983). This enzyme catalyses the reduction of 
all four ribonucleotides to their corresponding 
deoxyribonucleotides, and has different properties to the 
host enzyme including insensitivity to dTTP and dATP 
inhibition. Characterization of the HSV-RR has been of 
topical interest. Studies with t_s 1207, a mutant which 
has a single amino-acid change in the large RR subunit (RR^
- Vmwl36 (Preston,V. et a l ., 1984)), combined with 
experiments using a monoclonal antibody specific for Vmwl36 
and an oligopeptide-induced antiserum directed against the 
small RR subunit (RR2 - Vmw38), showed that these two 
subunits form a complex in infected cells (Frame et a l ., 
1985). An exciting finding was that a synthetic nonapeptide 
corresponding to the carboxy 9 amino-acids of the small 
subunit specifically inhibited the viral but not the 
cellular enzyme (Dutia et a l ., 1986; Cohen et a l ., 1986). 
Dutia et a l . (1986) proposed that the inhibitory
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oiigopeplide prevents asscjciation of the two subunits by 
competing for the small subunit binding site on the large 
subunit, thus displacing Vmw38. This finding suggests a 
novel approach to the development of antiviral agents.
HSV enzymes involved in DNA metabolism, which are not 
esential for virus growth in tissue culture, include 
thymidine kinase (Kit and Dubbs, 1963; Klemperer et a l ., 
1967; Jamieson and Subak-Sharpe, 1974; McKnight, 1980) and 
dUTPase (Wohlrab and Francke, 1980; Preston and Fisher,
1984). In addition, a type 1 DNA topoisomerase activity
(topo 1) has been described in HSV virions (Muller et a l .,
1985). Although topo 1 activity tends to co-purify with an 
HSV-encoded 65K DNA binding protein (65Kpgp), there is 
currently some doubt whether this function is virally 
encoded (M. Gallo, M.T. Muller, H.S. Marsden and D.S.
Parris, personal communication).
Attempts to define all the HSV functions essential for 
DNA replication are being approached by determining the 
minimum fragments of the HSV genome required to support 
replication of an ORI+ plasmid in a short-term replication 
assay (Challberg, 1986). The locations of the genes known 
to be involved in DNA replication are shown in Figure 1.
3. Inversion
A remarkable property of the HSV genome, predicted by 
Sheldrick and Berthelot (1974), is the ability of the L and 
S segments to invert with respect to one another, resulting 
in a viral population of all four possible isomers (Hayward 
et a l ., 1975; Delius and Clements, 1976; Clements et a l ., 
1976). The isomers, shown diagrammatically in Figure 1, are 
either termed ' P ' (prototype); or Ip_, Ig and I^g for 
inverted L,S or both L and S segments relative to the P 
arrangement (Roizman et a l ., 1979). Studies with intertypic 
HSV-I/h SV-2 recombinants have occasionally identified 
mutants which fail to invert either one or both genome 
segments at normal frequencies (Preston et a l ., 1978;
Davison and Wilkie, 1983b). Fine structure mapping 
indicated that homologous sequences within the flanking 
repeats, R^ or Rj^ , were required for segment inversion
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Flanking the major repeated sequences is the a sequence, 
which is composed of a number of direct repeats (DR) 
interspersed by unique sequences (Ub and Uc), such that the 
SOlbp a sequence of HSV-1 strain F may be represented by;
DR1-Ub-(DR2)i9-(DR4 )3-Uc-DRl
(Mocarski and Roizman, 1982). Note that the exact number of 
direct repeats, DR2 and DR4, are variable among different 
virus isolates. The HSV-2 a sequence lacks reiterations, 
and its homology with the a sequence of HSV-1 is limited to 
one region of 27bp (Davison and Wilkie, 1981).
It was concluded by Mocarski et a l .(1980) and Mocarski 
and Roizman (1982) that a site-specific recombination system 
operating on the a sequence was responsible for HSV genome 
segment inversion. This conclusion was based on evidence 
showing that duplications of fragments bearing the a 
sequence generated additional genome inversions, but 
duplications of several other HSV fragments from and Ug 
as inverted repeats did not (Mocarski and Roizman, 1982).
It has subsequently been shown by Chou and Roizman (1985) 
that the region of the a sequence inserted into Ul 
responsible for inversion contains the direct repeats, DR2 
and DR4, but not the unique sequences, Ub and U c .
Although the possibility of a site-specific 
recombination system in HSV cannot be ruled out, an 
alternative explanation is that HSV genome segment inversion 
results from both the summed recombinational activity of 
sequences dispersed throughout Rl and R g , and from the use 
of alternative packaging phases on the precursor concatemer 
(Varmuza and Smiley, 1985). In both the repeated and unique 
regions of the HSV genome, there are a number of short 
tandemly reiterated sequences which vary in length between 
5bp to 54bp (Whitton and Clements, 1984; Rixon et a l .,
1984; Perry et a l ., 1986). It has been suggested that 
these repeats may be highly recombinogenic, since homologous 
recombination can occur between any members of the same 
family (Rixon et al., 1984). In addition, out-of-register
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generate progeny molecules with differing copy numbers of 
reiterations. The copy number of reiterated sequences does 
vary between different virus isolates, and this variation 
also occurs in the number of direct repeats within the a 
sequence (DR2, DR4 etc) (Davison and Wilkie, 1981; Mocarski 
and Roizman, 1981; Murchie and McGeoch, 1982; McGeoch e_t 
al ., 1985). Thus, homologous recombination, particularly in
the reiterated sequences of Rg and R^ (including the direct 
repeats of the a sequence), would appear to be a 
satisfactory explanation for the mechanism of genome segment 
inversion. Further evidence that inversion is not 
site-specific has come from the isolation of partially 
frozen genome arrangements, caused by deletions in the 
internal repeated region IR^/lRg (Longnecker and Roizman, 
1986; Jenkins and Roizman, 1986). One isolate was deleted 
for IRg, the internal a sequence, and most of IR^. Its S 
segment was frozen in Ig orientation, whilst its L segment 
continued to invert, albeit at a lower frequency than wild 
type virus (Longnecker and Roizman, 1986; Jenkins and 
Roizman, 1986). This result suggests that inversion of L in 
the absence of an internal a sequence was due to homology 
between the remaining sequences which flanked # but Ug was 
unable to invert as it had no flanking homology. The 
isolation of frozen genome arrangements has also 
demonstrated that at least 3 of the 4 possible isomers are 
viable for virus replication.
4. Cleavage and Packaging
Compelling evidence suggests that the a sequence 
contains the necessary signals for both cleavage and 
encapsidation of DNA, since plasmid molecules which contain 
an HSV origin of replication are replicated and packaged in 
the presence of helper virus, provided an a sequence is also 
located on the same plasmid molecule (Stow et a l ., 1983).
In the viral genome, a single a sequence is flanked by the 
20bp DRl element, whereas adjacent reiterated copies of the 
a sequence are separated by only a single copy of DRl 
(Davison and Wilkie, 1981; Mocarski and Roizman, 1982).
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Since ]>oUi vira] termini bear an a sequence which ends in 
partial coj)ies of DRl, it was initially supposed tliat the 
cleavage event may have occured by a single ds breakage 
within the DRl located between two adjacent a sequences 
(Davison and Wilkie, 1981). However, both defective viral 
genomes and plasmid molecules which contain an origin of 
replication and a non-reiterated a sequence may be 
replicated and packaged (Locker and Frenkel, 1979; Stow ejt 
al., 1983), which suggests that a single a sequence is 
sufficient to be a packaging substrate. Furthermore, 
packaged concatemeric plasmid molecules have been shown to 
contain an a sequence at both termini but do not generate 
internal a sequence duplications (Stow et a l ., 1986).
Models which adequately describe the cleavage/packaging 
process must therefore be able to account how single copies 
of the a sequence may be used as substrates and yet result 
in the presence of at least one a sequence at both ends of 
the mature packaged DNA.
The essential features of the two models proposed by 
Varmuza and Smiley (1985) and outlined in Figure 2, which 
are consistent with the available data, are as follows; (i) 
The "staggered nick-repair mechanism", involves duplication 
of the a sequence between adjacent viral genomes by repair 
strand synthesis of the 5' overhanging single-stranded a 
sequences adjoining the L and S termini; (ii) The "theft 
mechanism", proposes that packaging commences at an a 
sequence and once a full genome length has been packaged, 
cleavage occurs at the next a sequence, which is 'stolen' 
from the adjoining DNA. A consequence of this second model 
is that lengths of DNA without an a sequence will be 
generated, and since these have not been detected 
experimentally it must be assumed that if this mechanism is 
used, they are rapidly degraded. Deiss et a l . (1986) have
elaborated upon the 'theft' model in an attempt to explain 
how multiple a sequences may accumulate at the L terminus 
but not at the S terminus, by proposing polarity in the 
packaging process. They have also described an additional 
model which requires recombinational repair to duplicate 
single a sequences. Whilst no model has been proved
a.
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Figure 2 . Two cleavage/packaging models
(from Varmuza and Smiley, 1985).
a. Staggered nick repair mechanism. (i) The solid circles 
represent L and S recognition complexes (L-R and S-R), 
which are bound to signals in the Uc and Ub regions of 
the a sequence (see above), respectively. (ii) The L 
and S termini arise by single-stranded nicks, made by 
the bound complexes, followed by repair DNA synthesis,
(iii) In cases where there are two or more tandemly 
repeated a sequences, cooperation between the two 
complexes may produce a double stranded break.
b. "Theft" mechanism. Filled-in triangles represent 
packaging signals s ituated on the a sequences; the 
open circles represent cleavage/packaging complexes 
(perhaps empty capsids). Double-stranded cleavage 
occurs at an L terminus cleavage signal, such that the L 
terminus carrys the a sequence ("stolen" from the S 
terminus). Packaging proceeds until the next 
appropriately orientated L-S junction and a 
double-stranded cut is made at the S terminal. A 
consequence of this model is that some DNA fragments 
lack a sequences, and it is proposed that these must be 
rapidly degraded.
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formation of L and S termini are distinct, and that the 
signals for cleavage are located within Ub and Uc (Varmuza 
and Smiley, 1985; Deiss et a l ., 1986). Cleavage does not 
require DRl, the sequence which is usually cut, and indeed 
may occur outside the a sequence if DRl is deleted (Varmuza 
and Smiley, 1985).
Replicated DNA is not packaged by a simple 'headful' 
mechanism since short encapsidated DNA molecules may 
accumulate in the nucleus, although only those capsids 
containing an approximate genome equivalent of DNA can be 
enveloped and transported to the cytoplasm as mature virions 
(Vlazny et a l ., 1982; Stow et a l ., 1986). Cleavage of 
concatemeric DNA into unit length genomes is either 
prerequisite to, or occurs concomitantly with the packaging 
of DNA into capsids (Vlazny et a l ., 1982). A detailed 
characterization of ;^1201, a mutant with a defect in 
encapsidation at NPT, showed that packaging was linked to 
the processing of Vmw40, a major structural (tegument) 
protein (Preston,V et a l ., 1983). Unprocessed forms of 
Vmw40 in ^ 1 2 0 1  at NPT become associated with empty capsids, 
indicating that the failure in cleavage and packaging was 
not due to a gross aberration in capsid structure (Preston,V 
et a l ., 1983). Another mutant, ^1203, belonging to a 
different complementation group to ;^1201, also has defects 
in both encapsidation and cleavage at NPT, indicating that 
these processes are tightly linked, and may not occur by a 
simple one step mechanism (Addison, 1986).
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5 . H S V-1 s a V e c t o r
The large genome size and wide host range of HSV-1 makes 
it an attractive candidate for transducing manipulated or 
foreign DNA sequences into different types of mammalian 
cells. Features required for the replication, cleavage and 
packaging of the genome are now sufficiently well understood 
to allow rational design of HSV-based vectors.
Non-defective HSV-1 has been used as a vector for the 
expression of the hepatitis B surface antigen in cultured 
cells (Shih et a l ., 1984), and uv-irradiated recombinant 
HSV-1 containing the Chinese ham-ster ovary (CHO) aprt gene 
has been shown to stably transform Aprt" cells to the 
wild-type (Aprt+) phenotype (Tackney et a l ., 1984). Both 
types of recombinant virus were produced by flanking the 
foreign genes in plasmid vectors with HSV-1 sequences, 
and selecting for insertion into the non-essential locus 
of the virus by homologous recombination, following 
transfection of plasmid and viral DNA into animal cells.
Stow et a l . (1986) have described a helper-dependent viral
vector system. In the presence of helper virus, plasmids 
which contain an a sequence and ORIg can be propagated as 
tandemly reiterated genomes in virus stocks. Regulated 
expression of a foreign vector gene through the use of 
different viral promoters and helper viruses has been 
demonstrated (Stow et a l ., 1986).
However, the presence of helper virus or the use of a 
replication competent vector in current systems limits their 
potential applications, thus failing to fully exploit HSV-1 
as a gene-transducing vehicle. The existence of cell lines 
which express HSV-1 gene products required in trans for 
virus replication (Davidson and Stow, 1985; DeLuca et a l .,
1985) should allow the development of helper-free, defective 
HSV-1 vector systems. This would provide a useful 
complement to the amphotropic retroviral systems whose 
development is now quite well advanced (Miller et a l ., 1985; 
Hock and Miller, 1986; Yu et al., 1986).
2]
6 . S o q  u e n c  e;;_U t i j  i za  t i o r i
By the criteria of animal virology, the HSV genome is a 
large and complex genetic system. Many of its estimated 
70-plus genes are uncharacterized in structure and function, 
while others are recognised only through the existence of ts 
mutants or by the mapping of protein species originating 
from particular regions of genome. Large scale DNA sequence 
analysis has greatly increased our knowledge of HSV-1. An 
almost complete transcript map of the genome now exists 
(Wagner, 1985; McGeoch et a l ., 1985, 1986; Rixon and
McGeoch, 1984, 1985; Perry et a l ., 1986). The ability to
raise antisera against synthetic oligopeptides, predicted to 
occur in HSV-encoded proteins from sequence data, has 
provided a powerful method of allowing the correlation of 
gene and product (Palfreyman et a l ., 1984; Frame et a l ., 
1985, 1986; Johnson et a l ., 1986). One method of
identifying potential gene functions is to compare by 
computer analysis the predicted protein sequence of an 
unknown gene with the protein sequences available in data 
banks. This approach has led to the tentative 
identification of a protein kinase encoded by US3 of HSV-1 
(Figure 3; McGeoch and Davison, 1986). It is obviously 
necessary to identify and characterize all HSV genes for a 
full understanding of the virus.
The economic utilization of the HSV genome in terms of 
the density of protein coding sequences (gene compression), 
is intermediate between that found in smaller DNA viruses 
and in the eukaryotic genome, as judged in particular from 
the RNA mapping and DNA sequence data corresponding to Ug 
(McGeoch et a l ., 1985; Rixon and McGeoch, 1985). There are 
twelve genes in Ug (USl-12), expressed as thirteen mRNAs 
(Rixon and McGeoch, 1985; see Figure 3). In common with 
other studied areas of the genome, many of the mRNAs in the 
Ug sequence are overlapping (Hall et a l ., 1982; Costa ejt 
al., 1983). Nested families with unique 5' ends and common
3' ends are the most frequent arrangement of overlap (Figure 
3), although USIO and USll are the only HSV genes in Ug 
whose products are actually encoded by overlapping reading 
frames (Rixon and McGeoch, 1984).
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Figure 3 . Transcript map of the short unique region
of the HSV-1 genome
The Ug region contains 12 genes (numbered 1 to 12 from 
left to right) which are expressed as 13 mRNAs (McGeoch 
et a l ., 1985; Rixon and McGeoch, 1985). The probable 
polypeptide coding (boxes) and non-coding (single lines) 
portions of mRNAs are indicated, and transcription is in 
the direction of the arrows. Hatched boxes indicate 
membrane associated glycoproteins which have been 
predicted from the sequence data, and confirmed where 
designated. The coding region of US3 shows homology to 
the protein kinase family of eukaryotes and retroviruses 
(McGeoch and Davison, 1986). Identified proteins have 
been referred to in the legend to Figure 1.
Note that USll is the internal member of a family of 
three, 3' co-terminal genes. USll transcription begins 
in the coding rgion of IE gene 5 (US12), and the 
promoter for USIO (an early gene) lies in the coding 
portion of USll.
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If the standard Ug sequence is taken as 12979bp (the 
exact size is variable due to the varying copy number of 
short, tandemly reiterated elements - Rixon et a l ., 1984; 
McGeoch et a l ., 1985), then 79% of Ug is occupied by open 
reading frames specifying polypeptides, and a further 16% 
appears as untranslated 3' and 5' mRNA (Rixon and McGeoch,
1985). After allowing for transcription initiation and 
termination signals 5' and 3' of transcription units, only a 
few hundred bp of Ug is without an obvious function, 
illustrating the compact sequence utlilization of the HSV 
genome.
Splicing of HSV mRNAs is rare, in contrast to 
adenoviruses, papovaviruses, and some other herpes viruses 
including CMV and EBV. For these other viruses splicing 
allows the generation of individual mRNAs from overlapping 
gene families which have common 5' and 3' termini, thereby 
providing economic use of template DNA. Three of the five 
HSV-1 immediate-early (IE) mRNAs are spliced. However the 
purpose of this splicing does not seem to be related to gene 
compression since the IE gene introns do not lie within 
overlapping genes. HSV-1 IE mRNAs 4 and 5 have a single 
splice within their common 5' untranslated regions located 
within TRg/iRg (Watson et a l ., 1981; Rixon and Clements, 
1982). IE gene 1 contains two introns and three protein 
coding exons (Perry et al ., 1986). Interestingly, the 5' 
proximal intron of IE gene 1 contains three copies of a 
tandemly reiterated 54bp repeat sequence (Perry et a l .,
1986), and the IE gene 4/5 intron is composed of tandemly 
reiterated copies of a short 22bp repeat sequence (Murchie 
and McGeoch, 1982), but any significance or connection 
between reiterated sequences and splicing is unknown. 
Splicing has also been reported in two late HSV genes (Frink 
et a l ., 1983; Costa et a l ., 1985a).
The base composition of some areas of the HSV-1 genome 
is of exceedingly high G+C content. Although the estimated 
G+C content of the genome is 67% overall (Kieff et a l .,
1971), the protein coding sequences of IE genes 3 and 1 are 
81.5% and 75.4% respectively (McGeoch et a l ., 1986; Perry
et a l ., 1986). This extreme base composition is achieved
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partly by encoding high levels of amino acids witli G+C ricli 
codons, and partly by a heavy bias towards G+C in the third 
codon position. The codon set available at this base 
composition is therefore sufficiently biased that 
restrictions on the possible amino acid composition must 
exist, and this has probably come about despite, rather than 
through demands of protein functionality (McGeoch et a l ., 
1986; Perry et a l ., 1986). By comparison, the VZV 
homologue of IE gene 3 has a G+C content of 64% (Davison and 
Scott, 1985). McGeoch et a l . (1986) suggest that the
sequence of IE gene 3 must be near the attainable limit for 
extreme G+C content in protein coding DNA, although the 
nature of the evolutionary forces responsible for this 
effect are totally unknown.
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S E C T I O N  C : R N A  P O L Y M E R A S E S  A N D  m R N A  P R O C E S S I N G
1 . E u k a r y o t i c  R N A  P o l y m e r a s e s
In contrast to the DNA of bacteria, mitochondria and 
chloroplasts, which is transcribed by a single cognate 
DNA-dependent RNA polymerase, different classes of 
eukaryotic genes are transcribed by one of three RNA 
polymerase complexes. Each of these enzymes,
distinguishable by their differing sensitivity to CX-amanitin 
toxin, consists of 10-15 subunits, some of which may be 
common to two or more complexes (Paule, 1981). RNA 
polymerase (pol) I transcribes ribosomal RNA (rRNA) genes, 
and is insensitive to (X-amani t in. RNA pol II transcribes 
polypeptide coding genes into mRNA, and is sensitive to low 
levels of #-amanitin (less than lug/ml). RNA pol III 
transcribes 5S rRNA and tRNA genes, and requires higher 
levels of toxin (lO-lOOug/ml) than pol II for inhibition of 
activity. The control of RNA pol I and pol III 
transcription is briefly described in this section, followed 
by a discussion of RNA pol II transcript processing. The 
control of RNA pol II transcription initiation is discussed 
in Section D.
a . RNA pol I transcription
The rRNA genes, repeated 100-5000 times per haploid 
genome, are very actively transcribed in growing cells in 
order to provide new ribosomes to support protein synthesis 
in daughter cells. Precursor rRNA (processed to yield 188, 
288 and 5.88 rRNA) is the sole product of synthesis by RNA 
pol I. The rRNA genes are organised in the form of tandem 
repeats, separated by non-transcribed spacer (NT8 ) sequences 
(Long and Dawid, 1980). 8ynthesis and processing of 
pre-rRNA occurs in the nucleolus during interphase (Roeder 
and Rutter, 1970).
8tudies of cloned rDNA sequences required to direct 
transcription in vitro (Grummt, 1982; Learned et a l ., 1985) 
and in vivo (Moss, 1982; 8male and Tjian, 1985) have 
identified a bipartite promoter lying mainly 5' to the rDNA 
transcribed region. A detailed analysis of this region by
' J j i i k t T  B C c i i i n i n y '  mut  c i y c n e s  i s ( w l i i c h  p r o d u c e s  a s c r i e s  o f  
clustered point mutations) localised a 'core' element at -45 
to +18, with respect to the transcription initiation site at 
+ 1 , and an 'upstream' region between -157 to -106 (Haltiner 
et al., 1986). Mutations within the core element reduced 
transcription by up to 100-fold, compared to a 3 to 5-fold 
effect in the upstream region (Haltiner et a l ., 1986). It 
has recently been recognised that sequences further upstream 
from the bipartite pol I promoter, in the NTS region of 
Xenopus (Moss, 1983; Labhart and Roeder, 1985), rat 
(Cassidy et a l ., 1986) and probably of human rRNA genes 
(Haltiner et a l ., 1986), are responsible for a stimulatory 
transcriptional effect, independent of orientation and 
distance. This effect appears to be due to pol I specific 
enhancer elements contained in the repeats of the NTS 
(Labhart and Roeder, 1984). The pol I enhancer function 
cannot be recreated using a pol II enhancer (Smale and 
Tjian, 1985; Lopa-ta et a l ., 1986). In short-term 
transfection experiments using a rRNA promoter linked to 
either the HSV gene (Smale and Tjian, 1985) or the 
bacterial CAT gene (Lopa-ta et a l ., 1986), pol I initiated 
transcripts were not capped, polyadenylated or translated, 
(although some transcripts initiated at heterogenous start 
sites, presumably by pol II, were processed as mRNA). These 
results suggest that mRNA production by processing is 
specific to pol II initiated transcripts.
Two fractions ('C' and 'D ') from cell extracts contain 
pol I transcription factors which are essential in in vitro 
assays (Mishimi et a l ., 1982; Miesfeld and Arnheim, 1984). 
Fraction C contains mainly polymerase I, while fraction D 
contains a species-specific transcription factor(s) that 
probably recognises the (poorly conserved) core element 
(SolIner-Webb and Tower, 1986). The highly purified 'SLl' 
fraction of Learned et a l . (1985), which is functionally
equivalent to fraction D, appears not to bind directly to 
DNA. Sollner-Webb and Tower (1986) suggest that the species 
specificity of the pol I transcription apparatus may be 
because recognition of only a single promoter has put fewer 
constraints on divergent evolution than for pol II or III.
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b . RNA po] 11 I t r ansc r i pt i on
Class III genes are transcribed by pol 111, and 
include, 5S RNA, tRNA, and adenovirus VA-RNA genes (Heintz 
and Roeder, 1982). A hallmark of class III genes is that 
their promoters are intragenic. Sakonju et a l . (1980)
localised the Xenopus laevis 58 promoter to the region +50 
to +83, relative the 5' transcription start site. The 
bipartite tRNA promoter lies between +8 to +19, and +52 to 
+62 (Hofstetter et a l ., 1981; Sharp et a l ., 1981). The 
adenovirus VAl gene promoter lies between +9 and +72, and is 
possibly modulated by 5' flanking sequences (Fowlkes and 
Shenk, 1980).
Accurate pol III transcription of 5S gene template in 
vitro requires either the template to be isolated as 
chromatin (Parker and Roeder, 1977), or the presence of a 
38,600 mol.wt. 5S gene-specific transcription factor, TFIIIA 
(Engelke et a l ., 1980). Purified TFIIIA binds the 
intragenic 5S promoter region (Sakonju and Brown, 1982), and 
is able to locally unwind DNA (Hanas et a l ., 1984). Since
TFIIIA also binds 5S RNA (Pelham and Brown, 1980), it has 
the ability to autoregulate 5S gene transcription. TFIIIB 
and TFIIIC are two further fractions which contain general 
factors required for the transcription of all class III 
genes. In 5S gene transcription, TFIIIB and C form a stable 
complex with TFIIIA-bound 5S DNA, allowing multiple rounds 
of polIII transcription in vitro (Bieker et al., 1985).
2. Eukaryotic mRNA Processing: Initiation
Heterogeneous starts are characteristic of the 5' 
termini of many pol II catalysed transcripts, both viral and 
cellular. Examples of microheterogeneity include the early 
transcripts of SV40 (Gidoni et a l ., 1981), early and late 
transcripts of HSV-1 (Everett, 1983; Johnson et a l ., 1986), 
and chicken ovalbumin transcripts (Malek et a l ., 1981). 
Extended 5' heterogeneity of starts, associated with the 
absence of a TATA-box signal (Breathnach and Chambon, 1981), 
has been reported for the SV40 late gene (Gidoni et a l ., 
1981), chicken lysozyme gene (Grez et a l ., 1981) and the
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huniaii h yjK) X a 111 h i ne }^hos| >lior i bosy 1 t r ans f e r a se (HPRT) gene 
(Patel, P. et a l ., 1980), amongst others. Transcripts whicti 
have been initiated by RNA pol II are 'capped' at the 
initiator nucleotide (Gidoni et a l ., 1981; Malek et a l ., 
1981), rather than at endonucleolytic cleavage points of 
transcripts initiated further upstream. The addition of a 
cap structure, m ”^G ( 5 ' ) ppp ( 5 ‘ ) N , protects mRNA at its 5' 
terminus against attack by phosphatases and nucleases, and 
promotes initiation of translation (Shatkin, 1976). It has 
recently been shown in some in vitro systems that capped 
pre-mRNA is a better substrate than non-capped for RNA 
splicing (Konarska et a l ., 1984; Krainer et a l ., 1984) and 
3'-end processing reactions (Moore and Sharp, 1985; Hart e_^  
al., 1985). The addition of an exogenous cap analogue in
vitro inhibits these reactions. The mRNAs of HSV have also 
been shown to be capped (Bartkoski and Roizman, 1976; Moss 
et a l ., 1977). The control of pol II transcription 
initiation is discussed in Section D.
3. Termination
a . Gene regulation through termination of transcription 
and differential polyadenylation 
Although one of the main control points regulating 
eukaryotic gene expression is at the level of initiation of 
transcription, choice of termination site, 3' cleavage site 
(and/or splice sites) and correct 3' end processing offer 
additional levels of control. Inefficient termination leads 
to reduced translation efficiency, independent of the 
frequency of RNA initiation (McLauchlan et a l ., 1985). A 
secondary consequence of inefficient termination may be 
transcriptional interference. Proudfoot (1986) showed that 
the presence of a mouse 3 -globin gene 'terminator' located 
between two tandemly duplicated CX-globin genes increased 
transcription of the downstream promoter by 3-fold in a 
transient assay, and by 5 to 20-fold in biochemically 
transformed cells.
Tissue-specific regulation by differential selection of
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t w o  JK31 y a d e i i y  1 a t  i  Oi l  s i t e s ,  a n d  a l t e r n a t i v e  s p l i c i n g ,  e n a b l e s  
expression of unique C-terminal portions of calcitonin and 
calcitonin gene-related peptide (C&RP). The calcitonin and 
C&RP mRNAs share a common 5' terminus and are expressed in 
thyroid and brain tissue respectively (Rosenfeld et a l .,
1983; Edbrooke et a l ., 1985). The adenovirus major late 
transcription unit (LI through L5) offers a classic example 
of developmental regulation by differential selection of 
polyadenylation sites (Jones, 1986). Transcription 
termination early in infection precludes expression of L4 
and L5. Later in infection transeiption terminates distal 
to L5, enabling expression of L4 and L5 polypeptides, 
although the mechanism for this control is not understood 
(Impériale and Nevins, 1986).
HSV encodes a number of transcripts with shared S' 
termini and different 3' ends (Anderson et a l ., 1981;
Wagner, 1985). However, since these 5' colinear RNA species 
encode the same polypeptides, the purpose of this apparent 
redundancy remains obscure, although the longer transcripts 
may arise simply through inefficient termination (Wagner,
1985).
b . Mechanism of transcription termination and 
polyadenylat ion 
The 3' termini of the majority of eukaryotic mRNAs are 
formed by endonucleolytic cleavage of an mRNA precursor and 
the addition of 100 to 250 adenylate residues [poly(A)] to 
the newly formed 3' end (Nevins and Darnell, 1978). The 
exact sequences in the precursor molecule required for these 
processes have not been completely defined, but they include 
the poly(A) signal, AAUAAA, located 10 to 30 nucleotides 5' 
to the poly(A) site (Proudfoot and Brownlee, 1976), and a 
downstream element (GT-box) (McLauchlan et a l ., 1985). The 
non-polyadenylated histone mRNAs have a different conserved 
sequence, which is essential for processing, near their 3' 
ends (Birchmeier et a l ., 1983).
Deletions or single base changes in the AAUAAA signal 
can prevent RNA cleavage i_n vivo (Montell et a l ., 1983) and 
in vitro (using nuclear, rather than whole-cellular
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extracts) (Moore and Sharp, 19B5; Zarkower et a ] ., 1986).
Morever, polyadenlat ion is dependent on an intact AAUAAA 
sequence, even when pre-mRNA with 3' termini at the normal 
polyadenylation site is used as a substrate, suggesting that 
polyadenylation might require recognition of AAUAAA by the 
cleavage complex (Zarkower et a l ., 1986).
Sequences greater than 10 nucleotides downstream from 
the poly(A) site are required for efficient 3' termini 
production in vivo (Gil and Proudfoot, 1984; Cole and 
Stacy, 1985; McLauchlan et a l ., 1985), and in vitro (Moore 
and Sharp, 1985; Hart et a l ., 1985). The consensus 
‘GT-box’ sequence YGTYGTTYY (Y = pyrimidine) is located 
approximately 30 nucleotides downstream from the poly(A) 
signal of many, but not all, viral and cellular genes 
(McLauchlan et a l ., 1985). Deletions which eliminate the 
HSV-2 IE gene 3 GT-box reduce gene expression to 1-4% of 
wild-type in a transient assay (McLauchlan et a l ., 1985). 
However, since the GT-box is required for optimal processing 
of synthetic pre-mRNA in vitro (Hart et a l ., 1985), it would 
seem that this sequence is functional in the RNA (for 
cleavage/polyadenylation) rather than the DNA (for 
termination). The structural features of DNA involved in 
termination of pol II transcription, and the nature of this 
event, remain to be established. Also, the sequences 
adjacent to AAUAAA, and downstream or in place of YGTGTTYY 
which play a role in 3' processing events require further 
invest igation.
Recent evidence has indicated that (i) small 
ribonucleoproteins (snRNPs) are involved in the 3' 
processing reaction, and (ii) this reaction takes place 
after a time lag in vitro. This suggests an analogy to the 
splicing reaction which also shares these two parameters 
(Moore and Sharp, 1984; see following section). Anti-Sm 
antibodies from patients with autoimmune diseases recognise 
snRNPs (Lerner and Steitz, 1979), and inhibit
polyadenylation in vitro (Moore and Sharp, 1984). Fragments 
containing AAUAAA from the 3' terminal portions of pre-mRNAs 
can be protected from RNase T1 digestion and 
immunoprecipated by Sm antibodies (Hashimoto and Steitz,
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1 986), s u g g e s t i n g  t licit s n R N P s  mu y b e  c o m p o n e n t s  of a 
'p o l y a d e n y 1 a t i o n  c o m p l e x ' .  H o w e v e r ,  p u r i f i e d  S m  s n R N P s  (but 
t h i s  d o e s  n o t i n c l u d e  all  s n R N A  s p e c i e s )  a n d  R N A  s u b s t r a t e
were not found to associate by themselves; the nuclear
.he
extract capable of polyadenylation needed to/present for
complex formation (Hashimoto and Steitz, 1986). The
individual U RNAs (present in the snRNPs) which are required
for 3' processing have yet to be determined. Berget (1984)
proposed that U4 RNA which has a sequence complementary to
five nucleotides of the AAUAAA signal would be a likely
te
candidate, although any specific binding has yet to/shown.
In the case of sea urchin histone H3 mRNA, a specific 
involvement of U7 RNA for 3' end formation is required, and 
the U7 RNA has sequence complementarity to essential 
conserved sequences near the 3' end of histone pre-mRNA 
(Strub et al., 1984).
4. Splicing
Most RNA pol II transcribed genes of higher eukaryotes 
contain introns, which, in the primary transcript, separate 
the sequences found in the mature mRNA (exons). Whatever 
the origin or possible function of introns, their removal 
from primary transcripts by RNA splicing is an essential 
step in pre-mRNA maturation (reviewed by Breathnach and 
Chambon, 1981; Sharp, 1985; Gilbert et a l ., 1986). The 
human HPRT gene, for example, is 42kb in length and split 
into nine exons; the cDNA corresponding to the mature 
transcript is 1.6kb (Kim et a l ., 1986; Patel,P et a l .,
1986). As mentioned previously, splicing is not a common 
event in HSV (Watson et a l ., 1981; Wagner, 1985; Perry e_^  
al., 1986). However, it can play an important part in gene 
regulation, for example, by producing selective expression 
of late genes in the adenovirus major late transcription 
unit (Jones, 1986).
3]
The consensus secoue non s deduced from a study of many 
splice junctions (Mount, 1982), are shown as follows. The 
most important and highly conserved dinucleotides 
(underlined) flank the intron boundaries (colons):
5'-A/cAG:GTA/GAGT Yf,NCAG :G^/rp-3 '
Splice donor Splice acceptor
site site
The recent development of in vitro cell-free systems 
which faithfully splice mRNA precursors has greatly improved 
our understanding of the splicing reaction (for review, see 
Padgett et a l ., 1985). For use as a substrate in these 
reactions, unspliced pre-mRNA is often produced from an 
appropriate plasmid DNA template using either (i) a HeLa 
whole-cell extract (Manley et a l ., 1980) under conditions 
which inhibit splicing, or (ii) the bacteriophage SP6 RNA 
polymerase transcription system (Melton, 1984). The fate of 
pre-mRNA during the splicing reaction may be determined 
directly, if it is radiolabeled during synthesis, or 
indirectly by SI mapping and primer extension analysis.
From in vitro studies, it has been established that 
splicing occurs by a two step process (see Figure 4). 
Firstly, accompanying cleavage at the (5') splice donor 
site, the terminal G residue of the intron is linked to an 
internal A residue (at the intron 'branch site') through a 
2'-5' phoshodiester bond (Ruskin et a l ., 1984). Secondly, 
cleavage at the splice acceptor site removes the intron RNA 
as a lariat, and the flanking exons are ligated (Ruskin 
al. , 1984). Mutations in the mammalian branch site 
(consensus sequence - YNYTRAY) are usually not critical 
since they allow activation of cryptic branch sites (Ruskin 
et al ., 1984; Frendeway and Keller, 1985).
Precursor RNA is organized into a specific 50-60S 
complex (spliceosome) during the splicing process in vitro 
(Frendeway and Keller, 1985; Grabowski et a l ., 1985). 
Formation of the spliceosome requires ATP and takes place 
during the 15-30min lag period of the splicing reaction 
(Kramer et a l ., 1984; Frendeway and Keller, 1985;
Grabowski et al., 1985). The reaction requires snRNPs, of
OH 2' 
/
ApU-
L2
OH
+ (L i)
®OH^' ^ ^
GdG
(L2>
3'
The reaction occurs in the 'SPLICEOSOME',  which requires
ATP for formation, and includes U1,U2,U5 and U 4 /6  snRNPs
Figure 4 . Pathway of the pre-mRNA splicing reaction
The precursor RNA consists of 5' and 3' exons (LI and 
L2, double lines), intervened by an intron (single 
line). The dinucleotides which represent part of the 5 ‘ 
and S' consensus splice sites are cleaved at the 
indicated phosphodiester bonds. The central sequence of 
the branch site is A-U. The first covalent modification 
of the RNA is the formation of a phosphodiester bond 
between a 2 ' position in the ribose moiety of adenosine 
and the 5' phosphate at the 5' splice site. This first 
step gives rise to two products, a lariat RNA, which 
consists of the branched intron and L2, and a free Ll 
exon. In the second step, the intron is released in 
lariat form, and the two exons are spliced together.
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wliicli U 1 and U 2 snRNF were shown by Grabowski et a l . (19B5) 
to be associated with the 5Ü-60S spliceosome. Site-directed 
hydrolysis of U 1 or U 2 snRNA with RNaseH and synthetic 
complementary deoxyoligonucleotides abolishes splicing 
(Kramer et a l ., 1984; Black et a l ., 1985). On the basis of 
sequence complementarity and from specific 
immunoprécipitation of RNase T1 protected fragments, it 
seems likely that U1 and U2 snRNPs associate with the 5' 
splice site and the intron branch site of pre-mRNA 
respectively (Black et a l ., 1985). The 3' splice site is 
possibly recognised by U5 snRNP (Chabot et a l ., 1985). 
Grabowski and Sharp (1986) have recently isolated components 
of the spliceosome by affinity chromatography of 
biotin-labeled pre-mRNA to streptavidin-agarose. With the 
presence of heparin in the glycerol gradient to displace 
contaminants, a 35S spliceosome was isolated. The RNA 
species in the 35S spliceosome were labeled with [^^PjpCp 
and T4 RNA ligase, and identified by partial RNase T1 
digestion and comparison with known snRNAs. The results of 
this approach indicated that U2, U5 and U4/U6 (which are 
present together in a single RNP particle) snRNAs were 
present at appoximately one copy per 358 complex, in 
addition to an unknown species, 'X', and s prisingly, U1 
snRNA was absent. The absence of Ul snRNP in the 358 
spliceosome may be due to either unstable binding or a 
transient role in the splicing reaction. Grabowski and 
Sharp (1986) suggest that the involvement of multiple snRNPs 
in the splicing event may allow control and specificity, in 
addition to the potential catalytic role of the U snRNAs in 
the cleavage and ligation reactions.
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SECTION D ; CONTROL OF RNA POL II TRANSCRIPTION
INITIATION
The accumulation of data on the control of eukaryotic 
gene expression has been rapidly increasing in recent years. 
A general picture of the nature of transcriptional controls 
has emerged although the actual mechanisms involved remain 
poorly understood.
Two interdependent factors govern the initiation of 
eukaryotic RNA polymerase II mediated transcription at a 
primary level. The first is the presence, repetition, and 
positioning of a variety of cis-acting DNA sequence signals 
generally located 5' to the transcription initiation point. 
The second involves the transcription factors which can 
recognise the cis-acting signals, and thereby have the 
potential to modulate transcription initiation. The 
activity of DNA sequence-specific transcription factors may 
be modulated in cis by other sequence-specific factors, or 
in trans by regulatory proteins that might not bind directly 
to the promoter DNA that they regulate.
At a secondary level, the ability of transcription 
factors to interact with cis-acting signals, and of genes to 
respond to this interaction, may be dependent on the 
physical status of the template DNA. Although less well 
understood, this may be affected by DNA méthylation, 
chromatin organization, and particularly for some viral 
genes, DNA replication. It is unclear how the physical 
status of cellular DNA in particular is regulated, although 
this is probably a very important mechanism in controlling 
developmental and cell-type specific gene expression.
Some of the better characterized examples of cis-acting 
DNA sequences and transcription factors are described in 
this section. How these sequences and factors might 
interact to promote transcription is also discussed. An 
important aspect of gene expression, particularly relevant 
to viral systems, is trans-activation. Trans-activation is 
discussed in this section using adenovirus Ela and SV40 T 
antigen as examples. Although the study of HSV gene
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expression has made important contributions towards our 
overall understanding of eukaryotic transcriptional 
regulation and is mentioned in this section, it is 
considered in more detail in Section E.
1. Cis-acting Sequences
The individual DNA sequence elements which constitute 
promoter, enhancer and regulator regions may overlap. 
However, in general terms, a promoter usually occupies a 
region of about 100 nucleotides 5 '-flanking the 
transcription start site (+1) of a gene. It consists of a 
number of individual sequence elements and may exhibit 
'basal' or 'constitutive' activity, and respond to 
activation or repression in trans or in cis. Cis-activation 
mediated by an enhancer region, which may lie far-upstream 
(often -100 to -300) or even downstream from the RNA start 
site, is generally thought of as constitutive. In contrast, 
cis-activation mediated by regulator elements, which have 
been found to lie within promoter and enhancer regions, is 
inducible. However, since enhancers exhibit cell 
specificity, they must also be inducible to some extent. 
Trans-activation by regulatory proteins (see part 4) 
requires essentially the same promoter sequences needed for 
basal- or cis-activated expression. The constitutive and 
inducible transcription factors which interact with the 
examples of regulatory DNA sequence elements described below 
are considered in part 2 .
a . Promoter sequences
(i ) HSV-1 tk promoter
The identity and function of promoter and regulatory 
regions of eukaryotic genes have been studied by introducing 
mutations into cloned DNA in vitro, and then analysing the 
effects of the mutations on the expression of a cis-linked 
gene. The effects of deletion, 'linker-scanning' (clustered 
point), and specific base mutations in the HSV-1 promoter 
have been examined in detail in a number of assays. These 
include measuring RNA accumulation from a plasmid-borne ^
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promoter in microinjected frog oocytes (McKnight and 
Kingsbury, 1982; McKnight et a l ., 1984), transfected 
tissue-culture cells infected with HSV (Eisenberg et a l ., 
1985; El Kareh et a l ., 1985), and in vitro using infected 
or uninfected cell extracts (Jones et a l ., 1985). Oocytes 
provide a 'constitutive' transcription system for the ^  
gene since in these cells its promoter is active in the 
absence of virus-encoded trans-acting regulatory proteins 
which are normally required for efficient viral ^  gene 
expression during lytic infection (Preston, 1979a; McKnight 
and Kingsbury, 1982), and for expression of a plasmid-borne 
tk gene in transfected cells (Eisenberg et a l ., 1985) (see 
Section E(3)). The linker-scanning promoter mutants have 
also been introduced into the HSV genome and their activity 
assessed at the level of transcription, RNA accumulation, 
and by an indirect assay for t\ activity (Coen et a l .,
1986).
In all these assays, the same mutation-sensitive 
domains upstream of the RNA start site were revealed 
(although sequences between +4 to +16 were required for 
normal ^  promoter activity in the viral genome, but not in 
other assay systems), and have established the map of the 
promoter domains shown in Figure 5. There are at least four 
components, (i) a TATA box located proximal to the RNA 
start sites (at about -25); and in the "upstream" region -
(ii) an inverted GC hexanucleotide (5'-CCGCCC-3') (-103 and
-98), (iii) an inverted CCAAT homology (-86 to -82), and
(iv) a second GC hexanucleotide (5'-GGGCGG-3') (-55 and
-50) .
(i i) 3 -globin promoter
The functional importance of highly conserved regions 
in the DNA 5 '-flanking the transcription start site of a 
number of different mammalian (5-globin genes has been shown 
by in vitro mutagenesis studies (Grosveld et a l ., 1982; 
Dierks et a l ., 1983; Charnay et a l ., 1985). Myres et a l . 
(1986) studied the effects of over a 100 single 
point-mutations within the mouse B-globin promoter using a 
transient assay procedure. The ^-globin promoter
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Figure 5 . Structures of the SV4Q control region, and the
HSV-1 tk and mouse -globin promoters
a. SV40: The important features of the the SV40 control
region are as follows (from right to left): The large
box marked 'ORI' represents the SV40 origin of DNA 
replication. An AT-rich TATA-like element is 
represented by small box. The 2 Ibp repeats of the SV40 
early promoter are underlined by arrows and contain six 
GC-hexanucleotide motifs (boxes numbered 1 to 6). The 
two extended boxes represent the 72bp repeats which 
contain regulatory elements for enhancer activity and 
late promoter activity. The positions of the 
early-early (EE) and late-early (LE) RNA starts are 
indicated, as are the two major late RNA start sites. 
Higher affinities for the GC-hexanucleotides by the 
represented Spl protomer are indicated by thicker 
arrows. T antigen binds to the designated recognition 
sites in sequential order (I, II, III).
b. tk: The nucleotide sequence of the promoter is
given from -110 to beyond the first RNA cap site at
4-1 (McKnight, 1980). Hatched boxes represent Spl 
binding sites; the cross-hatched box represents a 
CTF/CBP binding site (arrows indicate the orientation 
of the consensus sequences). The dotted lines indicate 
the extent of DNAase I footprint protection (Graves et 
al., 1986; Jones et a l ., 1985). A TATA box binding 
factor is thought to bind to the indicated TATA box and 
overlap the mutation-sensitive cap site region (Coen et 
^ . ,  1986).
c. 0 -globin: Three mutation sensitive regions in the
mouse 0 -globin promoter were identified by saturation 
mutagenesis (Myers et a l ., 1986), which involved the 
isolation and analysis of individual point-mutat ions in 
nearly every nucleotide of the^-globin promoter. The 
numbers refer to the positions from the^globin RNA cap 
site (11 ) .
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substitutions were contained on plasmids with the SV40 
enhancer, in order to achieve expression in transfected HeLa 
cells. The identity of three mutation sensitive regions was 
confirmed, and their locations accurately delineated; (i) a 
CACCC box, located between -95 and -87, (ii) a CCAAT box, 
located between -77 and -72, and (iii) a TATA box located 
between -30 and -26 relative to the start site of 
transcription (Myers et a l ., 1986; see Figure 5). It could 
be argued, however, that the results from a HeLa cell 
transient assay may not reflect the normal in vivo situation 
since expression of the globin gene is being studied in the 
absence of tissue specificity.
Although it is difficult to study the effect of in 
vitro manipulations of cellular genes reintroduced into 
their natural environment, such studies have enabled 
problems of developmental and tissue-specific gene 
regulation to be addressed (Palmiter and Brinster, 1985). 
Transgenic mice and proerythroblast mouse erythroleukaemia 
(MEL) cells (which can be induced to differentiate), provide 
systems in which an introduced globin gene may be 
specifically expressed in differentiated erythroid cells.
In studies using MEL cells stably transformed with cloned 
P-globin DNA (Wright et a l ., 1984; Charnay et a l ., 1985) 
and germ-line transmitted human (3-globin genes in transgenic 
mice (Townes et a l ., 1985), 5' deletions of the 3-globin 
promoter to -48 still enabled relatively efficient gene 
expression. This contrasts the findings from transient 
assay experiments where sequences to -95 were important for 
efficient expression (Myres et a l ., 1986). However, the 
validity of the transient assay is supported by the 
existence of a naturally occuring ^-thalassaemia mutation in 
the conserved element of the 3-globin promoter lying at -90 
(Treisman et a l ., 1983a).
The apparently less stringent sequence requirements in 
erythroid cells probably arise for a number of reasons. 
Firstly, quantitative comparisons of gene expression between 
transgenic animals are difficult due to the limited sample 
size. Secondly, in both transgenic animals and 
biochemically transformed cells, it is not possible to
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control the copy number and integration sites of the 
introduced DNA. Thirdly, sequences which lie outside the 
globin promoter may be required for the induction of 
erythroid-specific expression, and these may be able to 
compensate for some promoter mutations in erythroid but not 
HeLa cells. Indeed, the chicken adult (B-globin gene is 
reported to have a tissue-specific enhancer lying 350-650bp 
3' to its polyadenylation site (Choi et a l ., 1986; Hesse e^ 
al., 1986). This 300bp enhancer region is required for the 
specific temporal induction of an exogenous chicken (^-globin 
gene transfected into a differentiation-inducible avian 
erythroid cell line (Choi et a l ., 1986).
(iii) SV40 E promoter
The SV40 early (E) promoter is usually activated in cis 
by its 72bp repeat enhancer region (Banerji et a l ., 1981; 
Moreau et a l ., 1981; see below). Important features of the 
E promoter (see Figure 5) are a proximal TATA box, involved 
in designating the locations of the E mRNA start sites 
(Benoist and Chambon, 1981), and three direct 21bp repeats 
which abut the TATA box. Each 21bp repeat contains two 
copies of the GC hexanucleotide (5'-GGGCGG-3') which bind 
transcription factor Spl (Dynan and Tjian, 1983a,b). Not 
all six GC hexanucleotides are essential for overall E 
promoter activity, but have different roles in driving 
'early-early' (EE) and 'late-early' (LE) transcription 
(Fromm and Berg, 1982; Everett et a l ., 1983; Baty et a l ., 
1984; Vigneron et a l ., 1984). Early-mRNA initiation 
switches from EE to the upstream LE start sites at the onset 
of DNA replication (Ghosh and Lebowitz, 1981), or as a 
result of repression of the overlapping EE promoter (Wasylyk 
et a l ., 1983). The SV40 T antigen plays multiple roles in 
this switch, by repressing EE- and stimulating 
LE-transcription, in addition to its requirement for SV40 
DNA replication (Buchman et a l ., 1984). Like the HSV tk 
(McKnight et a l ., 1984) and gD (Everett, 1984b) promoters, 
inversion of the distal (21bp repeat) region upstream of the 
TATA box does not render the SV40 E promoter non-functional 
(Everett, et al., 1983).
38
A requirement for an interaction between DNA-bound 
proteins at the SV40 TATA box, upstream early promoter 
region and enhancer, is suggested by the experiments of 
Takahashi et a l . (1986). By altering the spacing between 
the various regulatory regions it was shown that the exact 
distances between the TATA box, the 21bp repeats, and the 
enhancer region influence early promoter activity.
Moreover, by inserting either odd or even multiples of a 
half turn of the DNA helix, a requirement for stereospecific 
alignments between proteins which recognise different 
regulatory elements was indicated (Takahashi et a l ., 1986).
b. Enhancers
Enhancers, which were first discovered in SV40 (Banerji 
et a l ., 1981; Moreau et a l ., 1981), are viral or cellular 
transcriptional activation sequences whose operation is not 
critically dependent on orientation or distance (5' or 3') 
from a cis-linked promoter. They are composed of a variable 
number of individual DNA sequence modules, and may exhibit 
cell-specificity of action (for reviews, see Serfling et 
a l ., 1985; Voss et a l ., 1986).
The prototype SV40 enhancer shows less apparent 
cell-specificity than many other viral and cellular 
enhancers (Laimins et a l ., 1982; Herbomel et a l ., 1984;
Voss et a l ., 1986). A systematic mutagenesis (Zenke et a l .,
1986) and study of mutant revertants (Herr and Clarke, 1986) 
of the SV40 enhancer has revealed that it extends beyond the 
72bp repeat element and is composed of three domains. A, B, 
and C, which by themselves exhibit a very low 
transcriptional acivity. The synergistic activity of 
domains A and B is not critically dependent on their 
relative orientation to each other, or the exact distance 
between them (Zenke et a l ., 1986). Enhancer activity can be 
recreated by the duplication of either domain A or B alone 
(Zenke et a l ., 1986) or by partial duplications of the whole 
enhancer region containing mutations in all three domains 
(Herr and Clarke, 1986). Each domain is composed of several 
sequence motifs whose integrity is required for full 
enhancer activity in HeLa cells (Zenke et a l ., 1986). No
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individual point mutation decreases enhancer activity 
>8-fold, which still represents about a 50-fold enhancement 
relative to an enhancerless promoter (Zenke et a l ., 1986). 
The enhancer 'core' sequence, 5 '-GTGG^/<p^/«rA/rpG-3 ' (Weiher 
et a l ., 1983), is repeated twice in domain B, but 
nucleotides adjoining this sequence are also important for 
full activity (Zenke et a l ., 1986). The key feature of 
domain A are the directly repeated 'Sph-motifs', 
5'-AAGT/^ATGCA-3', the juxtaposition of which in the SV40 
enhancer generates the 'octameric' sequence (5'-ATGCAAAG-3') 
of the immunoglobulin heavy chain (IgH) enhancer (Banerji e;t 
a l ., 1983; Neuberger, 1983; Zenke et a l ., 1986). Domain A 
also contains the 'P-motif', 5'-TCAATTAGCA-3', which is 
found in the opposite strand of the polyoma virus enhancer 
domain A (Herbomel et a l ., 1984). In fact, the individual 
motifs of the SV40 enhancer all occur in various assortments 
in other viral and cellular enhancers, and have been shown 
to bind cellular proteins (Wildeman et a l ., 1986; Davidson 
et a l ., 1986). That the IgH octameric motif of the SV40 
enhancer is recognised in lymphoid cell extracts, whereas 
the Sph motifs which it overlaps are bound by protein in 
HeLa cell extracts, indicates how the remarkably wide 
cell-range of SV40 enhancer activity might be achieved 
(Davidson et a l ., 1986).
The polyoma virus enhancer contains two distinct 
cell-specific activities, which correspond to two 
non-overlapping domains within the enhancer region (Herbomel 
et a l ., 1984). Domain A is preferentially active in murine 
fibroblasts, whereas domain B is equally active in 
fibroblasts and mouse embryonal carcinoma cells (Herbomel e_t 
, 1984).
The first cellular enhancer to be discovered was in an 
intron of the IgH gene (Banerji et a l ., 1983). This 
demonstrated the potential of enhancers to operate 
downstream of the RNA start site in a natural situation.
The IgH enhancer, like many other more recently identified 
cellular enhancers, exhibits strict tissue specificity 
(reviewed by Voss et a l . 1986).
It now seems unlikely that enhancers function at the
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sequence level by providing a bidirectional entry site for 
RNA polymerase (Moreau et a l ., 1981), or inducing 
superhelical strain, e.g. by flipping to Z DNA (Nordheim and 
Rich, 1983). In an experiment designed to separate 
topologically the SV40 enhancer from a linked 3-globin gene, 
it was shown that expression of the linked gene was still 
enhancer dependent, and that 'twisting' of the DNA at the 
enhancer could not be solely responsible for gene activation 
(Plon and Wang, 1986). It seems that the action of 
enhancers is dependent on their recognition by cellular 
transcription factors [see part 2(iv)], which may function 
by interacting with promoter-bound transcription factors 
(see part 3), and at least in the case of cellular 
enhancers, be involved in organizing the formation of 
'active chromatin' (Voss et a l ., 1986). However, enhancers 
are sometimes associated with a nucleosome-free chromatin 
structure, which is also hypersensitive to nucleases 
(Jongstra et a l ., 1984).
c . Regulator elements
Regulator elements are considered here as specific DNA 
sequence motifs that confer inducibility to a given gene, 
which is mediated by DNA-binding regulatory proteins in 
response to certain stimuli. Examples of regulator elements 
include the glucocorticoid response element (GRE) (Geisse e_t 
a l ., 1982; Chandler et a l ., 1983; Payvar et a l ., 1983), 
the metal regulatory element (MRE) (Brinster et a l ., 1982; 
Karin et a l ., 1984b), and the heat shock element (HSE)
(Bienz and Pelham, 1982). The TAATGARAT motif of HSV IE 
genes, which is the target sequence for induction by the HSV 
virion component, also bears the hallmarks of a regulator 
element (see Section E(l)).
Transcription of glucocorticoid hormone-responsive 
genes is stimulated by the sequence-specific binding of the 
glucocorticoid receptor protein to its cognate GRE. It was 
first shown that receptor binding to a GRE within the long 
terminal repeat (LTR) of the mouse mammary tumour virus 
(MMTV) was involved in the stimulation of transcription in 
response to dexamethasone (Geisse et a l ., 1982; Chandler et
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al., 1983). Unlike MMTV, the Moloney murine sarcoma virus 
(MoMSV) LTR contains an enhancer that is constitutively 
active in murine L and NIH3T3 cells (Laimins et a l ., 1982), 
in addition to a physiologically distinct 
transcription-stimulatory activity which is hormone 
inducible. This second activity, which corresponds to a GRE 
presence within the MoMSV LTR enhancer region, can be 
separated at the sequence level from the originally 
identified enhancer activity (DeFranco and Yamamoto, 1986; 
Miksicek et a l ., 1986). This suggests a similarity in 
function between a GRE and 'constitutive' enhancer motifs.
Metallothionein genes (Karin, 1985) are induced by 
metal ions and glucocorticoid hormones. The response to 
metal ions is mediated by the well conserved MRE sequence, 
consensus 5'-CCTTTGCGCCCG-3', and an as yet unidentified 
"metal regulatory protein" (Searle et a l ., 1984; Karin ej^  
al., 1984b). The human metallothionein (hMT-II) gene 
contains one GRE copy (-237 to -268), and two MRE copies 
(-38 to -50, and -138 to -150) which can act singly or 
together (Karin et a l ., 1984b). Constitutive elements of 
most MT promoters appear to include a TATA box and two GC 
hexanucleotides (Serfling et a l ., 1985).
Karin et a l . (1984a) showed that hMT-II 5 '-flanking DNA
may confer heavy metal and hormone responsiveness when 
linked to the heterologous HSV-1 gene, even when placed
600 nucleotides upstream from the RNA start site.
Enhancer-like activity has also been shown for mouse MT 
5'-flanking DNA (-63 to -188), which has been integrated 
into the SV40 "enhancer trap" where it conferred metal 
regulation on the resulting virus (Weber et a l ., 1983;
Serf ling et a l ., 1985). Searle et a l . ( 1985) studied the
metal-induction response of the Uc linker-scanning mutants, 
after the insertion of one or more synthetic MREs at a 
variety of positions in the promoter. They found that 
two or more MREs were required to enable significant metal 
inducibility of the Uç gene. In contrast to the results of 
Karin et a l . (1984a), the synthetic MREs did not function 
efficiently at a distance from the gene (Searle et a l .,
1985). However, it is possible that sequences flanking a
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regulator element are important for an effect at a distance, 
or from a single copy. This is the situation in HSV where 
sequences flanking the TAATGARAT motif of IE genes, or the 
duplication of a synthetic oligonucleotide containing the 
TAATGARAT element, are important for response to the virion 
component (Gaffney et a l ., 1985; Bzik and Preston, 1986; 
see Section E(1)).
2. Transcription Factors
Given a map of the regulatory DNA sequences of a 
particular gene, it is possible to investigate how these 
sequences are recognised in the host cell. The 
identification of proteins which associate with known 
regulatory sequences is an important step towards 
understanding transcriptional control. Two main approaches 
have been used for this type of study. The first is based 
on the fractionation of cell extracts to purify (at least 
partially) transcription factors that can be detected by 
assay in vitro. The second is the detection of proteins 
bound to sequences of known functional importance by DNasel 
footprinting, méthylation protection experiments, or by gel 
mobiIty-shift assays (based on the retarded mobility of 
protein-bound DNA compared to unbound DNA migrating on 
non-denaturing polyacrylamide gel electrophoresis (Garner 
and Revzin, 1981)). One of the difficulties in detecting a 
protein that has specificity for a given DNA sequence in 
crude extracts is its affinity for other DNA sequences and 
the presence of other DNA binding proteins. The use of more 
rigorous fractionation procedures has helped to overcome 
this problem for some cellular transcription factors.
Significant progress in the investigation of promoter 
function has been made by the development of in vitro 
extracts that allowed accurate initiation of RNA pol II 
transcription from cloned DNA template (Weil et a l ., 1979; 
Manley et a l ., 1980). The reproduction of in vivo promoter 
specificity was initially a problem, as only a TATA-box was 
required for maximum (albeit poor) in vitro expression 
(Manley et a l ., 1980; Wasylyk et a l ., 1980). Crude 
fractionation of cell extracts improved transcription
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efficiency, and resolved several factors which appeared to 
be required for the (in vitro) transcription of all class II 
promoters (Matsui et a l ., 1980; Samuels et a l ., 1982).
The characterization of some transcription factors, 
such as the glucocorticoid receptor, is now quite advanced 
and has allowed the identification of functional domains.
In contrast, proteins that bind enhancer motifs have only 
recently been detected. An account of the characterizations 
of factors that recognise some of the previously identified 
important regulatory sequence motifs is given below.
(i) Spl
Dynan and Tjian (1983a) demonstrated that a partially 
purified factor isolated from HeLa cells (Spl) stimulated in 
vitro transcription of the SV40 early promoter but not the 
adenovirus (Ad) major late (ML) promoter. DNasel 
footprinting (Galas and Schmitz, 1978), and dimethyl 
sulphate méthylation protection studies on native and mutant 
versions of the SV40 early promoter have shown that Spl 
binds to one strand of the DNA duplex in the GC 
hexanucleotide sequence, 5 '-GGGCGG-3' (Dynan and Tjian, 
1983b). It is believed that single Spl protomers bind the 
closely spaced GC hexanucleotides of the SV40 21bp repeat 
region, which exhibits no discernible dyad symmetry (Dynan 
and Tjian, 1983b, 1985).
Many other regulatory regions besides the SV40 E 
promoter contain GC hexanucleotides which have been shown to 
bind Spl. These include the HSV-1 tk promoter (Jones e_^  
al., 1985), the promoters and far-upstream regions of HSV-1 
IE genes 3 and 4/5 (Jones and Tjian, 1985), the HIV LTR 
(Jones et a l ., 1986), the human MT promoter and the mouse 
dihydrofolate reductase promoter (reviewed by Kadonaga e^ 
a l ., 1986). Nucleotides adjacent to the 5 '-GGGCGG-3' motif 
appear to affect the affinity for Spl binding, and the 
sequence 5'-GGGAGG-3' functions as an Spl binding site in 
the HIV LTR (Kadonaga et a l ., 1986; Jones et a l ., 1986).
Since distal promoter elements can function in either 
orientation (Everett et a l ., 1983; McKnight et a l ., 1984; 
Everett, 1984b; Graves et al., 1986), how can the factors
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that recognise these elements stimulate transcription when 
their binding sites occur in opposing directions on 
different DNA strands ? Spl binding sites appear to be 
asymmetric, so it is possible that the orientation of 
DNA-bound Spl does not affect its function. However, 
Takahashi et a l . (1986) favour a two-domain hypothesis to 
explain the non-polarity of bound Spl. They suggest that 
the DNA-binding domain, which specifically recognises GC 
hexanucleotides, and a protein-interacting domain, are 
linked by a flexible stem.
Using sequence-specific DNA affinity chromatography,
Spl has now been purified to greater than 95% homogeneity, 
and this fraction has been shown to consist of two 
polypeptides of 105 and 95 kilodaltons (Briggs et a l .,
1986). The purification of sequence-specific transcription 
factors such as Spl has important applications. Firstly it 
enables antibodies to be raised against this factor, and 
secondly amino-acid sequencing will ultimately enable the 
preparation of DNA probes which can be used to isolate the 
gene encoding Spl. Many questions concerning the regulation 
and biochemical functions of Spl can then be addressed.
(ii) CTF/CBP
The pentanucleotide 5'-CCAAT-3‘ or "CCAAT box" binds 
the CAAT binding protein (CBP, Jones et a l ., 1985) or CAAT 
transcription factor (CTF, Graves et a l ., 1986). These two 
proteins may be equivalent or, since they were isolated from 
different cell types and have differences in heat stability 
and exact DNA footprinting (Jones et a l ., 1985; Graves ejt 
al., 1986), might represent different members of a family of 
cellular transcription factors that have different functions 
but recognise the same consensus sequence (McKnight and 
Tjian, 1986). Mutations in the CCAAT sequence that 
adversely affect the function of the MSV and HSV-1 tj( 
promoters, correlate with reduced binding of CTF/c BP 
transcription factors (Jones et a l ., 1985; Graves et a l ., 
1986). The observation that the CCAAT pentanucleotide 
occurs in opposite orientations in the MSV and tk promoters
A  ~is in accordance with the ability^an inverted ^  distal
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promoter region to function (McKnight et a l ., 1984).
In mapping the binding domains of CBP on the MSV and 
promoters, Graves et a 1 . ( 1986) found that the nuclease
protection extends asymmetrically upstream from the MSV 
CCAAT box (on the coding strand), and asymmetrically 
downstream from the CCAAT box (on the non-coding strand; 
see Figure 5). Also, a G to C transversion in the sequence 
abutting the ^  inverted CCAAT box which established perfect 
dyad symmetry, resulted in both elevated t_k promoter 
function and CBP binding (Graves et a l ., 1986).
Rotational symmetry is a hallmark of prokaryotic DNA 
regulatory sequences that bind proteins in the form of 
dimers of two identical subunits (reviewed by Takeda et a l ., 
1983). It is possible that the interaction of CBP and its 
cognate DNA sequence differs substantially from that of Spl 
(see above), but has more similarity to the prokaryotic 
situation, if the binding of one CBP protomer to a CCAAT box 
facilitates dimerization at a nearby less perfect 
dyad-symmetrical sequence (Graves et a l ., 1986).
(iii) TFIIB-D and TATA box factor
In addition to Spl, another fraction (Sp2) was required 
for transcription of both the SV40 early and Ad ML promoters 
(Dynan and Tjian, 1983a). The Sp2 fraction probably 
contains the multiple transcription factors TFIIB, TFIID and 
TFIIE (also fractionated from HeLa cell nuclear extracts), 
shown to be required for Ad ML transcription in vitro 
(Sawadogo and Roeder, 1985a). Reconstitution of 
fractionated components indicated that the basal level of Ad 
ML transcription in vitro is stimulated 10 to 20-fold with 
the addition of another transcription factor, USF, present 
in unifected HeLa cell nuclear extracts (Sawadogo and 
Roeder, 1985a). TFIID and USF are sequence-specific 
transcription factors which were shown by footprinting DNA 
to interact respectively with the TATA box and the -52 to 
-63 (5’-GGCCACGTGACC-3') upstream element of the ML promoter 
(Sawadogo and Roeder, 1985a,b).
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(iv) Enhancer factors
Results of in vitro (Sassone-Corsi et a l ., 1985; 
Wildeman et a l ., 1984) and in vivo (Scholar and Gruss 1984; 
Mercola et a l ., 1985) competition studies have indicated 
that specific trans-acting factors are involved in enhancer 
function. More recently, DNasel footprinting experiments 
have confirmed that the individual SV40 enhancer motifs 
identified by systematic mutational analyses (Zenke et a l ., 
1986; see above) are recognised by proteins present in Hela 
(Wildeman et a l ., 1986) and lymphoid cell (Davidson et a l ., 
1986) nuclear extracts. Moreover, mutations which were 
detrimental to the function of a particular enhancer motif 
correlated with impaired DNasel protection of that motif.
Sen and Baltimore (1986), using a gel mobility-shift assay, 
found that both ubiquitious and lymphoid B cell-specific 
nuclear factors interacted with immunoglobulin enhancer 
sequences. These studies indicate that various enhancer 
motifs bind specific proteins, a process which is presumably 
involved in the generation of enhancer activity. The 
purification and characterization of these proteins will 
surely be an important advance.
(V ) Glucocorticoid receptor
Glucocorticoid receptor proteins activate transcription 
in response to steroid hormones by binding the 
glucocorticoid response elements (GREs) of certain 
hormone-induc ible genes (Geisse et a l ., 1982; Chandler e_t 
al. , 1983; Payvar et a l ., 1983). Both human (Hollenberg e;t 
al., 1985) and mouse (Danielson et a l ., 1986) cDNAs encoding
glucocorticoid receptors (h/mGRs) have been isolated, which 
has enabled the mapping of their functional domains.
Giguere et a l . ( 1986) transfected GR-negative monkey
kidney (CV-1) cells with an expression vector containing 
wild-type or mutant copies of the hGR cDNA. In the presence 
of the synthetic steroid hormone, dexamethasone, hGR 
produced from the expression vector induced transcription of 
a cotransfected MMTV-CAT fusion gene. Since the MMTV LTR 
appears only to have GRE-associated enhancer activity 
(Chandler et al., 1983), measurement of its induction
47
provided a suitable assay for functional hGR. A number of 
insertional mutants of the cloned hGR cDNA were then made, 
and their characterization has allowed at least four 
functional domains to be located; a DNA- and a 
steroid-binding domain; and two other domains required for 
transcriptional activation (Giguere et a l ., 1986).
3. Mechanisms of Action of Transcription Factors
How do transcription factors such as Spl and CBP/CTF 
activate transcription ? Prokaryotic proteins that 
selectively activate gene expression by binding regulatory 
sites facilitate either the initial binding of RNA 
polymerase to a promoter (e.g. catabolite activator 
protein-activation of lacP), or the subsequent isomerization 
of the RNA polymerase/promoter complex to an "open" 
configuration (e.g. lambda cl repressor activation of 
(reviewed by McClure, 1985). Eukaryotic transcription 
factors may perform analogous functions during the 
initiation reaction, or have additional or different 
functions that cannot be predicted from prokaryotic 
mechanisms. McKnight and Tjian (1986) offer a number of 
speculative mechanisms for the action of Spl and CBP/CTF:
(i) Derepression, resulting from the displacement of 
proteins, e.g. histones (but note that Spl and CBP/CTF are 
capable of activating transcription in vitro in the absence 
of histones); (ii) enzymatic modification of a substrate at 
the promoter, such as an RNA pol II subunit; (iii) enabling 
the binding of nuclear proteins that otherwise lack 
sequence-specificity (a mechanism for trans-activation?);
(iv) guidance of cognate promoters into transcriptionally 
active areas of the nucleus (this is difficult to reconcile 
with in vitro transcription data, but the level of 
transcription in vitro may be orders of magnitude down on 
the effect in vivo); and (v) stabilization of a promoter-DNA 
complex, by interaction with neighbouring DNA-bound 
transcription factors.
Ptashne (1986) has cited a number of experiments that 
support the case for (v); that DNA-bound transcription 
factors operate by protein-protein interactions. Such an
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interaction is favoured by Echols (1986), and described as a 
'specialised nucleoprotein structure' (snups), which would 
apparently "provide the necessary regulated reactivity and 
site localization to direct DNA transactions", such as 
initiation of transcription and DNA replication, and 
site-specific recombination. This model predicts the 
looping out of intervening DNA between proteins bound at 
widely separated sites, and that transcription factors 
recognise specific sequences in DNA using structures that 
are complementary to the ordinary (B-form) helix (Ptashne,
1986). The requirement for a stereospecific alignment of 
the proteins which interact with the SV40 enhancer, 21bp 
repeat region, and TATA box (Takahashi et a l ., 1986) is 
cited in support for this model; these proteins could only 
interact by a simple looping if located on the same side of 
the helix. However, there is currently insufficient 
information on the nature of transcription factors to 
explain how the orientation independence of enhancers and 
upstream promoter elements fits in such a with model. It is 
likely that other mechanisms of transcription activation 
take place; for instance, some protein-DNA interactions must 
presumably influence chromatin structure; and some 
transcription factors (the TATA box recognition factor?) may 
well have catalytic activity.
Enhancers and regulator sequences may have important 
functions in addition to their ability to form a 
transcription complex. In contrast to the situation of 
viral genes, many cellular genes in differentiated cells are 
not expressed. It is likely that chromatin organization and 
DNA méthylation are involved in the general repression of 
cellular genes (see reviews by Razin et a l ., 1984;
Weintraub, 1985; Jackson, 1986). A primary step in 
activating tissue-specific genes may involve local 
inactivation of this general repression system. The 
observation that globin-specific trans-acting factors can 
stimulate the endogenous 3-globin gene of non-erythroid 
cells indicates that this gene is not irreversibly repressed 
in at least some differentiated non-erythroid cell types
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(Baron and Maniatis, 1986). It has been suggested that/role 
for enhancers besides a direct cis-activating function may 
be to influence the potential of genes to be activated (Voss 
et a l ., 1986 ) .
4. Regulation of Transcription by Trans-acting Proteins
Gene expression can be modulated in response to 
trans-acting regulatory proteins. The immediate-early or 
early proteins of several DNA viruses form a group of such 
trans-acting regulators, which have in common the function 
of activating viral genes expressed during the later stages 
of the lytic cycle. The best characterised of these, 
excluding those of the herpesviruses (see Section E) are the 
adenovirus (Ad) Ela proteins (Berk et a l ., 1979; Jones and 
Shenk, 1979), and the simian virus 40 (SV40) large T antigen 
(Keller and Alwine, 1984; Brady et a l ., 1984; Hartzell e^ 
al., 1984). A number of other viral proteins associated 
with transcriptional activation, which do not fall into the 
"immediate-early" category, include the Ad E4 protein 
(Goding et a l ., 1985), and the HSV virion component, Vmw65 
(Batterson and Roizman, 1983; Campbell et a l ., 1984; see 
Section E). The tat gene products of human lymphotropic 
viruses HTLV-I and HTLV-II, and HIV (or HTLV-III), are also 
associated with trans-activation (Chen , 1986). While
it is clear that tat is required for a high level of HIV 
gene expression, its precise mode of action (at a 
transcriptional or post-transcriptional level) is currently 
unresolved.
Some viral trans-acting proteins are also associated 
with transformation. Transformation of cells in tissue 
culture can be mediated by Ela and T antigen (Kingston e_t 
al., 1985), and possibly by IE proteins (Macnab et a l .,
1985). This has led to the speculation that the ability of 
viral trans-acting regulatory proteins to stimulate 
transcription of some cellular genes may be related to the 
function of a subset of cellular oncogenes such as c-myc and 
p53, which have some shared properties (Kingston et a l .,
1985) .
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a . Adenovirus Ela
(i) Sequences required for trans-activation
The Ela region encodes two closely related polypeptides 
of 289 and 243 amino acids (from 138 and 128 mRNAs), which 
are processed from the same primary transcript and differ 
only in the size of the intron removed. No studies have 
been able to find specific sequences required for 
Ela-induced expression in adenovirus early promoters that 
are not also required for uninduced expression (Jones,
1986). Nor does it appear that Ela activates transcription 
by binding DNA (Jones, 1986). Consistent with these 
observations, it has been shown that Ela can activate 
cellular promoters or those of other viruses (Green et a l ., 
1983; Triesman et al ., 1983b; Everett and Dunlop, 1984; 
8vensson and Akusjarvi, 1984). However, the observation 
that not all heterologous promoters are activated by Ela 
(Alwine, 1985; Weeks and Jones, 1985), provides an approach 
towards delineating which sequences within an inducible 
promoter may be especially important in trans-activation.
All Ela inducible Ad early promoters contain an AG-rich 
sequence upstream from the TATA box (Jones, 1986).
Mutations in this sequence appear to have the greatest 
quantitative effect on induced compared to basal expression 
(Impériale et a l ., 1985). The H8V-1 ^  gene does not have a 
homologue of this sequence. Weeks and Jones (19861 have 
shown that the expression of a transfected H8V 
promoter/CAT fusion gene (in a pBR322-based vector) was not 
appreciably induced by Ela. The introduction of the AG-rich 
sequence from the Ad E3 gene, to -79 of tk, rendered a 
hybrid promoter sensitive to Ela action. 8ince the hybrid 
promoter was not as strongly induced as the E3 promoter, it 
would suggest that either the positioning or combination of 
multiple promoter elements is important in determining the 
overall level of Ela induction.
Leff and Chambon (1986) have reported that the Ad ML 
promoter is poorly induced by Ela, but can be made 
responsive in a similar way to the H8V t_k gene, by fusing 
the E3 upstream promoter region to the TATA box/cap site
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region of the ML promoter. In this study, the 
Ela-uninducible ML promoter starting construct had sequences 
from -667 to +33 with respect to the ML transcription 
start-site (Leff and Chambon, 1986). It therefore lacked 
the 'downstream' region (+33 to +190) shown by Mansour e_t 
al. (1986), to influence ML promoter activity in response to 
an adenovirus-induced trans-acting factor. A fragment of 
the ML promoter, spanning -260 to +30, fails to compete for 
the transcription factor that binds the upstream region of 
the E2 promoter (SivaRamen et a l ., 1986). This raises the 
possibility that a cellular transcription factor which 
recognises Ad E promoters, but not an Ela-uniducible 
fragment of the ML promoter, is involved in Ela-mediated 
trans-activation.
(ii) Factors involved in Ela-mediated trans-activation
Cellular transcription factors have recently been 
identified that may be involved in Ela-mediated 
trans-activation. It is appropriate to ask how Ela exerts 
its effect through such factors. For instance, does Ela 
cause an increase in the concentration of transcription 
factors, or does it cause an increase in the activity of 
transcription factors (assuming that general transcription 
factors can be 'activated')?
Kovesdi et a l . ( 1986) used a gel mobility shift assay
to investigate the effect of Ela on the binding of cellular 
transcription factors to the Ad E2a promoter. A protein, 
just detectable in nuclear extracts of uninfected HeLa 
cells, was shown to bind upstream sequences (-74 to -33) 
that overlap those important for Ad E2a promoter activity 
(see below). Binding of this factor was greatly increased 
in nuclear extracts of adenovirus-infected cells which 
suggests that Ela increased the concentration of this factor 
(Kovesdi et a l ., 1986).
In apparent contradiction, SivaRamen et al . (1986),
using a similar approach, identified a protein present at 
comparable levels in Ad-infected and uninfected HeLa cells, 
which also bound to DNA in the the Ad E2a promoter upstream 
region (-82 to -66). It is not clear if the cellular
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factors identified by Kovesdi et al . ( 1986) and SivaRamen ejl
al. (1986) are the same or different proteins due to the
apparent difference in their sequence-binding specificity. 
However, the E2a promoter has only been shown to have two 
distinct sequence elements important for basal and induced 
activity (Jones, 1986). These are the -82 to -66 upstream 
region which includes the AG-rich sequence 5'-AGATGACGTA-3' 
between -79 and -70 (of which there are similar counterparts 
important for the activity of other Ad early promoters), and 
the -35 to -21 region which houses a functional 'TATA 
box-like' element. Differences in nuclear extract 
preparation might influence the abundance of the protein(s) 
detected by Kovesdi et a l . (1986) and SivaRamen et a l .
(1986) in uninfected cells; or there could be two closely 
associated or overlapping sequence elements within the E2 
promoter upstream region which are recognised by different 
proteins.
Leong and Berk (1986) have shown that nuclear extracts 
from various mutant adenovirus-infected cells only require 
prior expression of the 13S Ela in order to stimulate 
transcription from a number of adenovirus promoters in 
vitro. By limiting in vitro transcription to one initiation 
per template, it was found that the higher activity of the 
infected-cell extracts was due to an increase in the number 
of templates transcribed (Leong and Berk, 1986). This 
suggests that Ela has increased the availability of active 
transcription factors, but does not distinguish between an 
increase in the overall number of factors or the conversion 
of inactive to active factors. To distinguish between the 
two possibilities it will be important to test whether 
purified Ela can stimulate transcription when added to 
uninfected cell extracts.
Another mode of Ela action may be to relieve the effect 
of a cellular factor that represses Ad early transcription 
(Nevins, 1981; Borelli et al, 1986). That early 
transcription is increased at high multiplicities of 
infection of an Ela-negative virus (dl312), and by 
inhibition of cellular protein synthesis, supports this 
idea, assuming that such a cellular repressor can be
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titrated out and has a short half-life (Nevins, 1 9 8 1 ).
(iii) Repression
In addition to the ability of Ela to activate 
transcription of both viral and cellular genes (Green e_t 
al., 1983; Kingston et a l ., 1985), it can also repress the 
transcription of transfected genes linked to the SV40, 
polyoma, Ad2 Ela, or IgH enhancers (Borrelli et a l ., 1984, 
1986; Velcich and Ziff, 1985; Lillie et a l ., 1986). The 
wild-type polyoma virus (Py) enhancer is repressed in 
undifferentiated embryonal carcinoma (EC) cells, as well as 
by Ela (Hen et a l ., 1986). A point-mutant of the Py 
enhancer that allows Py activity in EC cells is not 
repressed by Ela (Hen et a l ., 1986). These results, 
together with the fact that adenovirus mutants defective in 
Ela can replicate in EC cells, suggest that EC cells contain 
an Ela-like activity that can repress some promoters and 
trans-activate others.
The transcriptional activity of stable integrations of 
the mouse immunogloq^in gene is repressed by Ela in lymphoid 
cells (Hen et a l ., 1985), but stimulated in mouse fibroblast 
cell lines in the presence of Ela (Borrelli et a l ., 1986). 
Enhancer competition experiments suggest that Ela may be 
preventing the action of a cellular repressor, thus the 
‘activation* is indirect (Borrelli et a l ., 1986). It is 
intriguing to speculate that the transeription-repression 
activity of Ela might operate on the putative gene(s) 
encoding a short-lived cellular repressor, thus resulting in 
indirect 'activation* of transcription of formerly repressed 
genes in some cell types.
An analysis of Ela mutants with lesions in the unique 
portion of the 13S mRNA product has revealed that the 
transcription-stimulatory activity of Ela can be separated 
from its repression function, and also that some 
repression-negative mutants (with lesions in the shared 
portion of both 12S and 13S products) are defective in 
transformation (Lillie et al., 1986).
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b . SV4Q T antigen
Simian virus 40 (SV40) is a small oncogenic virus of 
the papovavirus group, and has a double stranded DNA genome 
of length 5243bp (for review, see Tooze, 1980). During 
lytic cycle in 'permissive' monkey kidney cells, SV40 is 
expressed in two temporally regulated phases. Early gene 
expression begins shortly after infection, and gives rise to 
two tumour antigens, large T (94,000 m.wt.) and small t 
(17,000). These proteins continue to be synthesized in a 
regulated fashion throughout the cycle. High levels of late 
gene expression (for production of viral capsid proteins, 
VPl, VP2, and VP3) is generally delayed until after the 
onset of viral DNA replication.
Large T antigen binds specifically to several sites in 
the control region of the viral genome (see Figure 5), and 
plays a regulatory role in the developmental cycle of SV40, 
including autoregulation of early transcription, initiation 
of DNA replication, and stimulation of late transcription. 
Recent evidence demonstrating the ability of T antigen to 
trans-activate transcription is outlined below.
(i) Late promoter activation
Efficient utilization of the SV40 late promoter 
requires activation in trans by T antigen, in addition to 
DNA replication for maximal expression (Brady et a l ., 1984; 
Hartzell et a l ., 1984; Keller and Alwine, 1984). The 
requirement for T antigen (and DNA replication) is 
circumvented in germ cells, where late gene products exceed 
early gene products (Chalifour et a l ., 1986). This is 
reminiscent of the bypass of HSV trans-activating proteins 
for HSV-1 gene expression in oocytes (McKnight and 
Kingsbury, 1982). Competition experiments in vivo suggest 
there may be negative factors involved in regulating the 
SV40 late promoter (Brady and Khoury, 1985).
Activation of the SV40 late promoter can occur by at 
least two independent mechanisms which have different 
sequence requirements within the SV40 control region (Keller 
and Alwine, 1985; Brady and Khoury, 1985). One mechanism 
requires T antigen binding to an intact origin region, in
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addition to the presence of the 21bp repeats and late 
promoter-proximal sequences within 72bp enhancer (Keller and 
Alwine, 1985; Brady et a l ., 1985). The second mechanism, 
involving trans-activation by T antigen, requires sequences 
at the junction of the 72bp repeat, and is independent of an 
intact ORI region. The ORI-dependent activation is 
responsible for about a 10-fold stimulation of late promoter 
activity, but it is not clear if DNA replication is actually 
required (Keller and Alwine, 1985) or not (Brady and Khoury,
1985). ORI-dependent activation accounts for 25-35% of 
total late promoter activity; the remaining 65-75% activity 
is mediated in trans by T antigen in the absence of binding 
to DNA (Keller and Alwine, 1985).
A detailed deletional analysis of the late promoter 
region revealed a 33bp element located at the internal 
junction of the 72bp repeats which is involved in 
trans-activation by T antigen (Keller and Alwine, 1985). 
Interestingly, this element contains the SV40 enhancer 
'core' sequence (Weiher et a l ., 1983), and a limited 
homology to the HSV TAATGARATTC consensus sequence (Whitton 
et a l ., 1983; Preston et a l ., 1984; see Section E(2)). A 
reasonable supposition would be that trans-activation by T 
antigen is mediated through cellular transcription factors 
that bind control DNA sequence elements. SV40 chromosomes 
from lytically infected CV-1 cells are tightly bound by 
SV40-induced cellular factors, which are required for 
efficient late gene transcription in vitro (Tack and Beard,
1985).
(ii) Early promoter activation
A potential involvement of T antigen in trans- 
activating the expression of the SV40 early promoter [LE 
rather than EE (Wasylyk et a l ., 1983)] is complicated by its 
binding to three adjacent sites that overlap the early 
promoter and origin of DNA replication, and its requirement 
for DNA replication which also affects early gene 
expression. The proximity of the three T antigen binding 
sites to the 21bp repeats, or their direct overlap with the 
early mRNA cap sites, is likely to interfere with the
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interactions of transcription factors critical for 
(particularly EE) early gene expression (Myers et al.,
1981). After the onset of viral DNA replication, LE RNAs 
become predominant over EE RNAs.
Buchman et a 1 . (1984) have investigated the effect of 
DNA replication and the role of T antigen on LE promoter 
activity using a plasmid vector, in which manipulations of 
the SV40 origin of replication (ORI) and T antigen binding 
sites could be made. Their experiments have shown that DNA 
replication is important for abundant expression of the LE 
promoter, in the absence of the T antigen binding sites and 
the SV40 enhancer. The coupling of LE promoter activity to 
DNA replication bears similarity to HSV-1 late gene 
expression (see later), although a direct requirement for 
trans-activation of the LE promoter by SV40 T antigen has 
not been proven.
(iii) Activation of heterologous promoters
The SV40 T antigen stimulates a number of heterologous 
promoters including the adenovirus E2 and E3, and the &(2 
collagen and RSV LTR promoters (Alwine, 1985; Loeken e^ 
al ., 1986). Activation is better in CV-1 cells than in HeLa 
cells (Alwine, 1985). Loeken et a l . (1986) have shown that 
T antigen stimulation of an Ad E2 promoter/CAT fusion gene 
in CV-1 cells is as efficient as that mediated by Ela. 
However, at saturating levels, the effects of T antigen and 
Ela are additive, which suggests that stimulation by these 
two proteins occurs by different mechanisms (Loeken et a l .,
1986).
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SECTION E ; HSV-1 TRANSCRIPTIONAL PROGRAMME
1. Temporal Expression of the HSV-1 Genome
Lytic infection by HSV-1 is characterized by the 
coordinate, temporal control of the viral transcriptional 
programme. The classification of three groups of HSV genes, 
immediate-early (IE), early (E), and late (L) (Clements e^ 
al., 1977), or w , i5, ^ (Honess and Roizman, 1974; Jones and 
Roizman, 1979), is based on the kinetics of appearance of 
gene products, and their detection in the presence and 
absence of metabolic inhibitors of protein and DNA 
synthesis. IE genes are the only class to be expressed in 
the absence of de novo protein synthesis (Kozak and Roizman, 
1974; Clements et a l ., 1977; Jones and Roizman, 1979). E 
and L gene expression requires prior synthesis of IE gene 
products (Honess and Roizman, 1974, 1975), and late genes 
are most abundantly expressed following the onset of DNA 
replication (Swanstrom and Wagner, 1974; Powell et a l ., 
1975; Holland et a l ., 1980).
A similar pattern of gene expression has been described 
for other herpesviruses, including PRV (reviewed by 
Ben-Porat and Kaplan, 1985) and CMV (reviewed by Stinski, 
1983). The main control of HSV-1 gene expression appears to 
be at the level of transcription initiation, but with two 
exceptions. (i) At early times during HSV-1 infection, an 
HSV virion component is associated with post-transcriptional 
shut-off of IE- and host-polypeptide synthesis (Read and 
Frenkel, 1983; see Section A(2c)). (ii) At late times, 
nuclear RNA hybridizes to a greater proportion of the viral 
genome than cytoplasmic RNA, indicating a retention of some 
RNA coding potential in the nucleus (Jaquemont and Roizman, 
1975; Clements et a l ., 1977). Post- transcriptional 
events appear to play a role in the temporal regulation of 
CMV gene expression, notably in the delayed translation of 
at least two RNAs transcribed at early times which encode 
late proteins (Geballe et a l ., 1986).
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Early investigations of H S V - 1  gene expression were
based principally on two techniques; (i) identification by
size of radio-labelled viral polypeptides fractionated by
polyacrylamide gel electrophoresis (Honess and Roizman,
1974, 1975; Powell et a l ., 1975); and (ii) solution and
filter hybridization of infected-cell RNA to either HSV
genomic DNA (Swanstrom and Wagner, 1974; Swanstrom et a l .,
1975), or to isolated restriction endonuclease fragments of
HSV DNA (Jones and Roizman, 1979). The development of blot
hybridization techniques (Southern, 1975) enabled the crude
mapping of different transcript classes to physical
restriction maps of the HSV-1 genome (Wilkie, 1976; Morse
et a l ., 1977; Clements et a l ., 1977; Anderson et a l .,
1979; Holland et a l ., 1980). These studies showed that
viral genes were not grouped on the genome according to 
temporal class possible exception of the IE genes.
More detailed studies of HSV transcriptional control 
required the identification of individual genes and the 
sensitive and specific detection of their products. The 
locations of many individual transcripts have been 
determined on physical maps of the HSV genome (see Wagner,
1985), by such techniques as SI mapping and Northern 
blotting (e.g. as employed by Rixon and McGeoch, 1985). 
Individual proteins have been mapped by intertypic 
recombinant analysis (e.g. Marsden et a l ., 1978; Preston,V. 
et a l ., 1978; Morse et a l ., 1978), and marker rescue (e.g. 
Stow et a l ., 1978; Parris et a l ., 1980). In vitro 
translation of infected-cell RNA (Preston, 1977) made in the 
presence of eyeloheximide ('immediate-early conditions'), 
provided an approach to identify which IE proteins were 
specified by size-fractionated RNAs (Watson et a l ., 1979).
The availability of cloned HSV genomic fragments then 
enabled infected-cell RNA to be enriched (hybrid-selected) 
or depleted (hybrid-arrested) for specific sequences, 
thereby allowing individual mRNAs to be correlated with in 
vitro translated gene products (Anderson et a l ., 1980; 
Preston and McGeoch, 1981; Rixon and McGeoch, 1984).
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2. IE Gene Regulation
a . Viral IE gene expression
During a normal infection, IE RNAs can usually be 
detected by Ih, and later classes by 2-3h post-adsorption 
(p.a.). The synthesis and accumulation of IE RNAs peaks at 
around 2h and 3h p.a. respectively, but IE RNAs still 
persist in the cytoplasm at late times (Harris-HamiIton and 
Bachenheimer, 1985; Godowski and Knipe, 1986). Under 
immediate-early conditions, only a limited portion of the 
viral genome is transcribed. The mapping and orientation of 
IE transcripts on the HSV-1 genome revealed five IE mRNA 
species (Clements et a l ., 1979). The IE mRNAs 1 and 3 
mapped entirely within the TR^/lR^ and TRg/iRg segments 
respectively, and are therefore encoded by diploid genes.
The S' termini of IE mRNAs 4 and 5 are located within 
TRg/iRg, and share common promoter and S' untranslated 
leader sequences (Figure 3). IE 2 mRNA maps to a fragment 
within Ul (Figure 1).
The level of IE 3 RNA declines particularly sharply 
after its peak which reflects an effective shut-off of 
transcription of this gene by 4h (Godowski and Knipe, 1986; 
Yager and Bachenheimer, 1987). On the basis of experiments 
using metabolic inhibitors it was first suggested that E 
gene products negatively regulate IE gene expression (Honess 
and Roizman, 1974, 1975). Indeed, a mutant in the major
DNA binding protein (MDBP) fails to shut off IE gene 3 
transcription at NPT, but it also overexpresses E and L 
genes (Godowski and Knipe, 1986). Evidence that the product 
of IE gene 3, Vmwl75, represses transcription of its own 
gene is discussed in part 3a(iii).
Transcription of IE genes can be achieved without 
modification of the existing host-cell transcription 
machinery, since (i) deproteinised HSV-1 DNA is infectious 
(Graham et a l ., 1973), (ii) IE transcription can take place 
in the absence of de novo protein synthesis (Kozak and 
Roizman, 1974; Clements et al ., 1977), and (iii) HSV 
transcription is sensitive to ^.-amanitin, except in cell 
lines which possess an CX-amanitin-resistant RNA pol II
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(Costanzo et a l ., 1977). However, IE gene transcription is 
also stimulated 5 to 10-fold in response to a component of 
the virus particle (Post et a l ., 1981; Mackem and Roizman, 
1982a; Batterson and Roizman, 1983; Cordingley et a l .,
1983; Preston et a l ., 1984; Campbell et a l ., 1984).
b. IE gene regulatory sequences
The sequences regulating IE gene expression have been 
investigated in detail. Post et a l . (1981) were the first 
to demonstrate that sequences within the 5 '-flanking region 
of an IE gene differentiated the regulation of IE and E 
promoters. This was achieved by fusing the 5'-flanking 
sequences of IE gene 3 to the coding region of the HSV-1 
gene. The resulting lE-U^ fusion gene responded to IE 
control when inserted into recombinant virus or 
biochemically transformed cells (Post et a l ., 1981). 
Subsequent deletion mutant and gene fusion studies 
delineated two distinct regions controlling IE gene 
transcription; (i) a regulatory region located far-upstream 
(-174 to -331) of the IE 3 RNA start site; and (ii) a 
promoter region (contained within +26 to -108) required for 
basal and fully induced gene expression (Mackem and Roizman, 
1982a; Cordingley et a l ., 1983).
All five HSV-1 IE promoter/regulatory regions respond 
to the virion component (Mackem and Roizman, 1982a,b; 
Cordingley et a l ., 1983; Preston et a l ., 1984). The basal 
level of transcription of IE genes 4/5, for instance, is 
efficiently mediated by 69bp of promoter DNA. With the 
addition of the IE 4/5 far-upstream region to an IE 4/5-tk 
fusion gene, a further 8-fold stimulation of activity is 
achieved in the presence of the virion component (Preston e_t 
al., 1984). The target sequence for induction mediated by 
the virion component was identified by deletion mutant 
studies (Cordingley et a l ., 1983; Preston et a l ., 1984;
Bzik and Preston, 1986), and DNA sequence comparisons of the 
regions upstream from IE RNA start sites (Mackem and 
Roizman, 1982b; Whitton et a l ., 1983; Whitton and 
Clements, 1984). It is an AT-rich sequence, consensus 
5'-TAATGARAT-3', present in one or more copies in either
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orientation upstream from all HSV-1 and HSV-2 IE genes. A 
synthetic 20-mer oligonucleotide containing the target 
sequence confers IE regulation when linked in either 
orientation to a plasmid-borne IE promoter in the absence of 
other IE far-upstream sequences (Gaffney et a l ., 1985). In 
this system, the level of stimulation conferred by one 
TAATGARAT motif was quite small, but was increased by 
joining together two or three of the 20-mers (Gaffney ejt 
al., 1985). Additional sequence elements flanking the 
TAATGARAT motif appear to be important for full induction 
(Kristie and Roizman, 1984; Preston et a l ., 1984; Bzik and 
Preston, 1986).
The far-upstream regulatory region of IE gene 3 has 
uninduced enhancer activity. It can stimulate expression of 
linked promoter sequences in an orientation-independent 
manner and at a considerable distance from a heterologous 
promoter (Lang et a l ., 1984; Preston and Tannahill, 1984), 
and thus resembles a classical enhancer element. However, 
the IE gene 3 enhancer differs from that of SV40 (Banerji e;t 
al., 1981; Moreau et a l ., 1981), in that its activity is 
further stimulated by the virion component, and it is 
apparently inoperative when located downstream of a gene 
(Preston and Tannahill, 1984).
Bzik and Preston (1986) have investigated the DNA 
sequences within the IE gene 3 far-upstream region which 
specifically mediate enhancer activity and/or response to 
the virion component. The enhancer-like activity was 
assigned to three separate elements which each impart a 
cumulative 2 to 3-fold effect. Two of these regions contain 
the GC hexanucleotide, 5'-GGGCGG-3', and bind the cellular
transcription factor Spl (Jones and Tjian, 1985). Deletion 
of two other Spl binding sites in the IE gene 3 far-upstream 
region did not affect promoter function (B.zik and Preston,
1986). The third element involved in enhancer activity is 
GA-rich and contains sequences which resemble the SV40 
enhancer 'core' sequence (Weiher et a l ., 1983), and 
important motifs in the adenovirus Ela and polyoma virus 
enhancers (Hearing and Shenk, 1983; Herbomel et al ., 1984). 
The DNA sequences involved in response to the virion
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component were separable from those required for enhancer 
activity. The most important sequence was the previously 
defined TAATGARAT element. In addition, a sequence largely 
overlapping the GA-rich element of the IE gene 3 enhancer 
was also required for full response to the virion component 
(Bzik and Preston, 1986). The far-upstream region of IE 
gene 3 thus has a complex, modular structure, which 
resembles the organization of other enhancers and regulatory 
regions.
c . Characterization of the virion factor which stimulates 
IE gene expression 
Since the initial observation that a component of the 
virus particle could stimulate IE gene expression (Post e_t 
al., 1981), the identification and characterization of this 
factor has been an important focus of study. The factor is 
present in an active form in uv-irradiated HSV-1 and is also 
provided by an uncoating mutant of HSV-1, which suggested 
that it is a tegument protein (Batterson and Roizman, 1983). 
While the stimulation was greater with increased m.o.i. of 
HSV-1, it was not induced by the related herpesviruses PRV, 
BMV, or HCMV. Campbell et a l . (1984) investigated the 
identity of the virion component by co-transfection of 
cloned restriction fragments of the HSV genome together with 
an lE-;^ fusion gene. A region of the genome which 
stimulated Uç activity with IE specificity was located. By 
further sub-cloning, insertional mutagenesis, and 
immunoprécipitation studies, the virion component was 
identified as the major tegument protein, Vmw65.
The DNA and predicted amino-acid sequences of the HSV-1 
Vmw65 gene have been determined (Dalrymple et a l ., 1985; 
Pellet et a l ., 1985). A gene homologous to the HSV-1 Vmw65 
has been found in VZV, but the corresponding protein, VZV 
45K, lacks the carboxy-terminal 80 amino-acids of Vmw65 
(Dalrymple et a l ., 1986; Davison and Scott, 1986), and it 
is not known if the 45K protein has any transcription 
stimulatory activity in VZV.
Preliminary studies of the HSV-1 virion component
suggest that it does not bind to DNA (Marsden et a l ..
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submitted), although specific binding to HSV DNA has not 
been investigated. This observation contrasts with other 
regulatory-proteins, such as the glucocorticoid receptor 
(Giguere et a l ., 1986), and the heat-shock transcription 
factor (Parker and Topol, 1984), which bind their cognate 
"response" elements in order to induce transcription 
(Chandler et a l ., 1983; Payvar et a l ., 1983; Bienz and 
Pelham, 1982). It is possible that the mechanism of 
'trans-induction' by Vmw65 has more in common with that of 
other viral trans-acting regulatory proteins, such as Ad 
Ela, SV40 T antigen (see Section D), PRV IE180, and HSV 
Vmwl75 (see below), which 'trans-activate' transcription 
apparently without directly binding to target promoter 
sequences. An important difference, however, is the 
essential and specific target sequence for Vmw65-mediated 
induction, which is located upstream of the IE basal 
promoter sequences.
The HSV-1 virion component also stimulates expression 
of the single IE gene of PRV, although PRV does not harbour 
a corresponding trans-inducing activity (Batterson and 
Roizman, 1983; Campbell and Preston, 1987). Sequence 
analysis of the PRV IE gene upstream region revealed the 
presence of two TAATGARAT-like motifs, which are presumed to 
mediate response to Vmw65; and a six-times repeated 15bp 
element (see below) which contains a CCAAT box homology 
(Campbell and Preston, 1987). The organization of the PRV 
IE gene upstream region shows more similarity to the strong 
enhancer of HCMV (Boshart et a l ., 1985), than to the HSV-1 
IE gene 3 far-upstream region (Bzik and Preston, 1986). It 
is interesting to speculate that the PRV ISbp motif may be 
recognised by a cellular transcription factor (possibly 
related to the CAAT-binding protein?) that stimulates PRV IE 
gene transcription, thus dispensing with the requirement for 
a trans-inducing factor. Whereas in HSV, trans-induction 
may be important for the co-ordinate regulation of the five 
IE genes, without recourse to multiple enhancers in addition 
to that of IE gene 3.
The detection of a cellular protein that recognises the
HSV TAATGARAT motif (Kristie and Roizman, 1987; R.Thompson,
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personal communication) is a compelling area for further 
study. The degree of relatedness between conserved motifs 
in the far-upstream regions of herpes virus IE genes (HSV,
5'-TAATGARATTC-3'; PRV, 5'-GGCCAATGGGATTTY-3'; HCMV, 
S'-C/^CTAACGGGACTTTCCAA -3'), suggests their recognition by 
related transcription factors. Whether Vmw65 substitutes 
for a cellular transcription factor, or alters the activity 
or availability of endogenous factors, is not known.
A similarity between the HSV TAATGARAT motif and part 
of the progesterone receptor binding sequence 
(5 “TACAA^/QCAGA^/tpAAT^/Q^/QGAT -3 ' ) of hormone-responsive 
genes of the chicken oviduct (Heilig et a l ., 1982), has been 
noted (Whitton, 1984). However, studies to date have failed 
to demonstrate any significant hormonal induction of HSV IE 
genes, although the converse possibility of a Vmw65-mediated 
induction of steroid hormone-responsive genes has not yet 
been investigated (E.Offord and J.Macnab, personal 
communication).
3. Herpes Virus IE Gene Products
The five IE polypeptides of HSV-1 are named according 
to their mobility on SDS-PAGE gels in terms of apparent 
molecular weight (Vmw) (Preston,V. et a l ., 1978; Watson ejt 
al., 1979), or 'infected cell polypeptide' (ICP) number
(Honess and Roizman, 1974; Morse et a l ., 1978):
Gene Number Apparent M.Wt. ICP Number 
IE 1 VmwllO ICPO
IE 2 Vmw63 ICP27
IE 3 Vmwl75 ICP4
IE 4 Vmw68 ICP22
IE 5 Vmwl2 ICP47
Apart from Vmwl2, all the IE proteins become 
phosphorylated (Pereira et a l ., 1977; Marsden et a l ., 1978; 
Fenwick and Walker, 1979; Ackermann et a l ., 1984), and 
migrate to the nucleus where they become tightly associated 
with chromatin (Hay and Hay, 1980, 1981). The functions of
the IE proteins are outlined below and have been studied 
principally by two approaches; (i) characterization of
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mutants carrying lesions in IE genes, and (ii) use of 
plasmids encoding IE gene products in short term 
transfection assays. The role of IE gene products in the 
activation of E gene transcription is discussed mainly in 
part 4.
a . HSV-1 IE gene products
(i) VmwllO: Conditional-lethal mutants have not been
isolated in IE gene 1. Stow and Stow (1986) constructed a 
recombinant virus, ^1403, which contains a deletion in both 
copies of IE gene 1. The same deletion has been shown to 
inactivate the E gene transcription-stimulatory activity of 
VmwllO in a transient assay (see below; Perry et a l .,
1986). Although initially isolated on a cell-line 
containing IE gene 1, ^ 1 4 0 3  grew on a number of other 
cell-lines, at 20 to 100-fold reduced efficiency compared to 
wt HSV-1. Functional VmwllO is therefore not crucial for 
virus growth in tissue culture. However, stocks of dll4Q3 
have an exceptionally high particle/pfu ratio. This is not 
thought to result from a defect in the virus particle but 
rather from a reduced ability of the mutant virus to 
initiate a productive infection at low m.o.i. (Stow and 
Stow, 1986).
Sandri-Goldin et a l . (1987) have investigated the 
effect of reducing VmwllO expression during infection by use 
of cell lines which carry a plasmid engineered to express 
the antisense VmwllO message. During HSV-1 infection of 
antisense cell lines the level of VmwllO was reduced to less 
than 10%; but this had little effect on the expression of 
HSV-1 early or late genes, or on virus yield.
Sequence analysis of IE gene 1 revealed the presence in 
VmwllO of a cysteine-rich region (Perry et a l ., 1986), which 
is similar to that present in many DNA binding proteins 
(Berg, 1986), and may form a "metal-finger" binding domain. 
This may correlate with the binding of VmwllO to chromatin 
in infected-cell nuclei (Hay and Hay, 1980), but it has yet 
to be shown that purified VmwllO binds directly to DNA.
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(ii) Vmw63; A number of mutants have been isolated 
in IE gene 2 which demonstrate that Vmw63 is essential for 
lytic growth (Sacks et a l ., 1985). At NPT, these mutants 
overproduce at least two IE proteins, Vmwl75 and Vmw63 (but 
not VmwllO), exhibit normal levels of E proteins, have a 
spectrum of effects on EL proteins, and severly underproduce 
L proteins, although there is no block in viral DNA 
synthesis. Thus Vmw63 does not appear to be required until 
after the onset of E gene expression and viral DNA 
synthesis, and its effect appears to be limited to a subset 
of HSV promoters (Sacks et a l ., 1985; see part 4(c)).
(iii) Vmwl75;
Genetic Studies:
The product of IE gene 3 has a critical role in the HSV 
transcriptional programme. Many ts-Vmwl7 5 mutants at NPT 
overproduce IE gene products and fail to express E and L 
genes (Marsden et a l ., 1976; Preston, 1979a; Dixon and 
Schaffer, 1980; Watson and Clements, 1978; 1980). In 
temperature shift-up experiments, these mutants resume IE 
gene expression and discontinue E expression, suggesting 
that functional Vmwl75 is continuously required for E gene 
expression, and is also involved in the negative regulation 
of IE genes (Watson and Clements, 1980; Dixon and Schaffer, 
1980). The phenotypes of ts-Vmwl75 mutants may vary from 
being non-permissive to being partially or completely 
permissive for E gene expression (DeLuca et a l ., 1984). 
Mutants permissive for E gene expression may exhibit 
reasonably high levels of DNA synthesis, but late gene 
products are consistently underproduced. This suggests that 
a distinct function of Vmwl75 may be required for late gene 
expression. A similar variation in the permissiveness of E 
gene expression is seen during infection in experiments 
using the arginine analogue, canavanine, depending on the 
stringency of the conditions used (Honess and Roizman, 1975; 
Harris-HamiIton and Bachenheimer, 1985).
DeLuca et a l . (1985) isolated two deletion mutants of
IE gene 3, dl20 and d202, on cell lines that express Vmwl75. 
These mutants expressed truncated forms of Vmwl75. When
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grown on non-permissive cells, dl20 and d202 failed to 
express E genes but differed from most ^  mutants of Vmwl75 
in that IE polypeptides were not overexpressed. A possible 
explanation is that the truncated forms of Vmwl75 retained 
autoregulatory activity but were defective in trans­
activation. However, since the mutant dl20 retains very 
little of the coding sequences of Vmwl75 (less than 
one-fifth), it would be surprising to find that it also 
retains some functional activity.
Autoregulation of IE gene 3 expression by Vmwl75 has 
been demonstrated by three groups using cloned IE genes in 
transient assays (O'Hare and Hayward, 1985b; DeLuca and 
Schaffer, 1985; Gelman and Silverstein, 1986). In these 
studies, it was apparent that the level of Vmwl75 was 
critical for determining whether IE gene expression was 
stimulated or inhibited (O'Hare and Hayward, 1985fe; Gelman 
and Silverstein, 1986) which indicates how such factors as 
multiplicity of infection could influence the outcome of an 
infection. A cloned ts-Vmwl7 5 gene has been used to provide 
further evidence that functional Vmwl75 is directly required 
for autoregulation (DeLuca and Schaffer, 1985). When 
co-transfected with an IE 3-CAT fusion gene it was found 
that increased levels of CAT were produced at NPT; 
consistent with the corresponding ^  mutant virus phenotype 
of overexpression of IE gene products at NPT.
Physical Properties:
There are three phosphorylated forms of Vmwl75 (a,b and 
c), which exhibit different electrophoretic mobilities on 
SDS-PAGE gels (Pereira et a l ., 1977). The HSV-1 mutant, 
tsK, has a single base-change in the coding region of Vmwl75 
(Davison,M-J. et a l ., 1984). Transcriptionally inactive 
tsK-Vmwl7 5 (Preston, 1979a) correlates with the absence of 
the 'c' form of Vmwl75 (Preston, 1979b), and the failure of 
this protein to be modified by poly(ADP-ribosyl)ation at NPT 
(Preston and Notarianni, 1983).
Vmwl75 has been isolated as a homodimeric complex 
(Metzler and Wilcox, 1985). Hay and Hay (1980) reported 
that Vmwl75 binds to DNA. However, Freeman and Powell,
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1982) have shown that the ability of Vmwl75 to bind to DNA 
was lost after extensive purification, but could be restored 
by the addition of uninfected cell extracts. This suggested 
that Vmwl75 does not directly bind to DNA. A number of 
"Vmwl75/protein"-DNA binding sites have recently been 
identified (see below) and their possible relevance in the 
regulation of transcription is considered further in part 
4(e) .
Faber and Wilcox (1986), by use of a DNA binding 
immunoassay, found that their partially purified preparation 
of Vmwl75 could bind to DNA and that it bound preferentially 
to one site in the gD promoter region, and two more in 
pBR322 DNA. Comparison of the sequences bound yielded a 
suprisingly good consensus sequence (5'-ATCGTCN^YCGRC-3'). 
However, the binding site in gD DNA lies outside the 
essential gD promoter sequences (Everett, 1983; Faber and 
Wilcox, 1986) and its significance in gD transcription is 
not yet known. In addition, it is not known if the binding 
of Vmwl75 in these studies is occuring through an 
intermediate.
Kristie and Roizman (1986a,b) used a gel retardation 
assay in the presence and absence of anti-Vmwl75 monoclonal 
antibodies, in order to identify HSV-1 DNA fragments which 
bind Vmwl75/protein. Binding was detected to the regulatory 
sequences of IE genes 1, 2 and 3, and a late promoter, but
the promoter did not significantly bind Vmwl7 5/protein. 
The binding site in the far-upstream region of IE gene 3 was 
investigated in further detail. Binding did not require the 
retention of nearby Spl binding sites (Kristie and Roizman, 
1986b), nor did the bound DNA contain the consensus sequence 
of Faber and Wilcox (1986). The meaning of these results is 
unclear. It is possible that Vmwl75 binds its own promoter 
DNA (which does have a consensus binding site - Murchie and 
McGeoch, 1984; McGeoch et a l .,1986) in order to 
autoregulate IE gene 3 transcription, and that the detection 
of other binding sites is either fortuitous or an artifact 
of the DNA binding assays. Further purification of Vmwl75 
should help solve these current problems, and aid a better 
understanding of this multifunctional protein.
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(iv) Vmw68; A recombinant HSV-1 virus, R325-pTK+, 
which contains a 550bp deletion within the coding sequences 
of IE gene 4, grew as well as ^  HSV-1 in some, but not all 
cell-types, in tissue culture (Post and Roizman, 1981;
Sears et a l ., 1985). It has been speculated that a cellular 
function substitutes for Vmw68 in cells permissive for 
normal growth of R325-PTK+, and that this function is 
involved in late gene expression (Sears et a l ., 1985).
(V ) Vmwl2 ; Very little is known about the the product 
of IE gene 5. It is evidently not essential for HSV-1 
growth in tissue-culture, since viruses deleted for this 
gene (along with several others) are still able to grow 
reasonably well in tissue culture (Longnecker and Roizman, 
1986; Umene, 1986; Brown and Harland, 1987).
b. PRV IE protein
PRV appears to specify only one IE protein, of M.Wt. 
180K - IE180 (Ihara et a l ., 1983), whose coding sequences 
share homology with the HSV-1 IE gene 3 (Ben-Porat et a l ., 
1983; Davison and Wilkie, 1983a). Infection of cells with 
a temperature-sensitive mutant defective in the 180K protein 
(tsG) results in the failure to transcribe early genes 
(Ihara et a l ., 1983). Both IE180 and HSV Vmwl75 can 
substitute for Ela function in the adenovirus Ela-deficient 
mutant, d_1312 (Feldman et a l ., 1982; Tremblay et a l .,
1985). IE180 can also mediate strong transcriptional 
activation of a variety of heterologous promoters in 
transient tranfection assays (Green et al ., 1983; Impériale 
et a l ., 1983; Everett, 1984a; Alwine, 1985).
Abmayr et a l . (1985) have shown that IE180 can
stimulate transcription in vitro from the Ad ML and E3 
promoters, and the mouse ^-globin promoter. This was the 
first report of the action of a trans-acting regulatory 
protein in vitro. However, the stimulation (about 10—fold) 
was not high and it was necessary to make extracts from a 
cell line apparently deficient in transcription factors for 
the stimulatory effect to be observed (Abmayr et a l ., 1985"). 
Despite these reservations, this approach to study the
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mechanism of trans-activation induced by PRV is very 
promi sing.
4. Early Gene Expression
Early gene transcription begins after the appearance of 
functional IE products in the cell and usually reaches a 
maximum level at 4-6h p.a.. The criteria which define E 
genes are not as clear as those which define IE genes, and 
there is some variation in their kinetics of expression.
For instance, the large subunit of the ribonuclease 
reductase (RR^) has been classed as an E gene product (ICP6 
- Honess and Roizman, 1974), although it may be expressed 
under IE conditions and by some mutants of Vmwl75 that do 
not otherwise express E gene products (DeLuca et a l . 1985). 
Hence RR^ has also been described as a gene product 
(Roizman and Batterson, 1985). Some genes such as gD are 
detected early in infection but require viral DNA synthesis 
for maximum expression, although they are expressed at 
moderately high levels in its absence (Gibson and Spear, 
1983; Johnson et a l ., 1986). VP5 is often described as a 
late gene, but it too is expressed moderately well in the 
absence of DNA replication, although its response to 
activation by IE gene products is poorer than gD (Costa e_t 
al., 1985b; DeLuca and Schaffer, 1985; Harris-HamiIton and
Bachenheimer, 1985; Everett, 1986). Descriptions of genes 
whose expression is moderately sensitive to inhibition of 
DNA replication include early-late (EL), leaky-late, |32f, and 
^1 genes (Roizman and Batterson, 1985; Wagner, 1985;
Harris-HamiIton and Bachenheimer, 1985).
a . Early gene promoter DNA sequences
The sequences required for expression of the HSV-1 Uç 
promoter have been studied in considerable detail (McKnight 
et a l ., 1982; Eisenberg et a l ., 1985; El Kareh et a l .,
1985; Coen et a l ., 1986), as discussed in Section D(la). 
These studies have identified three upstream promoter 
elements (the CAAT box and two GC hexanucleotides) which are 
required for efficient transcription of the gene, and are
71
recognised by the cellular transcription factors CBP/CTF and 
Spl, respectively (Jones et a l ., 1985; Graves et a l .,
1986). In addition, the TATA box was shown to be
especially important for transcription of the ^  gene when 
situated on the viral genome, and a mutation-sensitive 
region 3'-flanking the ^  RNA start site has been noted 
(Coen et a l ., 1986).
A short term transfection procedure was employed by 
Everett (1983, 1984b) to investigate the sequence 
requirements of the gD promoter. Deletion analysis showed 
that sequences within -83 and +17 of the gD RNA start site 
(+1) were sufficient for fully regulated expression of a 
plasmid-borne gD promoter in HSV-1 infected cells (Everett,
1983). Four regions important for full gD promoter activity 
were subsequently identified; (i) A G-rich region between 
-73 and -63; (ii) A G-rich region between -53 and -41; (iii) 
A TATA box between -25 and -18; (iv) The cap site region 
between -4 and +11 (Everett, 1984b; see Figure 21 for the 
gD promoter sequence). How do the gD and promoters 
compare? The gD promoter appears to have a less complex 
upstream region than ^  in that it lacks a CAAT box, 
although point-mutation analysis would be required to 
confirm the absence or otherwise of functional elements in 
addition to the G-rich motifs. A reasonable conjecture is 
that both promoters have two Spl binding sites, since the 
G-rich regions of the gD promoter (5'-GG^/^GAGGGGC-3') are 
highly similar to an Spl binding site in the HIV LTR 
(5'-GGGGAGTGGC-3') (Jones et a l ., 1986). In the proximal 
promoter region, the TATA boxes of both and gD are very 
important for full activation, and both promoters have 
mutation-sensitive cap site regions (Coen et al ., 1986; 
Everett, 1984b). It is interesting to note that the 
upstream regions of the gD (Everett, 1984b) and t_k (McKnight 
et a l ., 1984) promoters are able to function in the inverse 
orientation relative to the TATA box, as can the SV40 
upstream region (Everett et a l ., 1983).
The V P 5 promoter is regulated with essentially EL 
kinetics during HSV-1 infection (Harris-Hamilton and 
Bachenheimer, 1985). The DNA sequence requirements of the
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VP5 promoter extend 5 ’ between -75 to -125 from the VP5 RNA 
start site (Costa et a l ., 1985b). It is therefore likely 
that the V P 5 promoter has a functional 'upstream region', 
although the nature of the important sequences within this 
region await investigation.
b. Specificity of promoter activation
The activity of deletion mutants of the gD promoter 
were examined in response to (i) trans-acting viral products 
provided by HSV-1 infection, and (ii) cis-activation by a 
linked SV40 enhancer (Everett, 1984b). A striking 
observation was that the same mutation-sensitive sequences 
were revealed in both situations, and no specific sequences 
for viral trans-activation were detected. Likewise, no 
virus-specific sequences have been detected for activation 
of the promoter (Eisenberg et a l ., 1985; Coen et a l ., 
1986). These observations suggest that the same basic 
transcriptional machinery is used in the activation of viral 
promoters, whether mediated in the presence or absence of 
viral transcription factors.
A second important observation made by Everett (1983, 
1984b), was that the activity of a co-transfected rabbit 
^-globin promoter (which was included to provide a reference 
to standardize transfection efficiencies) was also 
stimulated by HSV-1 infection. Subsequently, a large 
variety of herpes viruses were shown to trans-activate both 
the HSV-1 gD and the rabbit |3-globin promoters (Everett and 
Dunlop, 1984). This activation was mediated by their IE 
gene products (Everett, 1984a). Similar results have been 
obtained for other viral trans-acting regulatory proteins, 
demonstrating that activation by viral gene products is not 
specific for viral promoters (Green et a l ., 1983; Impériale 
et a l ., 1983; Alwine, 1985; see Section D ) . However, 
activation of heterologous promoters by viral trans-acting 
regulatory proteins is not universal. For instance, the 
SV40 early promoter (without the enhancer) responds poorly 
to activation during HSV-1 infection (O'Hare and Hayward, 
1984; Everett, 1987).
Is the state of the promoter DNA important for
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trans-activation? HSV-1 infection can stimulate viral 
(Smiley et a l ., 1983; Sandri-Goldin et a l ., 1983; Dennis 
and Smiley, 1984; Mosca et a l ., 1985) and cellular 
promoters (Everett, 1985) stably integrated into the genome 
of biochemically transformed cell-lines. Thus promoter 
activation by trans-acting regulatory proteins is not 
dependent on the extrachromosomal nature of infected viral 
or transfected plasmid DNA. Stimulation of an integrated 
rabbit P-globin promoter was shown to be mediated by HSV IE 
gene products, although the resident ^-globin promoter in 
rabbit kidney cells did not respond to HSV-1 infection 
(Everett, 1985). This suggests that chromatin structure is 
likely to play an important role in determining whether or 
not a particular promoter may respond to trans-activation.
It has recently been shown that the rabbit p*-globin gene is 
regulated with E gene kinetics when inserted into the HSV-1 
genome (J.R.Smiley, C.Smibert, R.D.Everett, submitted for 
publication). Thus promoter selectivity is not dependent 
upon exclusive viral or cellular sequences, nor genome 
location, although it then becomes difficult to postulate 
mechanisms for the general shut-off of host cell 
macromolecular synthesis (Section A).
c . Trans-activation of E genes in co-transfection 
experiment s
Studies with mutant viruses have demonstrated the 
requirement for Vmwl75 in E gene transcription, and 
indicated that Vmw63 has a role in the expression of a 
subset of viral genes (part 3(a)). The development of 
short-term transfection procedures, using cloned IE genes, 
has enabled the individual or combinational functions of the 
various IE gene products of HSV-1 to be examined in greater 
detail.
Everett (1984a) investigated the ability of cloned IE 
gene products to activate a plasmid-borne gD promoter in 
co-transfected HeLa cells. The level of activation by 
Vmwl75 was very low, but was significantly increased when in 
combination with VmwllO. Other HSV-1 IE gene products had 
no effect on gD promoter activity, either alone or in
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combination with Vmwl75 and VmwllO. Similary, Quinlan and 
Knipe (1985) showed that although Vmwl75 or VmwllO could 
activate the E MDBP promoter, their effect in combination 
was synergistic. This was in apparent contrast to the 
findings of O'Hare and Hayward (1985a), who reported that 
co-transfection of Vmwl75 or VmwllO with a tk-CAT fusion 
gene produced significant levels of CAT activity, and those 
of Gelman and Silverstein (1985), who found that VmwllO was 
a better activator of the promoter than Vmwl75. However, 
differences in the test promoters, activator plasmid 
constructs, assay systems, and cell types, may account for 
the varied levels of activation in each system. Subseqent 
studies by Gelman and Silverstein (1986), and Everett
(1986), have shown that the synergistic effect of VmwllO and 
Vmwl75 also applies to the Uc promoter.
Using a similar approach, it has been found that Vmw63 
has a transcription stimulatory activity on the VP5 
promoter, but only in the presence of both Vmwl75 and VmwllO 
(Everett, 1986). Vmw63 had no effect on the activity of the 
tk or gD promoters, either alone or in combination with 
other IE gene products. In this study, Uç was activated 
better than gD in a single co-transfection with either 
Vmwl75 or VmwllO, and both gD and were activated better 
than VP5 with all combinations of activators (Everett,
1986). DeLuca and Schaffer (1985) have shown that a 
plasmid-borne ts-Vmwl75 mutant, capable of activating a 
tk-CAT fusion gene, did not stimulate a VP5-CAT construct 
(unlike wt-Vmwl7 5 ), except in the presence of additional IE 
gene products including Vmw63. These studies suggest that 
the multiple activators of HSV-1 may be required to regulate 
differentially subsets of HSV promoters, and that Vmwl75 may 
have more than one function in this process.
d . A Role for the TATA box?
An alternative approach towards investigating 
trans-activation mediated by HSV-1 IE gene products has been 
to identify which elements within a responsive promoter can 
confer indueibility to a poorly responsive promoter. This 
approach has been used successfully to identify an upstream
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element present in adenovirus early promoters which has the 
ability to confer Ela indueibility to the normally 
unresponsive HSV-1 Ut gene (Weeks and Jones, 1985).
Everett (1987) constructed hybrid promoters consisting 
of the upstream or TATA box region of the HSV-1 gD promoter 
(which reponds well to HSV-1 trans-activation) with the 
complementary region from the SV40 early promoter (which is 
poorly responsive - O'Hare and Hayward, 1984). Alteration 
of the SV40 TATA box region to that of gD resulted in a 
promoter that could be efficiently activated by HSV-1 
infection. The upstream regions of the SV40 and gD 
promoters were functionally interchangeable (Everett, 1987). 
These results imply that the DNA sequence of the TATA box is 
of crucial importance to the mechanism of activation by 
HSV-1 IE gene products, and yet are consistent with the 
absence of virus-specific regulatory signals within the gD 
and promoters.
Cellular transcription factors have been identified 
which interact with upstream promoter sequences (see Section 
D) and the TATA box (Sawadogo and Boeder, 1985b). Given the 
variation in functional TATA box sequences (Breathnach and 
Chambon, 1981), it is possible that there is more than one 
TATA box factor, and that these factors have different 
sequence-recognition specificities. The results of Everett
(1987) could be explained if HSV-1 IE gene products interact 
poorly with the SV40 TATA box factor, but efficiently with 
the gD TATA box factor. Since HSV TATA box sequences are 
not strictly conserved (Wagner, 1985; McGeoch et a l .,
1985), it would be useful to investigate the identity and 
specificity of TATA box binding factors, and determine 
whether or not they interact with IE gene products, or if 
HSV gene products can substitute for a TATA box factor.
That HSV-1 IE gene products may interact with the TATA 
box or TATA box factors is consistent with two observations. 
Firstly, Tackney et a l . (1984) found that a recombinant 
HSV-1 virus, containing the Chinese ham ster aprt gene and 
regulatory sequences, did not express aprt during lytic 
infection. In common with other housekeeping genes (Kim et 
al., 1986), the aprt gene does not appear to contain a TATA
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box (or a CCAAT box), although it does possess potential Spl 
binding sites (Dush et a l ., 1985). Secondly, Coen et a l . 
(1986) showed that linker scanning mutations within the 
viral-borne HSV-1 Ut TATA box region had the most severe 
effect compared to other sites during infection. The 
results of experiments investigating trans-activation of an 
HSV-1 L promoter are also consistent with the proposed 
importance of the TATA box (this thesis).
e . Trans-activation in vitro
The observation that purified Vmwl75 fails to bind DNA 
(Freeman and Powell, 1982), suggests that Vmwl75-mediated 
trans-activation occurs through direct or indirect 
interaction(s) with cellular transcription factors which 
themselves recognise general promoter sequences. Beard e^ 
al. ( 1986) have analysed the effect of partially purified 
(5%) Vmwl75 on gD transcription in vitro. The addition of 
Vmwl75 to HeLa cell nuclear extracts stimulated 
transcription of the gD gene. Pre-incubation of the Vmwl75 
preparation with anti-Vmwl75 antibody impaired its ability 
to stimulate transcription (Beard et a l ., 1986). If the 
binding of Vmwl7 5/protein to the gD promoter is significant 
(Faber and Wilcox, 1986; Beard et a l ., 1986), then 
Vmwl75-mediated transcriptional activation would seem to 
involve its direct presence in the transcription complex on 
promoter DNA.
f . The paradox of Vmwl75 mutants and transdominance
The fact that both VmwllO and Vmwl75 can separately
trans-activate E genes (O’Hare and Hayward, 1985a,b;
Quinlan and Knipe, 1985; Gelman and Silverstein, 1985,
1986; Everett, 1986) raises a paradox, namely, why can ^  
mutants be isolated in IE gene 3, if not in IE gene 1? It 
is also surprising that no tk activity is observed in cells 
infected with tsK at NPT (Preston, 1979a), given the ability 
of VmwllO to activate expression on its own or with 
Vmwl75 in transient assays.
DeLuca et a l . (1985) observed that Vmwl75-producing 
cell-lines poorly complemented an HSV-1 ts mutant of Vmwl75,
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whereas the deletion mutants, dl20 and d 202, grew reasonably 
well in these cells. Interestingly, these deletion mutants 
exhibit IE profiles in non-producer cells, indicating that 
VmwllO by itself was not able to stimulate E gene 
expression. The detectable levels of truncated Vmwl75 
expressed by dl20 and d202 (DeLuca et a l ., 1985), could 
conceivably act to inhibit VmwllO-mediated trans-activation, 
but allow complementation by wt Vmwl75. However, as stated 
above (part 3(i i i )), it would be very suprising if the 
mostly deleted gene product of mutant dl20 retained any 
function, thus casting doubt on the possibility that mutant 
forms of Vmwl75 are transdominant over VmwllO.
Gelman and Silverstein (1986) have investigated the 
transdominance of tsK over ^  HSV-1 in co-infection studies. 
Increasing the ratio of tsK to ^  virus, or prior infection 
with tsK, caused a reduction in the accumulation of Uc RNA.
A tsK to ^  ratio of 1:1 had a barely noticeable effect on 
tk RNA levels, but increasing the ratio to 100:1 caused a 
significant reduction. These results indicate that the tsK 
form of Vmwl75 is transdominant over the wild-type product. 
Interestingly, transdominance has also been reported for 
another mutant viral trans-acting regulatory protein, the 
tat (or x) protein of HTLV-II (Wachsman et a l ., 1987).
The absolute requirement for functional Vmwl75 in the 
viral situation (compared to the dispensability of VmwllO), 
and the transdominance of some mutant forms of Vmwl75 over 
the wild-type product may be due to a number of 
possibilities: (i) Some mutant forms of Vmwl75 may retain
the ability to negatively regulate IE gene expression, thus 
masking the potential effects of VmwllO or wt-Vmwl75 on E 
gene transcription. (ii) Mutant forms of Vmwl75 may 
interfeæ stochastically with functional Vmwl75, particularly 
if Vmwl75 acts in a dimer as suggested by Metzler and Wilcox 
(1985). The trans-acting function of VmwllO may be blocked 
similarly, if Vmwl75 and VmwllO normally act as a complex,
(iii) There may be competition between mutant and wild-type 
forms of Vmwl75 for cellular transcription factors or 
promoter DNA binding sites; this too could interfere with 
the ability of VmwllO to activate transcription. (iv)
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Vmwl75 has been shown to affect the nuclear distribution of 
VmwllO (Gelman and Silverstein, 1986; Knipe and Smith,
1986). However, it is also possible that Vmwl75 has an 
essential function(s), possibly in the activation of EL and 
L gene expression, that VmwllO does not possess, or that in 
the complete absence of Vmwl75, the trans-activating 
function of VmwllO might simply not be strong enough to 
initiate infection, particularly in the presence of negative 
regulatory functions such as MDBP (Godowski and Knipe,
1986). Obviously, the paradox of Vmwl75 mutants is not 
solved,
5. Non-IE Gene Functions Involved in Transcriptional 
Régulât ion
The products of two HSV-1 non-IE genes are known to 
affect viral transcription. These are Vmw65, as discussed 
in part 2(c), and the product of an E gene which encodes the 
major DNA binding protein (MDBP, or ICPB), which is briefly 
discussed here.
The role of MDBP in the control of HSV transcription, 
as distinct from its requirement for DNA replication (see 
Section B(2b)), has been studied mainly by D.Knipe and 
colleagues. Defects in MDBP result in the increased 
accumulation of RNAs from all temporal classes of HSV-1 
genes (Godowski and Knipe, 1983, 1986). The conditional- 
lethal mutant, ^ 1 8 ,  has a temperature-sensitive lesion in 
MDBP, and is defective for DNA replication at NPT (Lee and 
Knipe, 1983). Infection with ^ 1 8  had an unexpected effect 
on the expression of an L gene (gC) at NPT: In the presence
of PAA, tsl8 accumulated significantly more gC RNA than ^  
virus, in the absence of detectable DNA replication 
(Godowoski and Knipe, 1985). By use of nuclear run-on 
assays, Godowski and Knipe (1986) showed that functional 
MDBP was required for the shut-off of IE gene 3 
transcription, and a decrease in the levels of E (- MDBP),
EL (- VP5), and L (- g C ) transcription in the absence of DNA 
replicat ion.
The simplest interpretation of these results is that 
MDBP causes a general repression of HSV gene transcription
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in the absence of DNA replication, which may well be 
mediated through its ability to coat ds DNA in a 
non-specific manner (Powell et a l ., 1975). The experiments 
of Godowski and Knipe (1986) have shown that MDBP directly 
effects RNA synthesis, but if MDBP is also able to bind RNA 
it may also have a role in post-transcriptional regulation 
(Godowski and Knipe, 1985). Another possibility is that 
since MDBP appears to be required for the negative 
regulation of IE gene 3, ;^18 may overexpress Vmwl75 which 
as a consequence, increases the level/trans-activation of 
other HSV genes. It seems unlikely that MDBP plays a part 
in the activation of specific genes, but it could be 
important at the early stages of infection in regulating the 
level of IE transcription, in addition to its role in DNA 
replication.
6. Late Gene Expression
a. Gene expression and DNA replication
Late gene products can be first detected by 2-3h p.a. 
and reach maximum levels of accumulation by 10-16h. HSV-1 
DNA synthesis is initiated by about 2h p.a., and peaks 
around 8h (Munk and Sauer, 1964; Roizman, 1969; Wilkie, 
1973). A reduction in both the 'genetic-complexity' of 
viral RNA, and the number of virus-induced polypeptides, is 
seen under conditions of DNA synthesis inhibition using 
chemical inhibitors or (DNA") mutant virus stocks 
(Swanstrom and Wagner, 1974; Honess and Roizman, 1974; 
Powell et a l ., 1975; Marsden et a l ., 1976; Jones and 
Roizman, 1979; Holland et a l ., 1980; Conley et a l ., 1981; 
Pederson et a l ., 1981). The limited sensitivity of the RNA 
and protein detection techniques available at the time of 
these studies did not allow a firm conclusion to be reached 
regarding the absolute role of DNA replication in late gene 
expression. Also, it was not possible to conclude that 
absolutely no DNA replication had taken place under 
conditions of DNA synthesis inhibition or with ts-DNA~ 
mutants at NPT. However, it did emerge that there are two 
classes of HSV genes whose expression is curtailed when DNA
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synthesis is inhibited: (i) Early-late genes (EL - see part
4), whose expression is reduced but still readily
detectable, and (ii) Late (L) genes (or 'true-late',% , #2)'
whose expression either does not take place or is hard to 
detect (Wagner, 1985; Roizman and Batterson, 1985).
In the presence of phosphonoacetic acid (PAA), which 
inhibits the HSV-1 DNA polymerase (Hay et a l ., 1977), the 
synthesis and accumulation of IE and E RNAs is unaffected at 
early times. At late times, the presence of PAA prevents a 
large increase in the amount of transcription of both coding 
and non-coding DNA strands of HSV-1 genes belonging to all 
temporal classes (Godowski and Knipe, 1986; Yager and 
Bachenheimer, 1987), a phenomenom known as 'symmetric
transcription' (Jaquemont and Roizman, 1975; Kozak and 
Roizman, 1974; Stringer et a l ., 1977). The accumulation of 
heterogeneously sized transcripts in the nucleus which are 
not transported into the cytoplasm (Clements et a l ., 1977),
may be a consequence of symmetric transcription.
b. What are late genes?
The ability of IE genes to be transcribed in the 
absence of de novo protein synthesis, the stimulation of 
their transcription by a component of the virus particle, 
and the presence of a far-upstream region including the 
consensus sequence TAATGARAT, are criteria which clearly and 
unambiguously define an IE gene. Fully efficient regulated 
activity of E and EL genes (which have not been 
distinguished at a molecular level) requires a proximal TATA 
box homology and a distal upstream region. Cellular 
transcription factors have been shown to specifically bind 
to the functional elements of an E promoter (McKnight and 
Tjian, 1986), but additionally require IE proteins (or other 
means) to effect promoter activation.
At the outset of the work conducted for this thesis, 
very little was known about the control of L gene 
expression. The requirement of DNA re^ication for efficient 
late gene expression has been discussed above, and the 
involvement of MDBP has been considered in part 5. However, 
it is not known why some HSV genes require DNA replication
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for their efficient expression, or if DNA replication is 
absolutely essential for L gene activation. If it is simply 
the case of increasing the copy number of a weak promoter, 
why is the expression from E promoters not increased 
similarly? It could be that replication causes a structural 
change to the DNA template, either lasting or transient, 
which provides a switch for L gene expression. Or perhaps 
part of the replication machinery is needed in situ to 
initiate L gene transcription. In order to improve our 
understanding of late gene regulation, an investigation into 
the control of expression of a particular L gene of HSV-1 
was undertaken.
c . Gene USll
The gene chosen for study was USll (McGeoch et a l ., 
1985), which lies in the Ug sequence of the HSV-1 genome and 
encodes a protein of 161 amino acids with a predicted M.Wt. 
17756 (McGeoch et a l ., 1985), and has an apparent M.Wt. on 
SDS-polyacrylamide gels of 21000 (21K) (Rixon and McGeoch, 
1984). This late gene was an attractive candidate for an 
investigation of late promoter regulation since (i) the 
sequence of USll and its upstream region had been determined 
(Murchie and McGeoch, 1982), (ii) the position the 5' end of 
its RNA had been approximately mapped (Rixon and McGeoch,
1984) and (iii) a protein of this apparent M.Wt. has been 
preliminarily classified as one of the latest viral proteins 
to appear during lytic infection and subsequently to 
accumulate in large amounts (Marsden et a l ., 1976)
A 21K polypeptide has been shown to bind DNA, and 
appears to interact specifically with the a sequence of 
HSV-1 (Dalziel and Marsden, 1984). It is possible that this 
21K polypeptide is the product of USll, which is also a DNA 
binding protein (MacLean et a l ., 1987). The predicted 
product of USll has a very unusual amino acid composition. 
The carboxy-terminal portion of the protein contains 24 
tandem repeats of the sequence 'X-Pro-Arg', where 'X' may be 
any one of nine amino acids (Rixon and McGeoch, 1984). The 
high arginine content renders this a highly basic protein, 
consistent with it being a DNA-binding protein. However, it
82
is unlikely that the product of USll plays an important role 
in the lytic cycle of HSV-1, or more specifically, in DNA 
maturation, since (i) this protein localizes to the 
cytoplasm and nucleolus, neither of which during HSV-1 
infection contain unpackaged viral DNA (MacLean et a l .,
1987), and (ii) HSV mutants have been isolated which lack 
gene USll, which shows that this gene is dispensible, at 
least in tissue culture (Longnecker and Roizman, 1986;
Umene, 1986; Brown and Harland, 1987). This does not mean 
to say that the product of gene USll is not useful to HSV in 
some situations, and it would be of interest to discover its 
role.
The aims of the work described in this thesis were (i) 
to carry out a thorough analysis of the time-course of 
appearance and dependence on DNA replication of the RNA and 
protein products of USll during a normal viral infection,
(ii) to develop a plasmid based system to study the 
regulation of the USll promoter, and (iii) to determine the 
characteristics of a late promoter that distinguish it from 
those of IE and E classes.
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MATERIALS AND METHODS
SECTION F; MATERIALS
1. Viruses
HSV-1 Glasgow strain 17 syn+ (Brown et a l ., 1973) was 
used in most studies. PAA^-1, a PAA-resistant mutant 
of HSV-1 17 syn+ (Hay and Subak-Sharpe, 1976), was 
used for a control in one experiment.
2. Cells
(i) BHK21 clone 13 (MacPherson and Stoker, 1962), a 
fibroblastic cell line derived from baby ham ster 
kidney cells, was used for growth of virus and study 
of viral gene expression.
(ii) HeLa cells (obtained from D r .W.Schaffner, Zurich) 
were mainly used for transient assays.
(iii) COS-1 cells (obtained from Dr.R.M.Elliot), which 
express SV40 T antigen, were used in one transfection 
experiment.
3. Bacteria
The following strains of E.coli K12 were used:
(i) C600 (F“ , thi-1, thr-1, leu-6 , tonA21, supE44,
Appleyard, 1954), and HBlOl ( ramCl, F“ , proA2, galK2, 
strA, recA; Boyer and Roulland-Dussoix, 1969), were
used as hosts for pBR322-based vectors and pUC-CAT 
gene constructs.
(ii) JM83 (ara, lac-pro^el, strA, thi, p80d^^^M15^®^ ), 
was used as a host for cloning in a pUC9 vector.
(iii) JMlOl (lac-prodel^ supE, thi, F 'traD36, proAB, 
lacI9,ZM15de l . Messing et a l ., 1981), was the host 
strain used for Ml3 bacteriophage vectors; it harbours 
an F factor essential for the transmittance of the 
male specific phage.
(iv) GM48 (dam-6 , dam-3, qalT22, dral4, lacyl, thr-1, 
leu-6 , tonA31, tsxA78, supE44; Marinus, 1973), was 
used as a host to prepare unmethylated plasmid DNA.
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4. Cloning Vectors
(i) Most of the constructs made during this work used 
pRE3 (Moreau et a l ., 1981) as the vector. This 
plasmid was derived from pBR322 (Bolivar, 1977), and 
has a mutation in the BamHI site but retains 
resistance to tetracycline.
(ii) pUC9 (Vieira and Messing, 1982) was used for 
sub-cloning fragments for nuclear run-on experiments.
(iii) M13 bacteriophage vectors (Messing and Vieira,
1982) were used for the production of single-stranded 
DNA to assay for strand-specific RNA in nuclear run-on 
experiments. Cloned HSV-1 fragments were sub-cloned 
into the double-stranded replicative forms (RFs) of 
M13mpl8 and M13mpl9 (obtained from J.Scott).
5. Plasmids
The following plasmids (generously provided by the 
person indicated) were either used directly, or for 
the generation of further constructs:
(i) pGX57, pGX48, pGX156 (Dr.F.Rixon).
(ii) pDG8 (Dr.D.Gaffney).
(iii) pRED4, pREDS, pRED122, pERD130/33, pERD130/83, 
pOR33, pOR83, pDERS, pDERlO, pgDCAT, pSCAT, p63, 
p63dell, pSV63, pill, pl75, pP(244+)P
(Dr.R.D.Everett).
The structures of these plasmids are given in the 
relevant places in the text.
6. Reagents
Most chemicals were purchased from BDH Chemicals UK or 
Sigma Chemical Co., and were of analytical grade. 
Otherwise, Bio-Rad Laboratories supplied ammonium 
persulphate and TEMED, Koch-Light Laboratories 
supplied caesium chloride, sodium hydroxide and boric 
acid; Camlab (Cambridge) supplied TLC plates (0.25mm 
silica gel); Schleicher and Schuell supplied 
nitrocellulose paper; P-L Biochemicals Inc. supplied 
unlabelled nucleotides; and New England Biolabs
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supplied synthetic oligonucleotide linkers and Ml 3 
dideoxy sequencing primer.
7. Radiochemical8
Radioisotopes were obtained from Amersham 
International pic, at the following specific 
activities:
5 ' [0(_32p]5NTPs; 3000 Ci (110 TBq)/mmol 
5'[%-32p] ATP; 5000 Ci (185 TBq)/mmol 
5'[%_32p] UTP; 410 Ci (15.2 TBq)/mmol 
^^C Chloramphenicol (Sp. activity 45.5 Ci (1.7 
TBq)/mmol) was obtained from NEN Research Products, 
Boston (Mass.).
8. Enzymes
Restriction enzymes were obtained from Bethesda 
Research Laboratories (BRL), New England Biolabs, or 
Nbl Enzymes Ltd. SI nuclease, proteinase K, Klenow 
polymerase and T4 DNA ligase were from Boehringer 
Mannheim Corporation. BRL also supplied SI nuclease, 
and Bal 31 exonuclease. Bovine alkaline phosphatase 
(BAP) was obtained from Worthington and purified by 
M.Dunlop. Lysozyme was obtained from Sigma.
9. Tissue Culture Media
(i) BHK cells were grown in Glasgow Modified Eagle's 
Medium (Busby et a l ., 1964) supplemented with 100 
units/ml penicillin, lOOug/ml streptomycin, 0.2ug/ml 
amphotericin, 0 .002% phenol red, 10% tryptose 
phosphate, and 10% calf serum (= ETCIO).
(ii) HeLa cells were grown in Dulbecco's medium (Flow) 
supplemented with 20mM glutamine, 100 units/ml 
penicillin, lOOug/ml streptomycin, 0.2ug/ml 
amphotericin, 2.5% foetal calf serum and 2.5% calf 
serum.
(iii) COS-1 cells were grown in ECTIO medium, 
additionally supplemented with 0 .01% non-essential 
amino acids (Gibco) and 0.01% sodium pyruvate (Gibco), 
and 10% foetal calf serum in place of calf serum.
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Versene (0.6mM EDTA in PBS, 0.002% (w/v) phenol red) and 
trypsin (0.25% (w/v) (Difco) in tris-saline) were used 
for the washing and removal of cell monolayers during 
passaging or setting up sub-confluent monolayers for 
infections or transfections.
- PBS t 170mM NaCl, 3.4 mM KC1, lOmM Na2HP04 , 2mM KH2PO4 
(pH7.2).
Tris-saline: 140mM NaCl, 30mM KCl, 280mM Na2HP0 4 , 
Img/ml glucose, 0.0015% (w/v) phenol red, 25mM 
Tris.HCl (pH7.4),100 units/ml penicillin, lOOug/ml 
streptomyc in.
10. Bacterial Culture Media
All strains of bacteria were grown in L-broth, except 
for JMlOl which was grown in 2YT broth. Agar plates 
contained 1.5% (w/v) agar in L-broth. Where 
appropriate, media was supplemented with ampicillin 
(lOOug/ml), tetracycline (15ug/ml), or chloramphenicol 
(lOOug/ml). JMlOl was plated on L-broth agar which 
had been surface-treated prior to use with 25ul of 
5-bromo-4-chloro-3-indoxyl-p-D-galactoside (BCIG) 
(25mg/ml in dimethylformamide) and 25ul of isopropyl- 
-D-thiogalactoside (IPTG) (25mg/ml in H 2O), in order 
to colour-test for the insertion of DNA into the 
multiple cloning site (mes) of MlSmp phage vectors.
- L-broth; 177mM NaCl, lOg/l Difco Bactotrytone, 5g/l 
yeast extract (pH7.5 pre-sterilization).
- 2YT broth: 85mM NaCl, 16g/l Difco Bactopeptone, lOg/l 
yeast extract (pH7.5 pre-sterilization).
11. Solutions
TE: lOmM Tris.HCl (pH8.0), ImM EDTA.
TBE: 90mM Tris, 90mM boric acid, ImM EDTA (pH8.3).
SSC: 0.15M NaCl, 0.015M tri-sodium citrate (pH7.5).
STE: 150mM NaCl, lOmM Tris.HCl (pH7.5), ImM EDTA.
STET: 50mM Tris.HCl (pH8.0), 50mM EDTA, 8% (w/v)
sucrose, 5% (v/v) Triton X-100.
TEN: lOOmM NaCl, 50mM Tris.HCl (pH7.5), lOmM EDTA.
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RNA Lysis Buffer: lOmM NaCl, lOmMTris.HCl (pH7.8), 2mM
MgC 1 2
Sucrose Gradient Solution: 25mM Tris.HCl (pH7.4), 200mM
NaCl, 5mM EDTA, 0.1% (v/v) sarkosyl, 5ug/ml 
EtBr (plus 5 or 20% (w/v) sucrose).
Elution Buffer: 500 mM NH4A C ., lOmM MgAc., 0.1% (w/v)
SDS, ImM EDTA.
TE(P) ImM Tris.HCl (pH7.5), 0.05mM EDTA.
2X HBS 280mM NaCl, 50mM HEPES, 1.5mM Na2HP04 (NaOH to
pH7.12).
Gel Soak I: 200mM NaOH, 600mM NaCl.
Gel Soak II: IM Tris.HCl (pH8.0), 0.6M NaCl.
5OX PAF 1% (w/v) polyvinylpyrrolidone, 1% (w/v)
Ficoll, 1% (w/v) BSA.
Loading Buffer: 49% (v/v) IX TBE, 1% (v/v) 10% SDS, 50% 
glycerol, O.lg/lOOml bromophenol blue.
Formamide Dyes: 98% (v/v) de-ionised formamide, 2%
(v/v) 0.5M EDTA, plus O.lg/lOOml xylene 
cyanol, O.lg/lOOml bromophenol blue.
lOX BRL CORE Buffer: 500mM Tris.HCl (pH8.0), lOOmM
MgCl2, 500mM NaCl.
5X Pst; 30mM Tris.HCl (pH7.8), 30mM MgCl2, 250mM NaCl, 
30mM B-mercaptoethanol.
lOX Dpnl: 60mM Tris.HCl (pH8.3), 1.5M NaCl, 6mM MgCl2, 
7mM B-mercaptoethanol.
5X Bal31: 20mM Tris.HCl (pHS.O), 200mM NaCl, 12mM MgCl2, 
12mM CaCl2, ImM EDTA.
5X Ligase Buffer: 250mM Tris.HCl (pH7.5), 50mM MgCl2,
50ug/ml BSA, lOOmM DTT.
lOX NT: 0.5M Tris.HCL (pH7.5), lOOmM MgCl2, lOOmM DTT,
500ug/ml BSA.
5X Kinase Buffer: 350mM Tris.HCl (pH7.5), 50mM MgCl2,
25mM DTT.
5X SI: 150mM NaAc. (pH4.5), 15mM ZnS04 , 2M NaCl.
lOX PIPES: 400mM PIPES (pH6.5), lOmM EDTA.
SI Stop: 0.5M Tris.HCl (pH8.0), lOOmM EDTA.
PK Buffer: 15mM Tris.HCl (pH8.0), ImM CaCl (plus
proteinase K @ lOmg/ml).
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SECTION G : METHODS
1. Tissue Cell Culture
Cells were usually passaged in IVScm^ (Nunclon) flasks, 
and kept in an atmosphere of 95% air, 5% C O 2 at 37°C. For 
storage, cells were harvested, pelleted (at 1500 rpm), and 
resuspended at approximately 10  ^ cells/ml in storage medium 
(15% foetal calf serum, 10% DMSO, 75% growth medium). 
Aliquoted cells were frozen slowly to -140^0. For recovery, 
cells were thawed quickly and resuspended in growth medium.
2. Virus Preparation
BHK cells in 80oz roller bottles were infected with 
HSV-1 at an moi of 0.003 pfu/cell (10& virus per bottle) in 
40ml ETCIO. Virus-infected cells were incubated at 31°C for 
3-4 days until extensive cytopathic effect (CPE) had 
developed. Cells were removed by shaking into the medium, 
and pelleted (MSE Coolspin, 1500 rpm/ lOmin/ 4^C). 
Supernatant medium was further centrifuged (Sorvall SS34 
rotor, 12K rpm/ 2h/ 4°C) to concentrate cell-released virus 
(CRV), which was sonicated and stored at -70°C. The 
pelleted material from the low-speed centrifugation was 
sonicated in a small volume of ETCIO for recovery of 
cell-associated virus (CAV). Cell debris was removed by 
further low-speed centrifugation, and sonicated and 
centrifuged again if necessary. Supernatant containing CAV 
was stored at -70^0.
The CRV and CAV fractions were checked for sterility (on 
blood agar plates) and titrated on BHK cell monolayers in 
the presence of human serum, as described by Brown et a l .
( 1973) .
3. Large Scale Plasmid Preparation
An "overnight" incubation of a bacterial colony 
(containing the desired plasmid) in 3ml L-broth was 
transferred to 800ml L-broth in a 21 shaking flask.
Bacteria were grown shaking at 370^ until an OD550 of about 
0.8 had been reached. Chloramphenicol was then added (final 
concentration lOOug/ml), and the culture was shaken
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overnight to amplify plasmid DNA.
Plasmid DNA was prepared by the "maxi-boiling" method 
(Holmes and Quigley, 1981). Bacteria were pelleted (Sorvall 
GS3 rotor, lOK rpm/ 6min/ R T ) and resuspended in 34ml STET, 
followed by the addition of 4ml of freshly prepared lysozyme 
(lOmg/ml). The suspension was brought to 100^0 for 45sec 
and the lysate cleared by high speed centrifugation (Sorvall 
SS34 rotor, 20K rpm/ 45min/ IS^C). DNA in the supernatant 
was precipitated with 0.9vol isopropanol and pelleted (MSE 
coolspin 3K rpm/ 4min/ RT). The pellet was resuspended in 
TE followed by the addition of CsCl to a final density of 
1.6g/ml and EtBr to 0.5mg/ml. DNA was banded by ultra­
centrifugation either in a Ti50 angle rotor (45K rpm/ 2-3 
days/ IS^c) or in a TV865 vertical rotor (40K rpm/ 16-20h/ 
15°C). The DNA was visualized in daylight or long wave uv 
light, and collected by side-puncture with a syringe. First, 
the upper band (chromosomal DNA) was removed and discarded; 
the lower band (supercoiled plasmid DNA) was then collected, 
extracted twice with butan-l-ol (saturated with TE) to 
remove EtBr, and dialysed for 3h against TE. The dialysed 
DNA was then treated with 50ug/ml RNAase A (Ih/ ), and
then with 50ug/ml proteinase K plus 0.1% (w/v) SDS (Ih/
37t>c ). Enzymes were removed by extraction with phenol and 
then chloroform and the DNA was precipitated twice with 
ethanol. Lyophilized DNA was resuspended in TE, the volume 
being adjusted to reach a final concentration of lug/ul 
estimated by spectrophotometry (AbS260  ^* 0 = 50ug DNA/ml).
4. Small Scale Plasmid DNA Preparation ("Miniprep")
Tubes containing 3ml of L-broth were inoculated with 
single plasmid-transformed bacterial colonies and incubated 
shaking at 370c overnight. Up to 24 samples were then 
processed simultaneously. Half the bacterial suspension was 
poured into a 1.5ml reaction vial and centrifuged for 15sec 
in a benchtop microfuge (<12K rpm). The remaining culture 
was kept at RT until its future requirement had been 
determined. The bacterial pellet was resuspended in 200ul 
STET and 5ul lysozyme (lOmg/ml), placed in a boiling water
bath for 45sec, and centrifuged (12K rpm) for lOmin. The
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glutinous pellet was discarded, and 0.9vol isopropanol added 
to the supernatant. The precipitated nucleic acids were 
pelleted (12K rpm/ 5min), washed in 70% ethanol and 
lyophilized. Finally, the pellet was resuspended in 20ul 
3mM EGTA and stored at 4^0. The addition of 0.2ul RNAase 
(Img/ml) to each restriction digest of miniprep DNA helped 
to visualize bands following gel electrophoresis.
5. Preparation of Single-Stranded Ml3 Phage-Vector DNA
1.5ml of a 1:100 dilution of "overnight" JMlOl bacteria 
in 2YT broth was inoculated with Ml3 phage from a plaque. 
Phage and bacteria were grown shaking at 370^ for 5-6h. The 
bacteria were then pelleted and the supernatant containing 
the phage was carefully transferred to a new 1.5ml vial. 
Phage were precipitated by the addition of 150ul 20% (w/v) 
polyethylene-glycol 6000 (BDH), 2.5mM NaCl, and pelleted.
The pellet was resuspended in lOOul TE buffer, then 
extracted with phenol, and precipitated with ethanol. The 
DNA was then lyophilized, and resuspended in 30ul TE buffer. 
Its concentration was determined by spectrophotometry. For 
large scale preparations of Ml3 DNA, this method was scaled 
up by 10-fold, and yielded approximately 0.5mg DNA.
6 . Preparation of Cytoplasmic RNA
Cytoplasmic RNA was prepared from tissue culture cells 
grown on 90mm Petri dishes. All solutions and vessels up 
until the phenol/chloroform extraction steps were cooled on 
ice. Cells were washed and harvested in STE, then pelleted 
(MSE Coolspin, 2K rpm/ 30sec/ 4°C), washed in STE again, and 
re-pelleted. Following resuspension in lysis buffer plus 1% 
(v/v) NP40, and a 2min incubation on ice, nuclei and 
cytoplasmic fractions were separated by centrifugation (MSE 
Coolspin, 3K rpm/ 3min/ 4°c). The supernatant was added to 
an equal volume of STE containing 2.5% (w/v) SDS, and 
extracted three times with phenol/chloroform, and once with 
chloroform. RNA was twice precipitated with ethanol, washed 
(70% ethanol), lyophilized, and resuspended in 20ul H 20.
The concentration of RNA was determined by spectrophotometry 
(AbS26Q 1.0 = 40ug RNA/ml).
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7. Preparation of Nuclear DNA
The cell-nuclei pellet from NP40-lysed cells (as above) 
was resuspended in SSC containing 0.6% (w/v) SDS, and 
treated with proteinase K (at lOOug/ml) for 3h at 37^0. 
Nucleic acid was extracted with phenol and chloroform, 
precipitated with ethanol, and resuspended in SSC prior to 
treatment with RNAase (at 50ug/ml) for 2h at 37°C. DNA was 
again phenol and chloroform extracted, and precipitated in 
ethanol. Lyophilized DNA was resuspended in 50ul TE, and 
its concentration determined by spectrophotometry.
8. Restriction Enzyme Digests
Restriction digests for diagnostic purposes were usually 
carried out in 15ul volumes of IX Pst buffer using 0.5ug 
plasmid DNA and 1 unit of enzyme for Ih at 370c, unless the 
reaction conditions specified by the enzyme supplier 
differed radically. Notably, Smal digests were carried out 
in 20mM KCl in place of NaCl; Sail digests required high 
salt (150mM NaCl) conditions; and TaqI and BstNI worked best 
at high temperature (65°c). For cloning and preparation of 
probe DNA, the incubation time and enzyme units were 
increased according to the amount of DNA to be cleaved, and 
the importance of achieving complete digestion. DNA 
fragments greater than 200bp were analysed on agarose gels 
with concentrations varying from 0.7 - 2.5% (w/v). DNA 
fragments of less than 500bp were analysed on non-denaturing 
5 - 8 %  (w/v) polyacrylamide gels, using 2ug of DNA per 
digest. Larger quantities of DNA (5-50ug) were sometimes 
fractionated by sucrose density gradient centrifugation.
9. Separation and Preparation of Purified DNA 
Restriction Fragments
(i) Non-denaturing agarose gels:
Slab gels of 0.7 - 2.5% (w/v) agarose in IX TBE were run 
submerged in IX TBE at up to 12V/cm. Samples were loaded in 
O.lvol loading buffer. Following gel electrophoresis, DNA 
was visualized by staining in EtBr (lug/ml) prior to 
examination under in short-wave or long-wave uv light.
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Short-wave uv light is more senstitive but damages the DNA. 
Long-wave uv light was used if DNA was to be recovered. To 
obtain a purified restriction fragment from a gel, a strip 
of DE-81 paper (previously treated with 2. 5M NaCl, washed, 
and stored at 4°C in ImM EDTA) was inserted below the 
required band and electrophoresis continued until the 
fragment had been adsorbed to the paper. The DNA was eluted 
from the DE-81 paper by pulverization and agitation (2h at 
370c) in 1.5M NaCl, lOmM Tris.HCl (pH8.0), ImM EDTA, and 
then strained through siliconized glass wool prior to 
ethanol precipitation.
(ii) Non-denaturing polyacrylamide gels
Polyacrylamide gels were prepared in a vertical gel
sandwich (0.35mm or 1mm thickness) using 5 or 8% (w/v) 
acrylamide: bis-acrylamide (19:1), diluted from a 20% stock 
solution, in IX TBE. For 0.35mm gel sandwiches, the 
acrylamide solution was filtered (0.45um millipore filter) 
and de-gassed before the addition of catalysts. 
Polymerization was catalysed by mixing in O.lvol 10% (w/v) 
ammonium persulphate and O.Olvol TEMED, before pouring the 
solution between the cleaned glass plates and inserting a 
gel comb. Samples were loaded as above, electrophoresed at 
a maximum voltage of 16v/cm, and the DNA visualized by EtBr 
staining or autoradiography. On occasion, DNA was recovered 
from a polyacrylamide gel slice by extrusion through a 
pierced 0.7ml reaction vial by centrifugation (12K rpm/
20sec) into a 1.5ml reaction vial. The DNA was eluted by 
shaking overnight in 1ml elution buffer at 370c, filtering 
the slurry through glass wool and then precipitation (twice) 
with ethanol in the presence, if necessary, of carrier tRNA 
(Sigma).
(iii) Strand-separation polyacrylamide gels
A 30% (w/v) stock solution of acrylamide/bis-acrylamide 
(59:1) was diluted to 8% in IX TBE, polymerized as above, 
and poured into a sequencing gel sandwich (230mm x 450mm x 
0.35mm). The gel was pre-run at 400V in the cold for 30min. 
Ethanol-precipitated end-labelled DNA fragments were
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resuspended in 2vols IX TBE plus Ivol DMSO, heated at 90^0
for 2min and rapidly cooled prior to loading, then 
elecrophoresed in the cold at 400V overnight. Single 
stranded DNA bands, visualized by autoradiography, were cut 
out and eluted directly into elution buffer, as above (ii).
(iv) Denaturing polyacrylamide gels
This type of gel was used to analyse the products of SI 
mapping and DNA sequencing reactions (Maxam and Gilbert, 
1980). Gels were prepared to a final concentration of 8% 
acylamide/bis-acrylamide (19:1), IX TBE, and 7M urea. This
solution was filtered, de-gassed and polymerized as 
described above (ii), and pre-run for 30min at 40W. 
Lyophilized samples were resuspended in 5 to lOul formamide 
dyes mix, denatured at 90^0 for 2min, and run at 40W for an 
appropriate length of time (usually 2-5h). Radiolabelled 
DNA was detected by autoradiography.
(V ) Sucrose gradients
5-20% (w/v) sucrose gradients were poured into 
pol yallomer tubes using a peristaltic pump linked to a 
mixing chamber. Between 10 to 50ug of DNA in lOOul TE was 
carefully applied to the top of the gradient. The samples 
were placed in a swing-out rotor (Sorvall AH650), and 
centrifuged according to the sizes of the fragments being 
separated (30-4ÜK rpm/ 3-20h/ 15°c). Bands, visualized by 
long-wave uv light, were removed by side puncture, and 
purified by phenol/chloroform extraction and ethanol 
precipitation. Lyophilized DNA was taken up in 20ul H 2O.
10. Radioactive Labelling of DNA
(i) 5 '-end labelling
To prepare a 5'-end labelled probe for SI nuclease 
mapping, plasmid DNA was restricted with appropriate enzymes 
and treated with bacterial alkaline phosphatase (BAP) to 
remove 5 '-terminal phosphate groups. The BAP was removed by 
phenol/chloroform extraction (3 times) and DNA was then 
ethanol precipitated. Lyophilized DNA was then taken up in
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H 20 at a concentration of about Ipmol/ul, and stored at 
-20°C. Ipmol of DNA (sufficient for about 50 SI nuclease 
reactions) was added to lOOuCi of 5'[#-32p] in 15ul
final volume of IX kinase buffer, and treated with 5 units 
of T4 polynucleotide kinase for 45min at 370c.
Unincorporated radio-nucleotides were removed by ethanol 
precipitation in the presence of carrier tRNA, and a 70% 
(v/v) ethanol wash. The pellet was lyophilized, and the 
labelled DNA strands fractionated and strand separated as 
described above (part 9(ii)).
(ii) Nick translation
lOOug of DNA was radiolabelled (Rigby et a l ., 1977) by 
the addition of 5uCi each of all four 5'[K-32p]d#TPs, 1 unit 
of E.coli DNA pol I, and 0.lug/ml DNAasel, in a final volume 
of 12.5ul IX NT buffer. The reaction was incubated at RT 
for 2h, and stopped by mixing with an excess of 1% (w/v) SDS 
in TE (with bromophenol-blue). Unincorporated radioactivity 
was removed by fractionation on a G50 Sephadex column, 
equilibrated with 0.1% SDS in TE. The fastest running peak 
of radioactivity (ahead of the dye) contained the 32p_£>isiA.
11. Quanti tat ion of Autoradiographs
Where appropriate, the amount of radioactive product was 
quantified by densitometry of autoradiographs using a 
Joyce-Loebl scanning densitometer. The areas under the 
peaks of the densitometer tracing were measured using a 
programme, DENS, written by Dr. P.Taylor for a DEC PDP 11/44 
computer linked to a digitizing tablet. The response to 
Kodak XSl film was found to be linear over the optical 
density range of the peaks analysed.
12. Ligations
DNA-DNA ligations were performed in 10-20ul IX ligase 
buffer, containing 0.5mM ATP, 1-2 units of T4 DNA ligase, 
and 50-500ug DNA. The amount of DNA and ligase used 
depended on the expected difficulty of the ligation reaction 
(e.g. blunt-ended vs sticky-ended), and the competence of 
the bacteria to be transformed with the ligation mix.
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For blunt-end ligations, restricted or exonuclease 
treated DNA was incubated with Klenow DNA polymerase and all 
four dNTPs (0.05mM each), in order to fill-in an 
underhanging 5' end or trim back an overhanging 3'-end, 
where necessary.
A 10-fold molar excess of a DNA fragment, or a 20 to 
50-fold molar excess of a linker, was used to improve the 
efficiency of simple insertions into a linearized vector, 
prior treatment of the vector with BAP also helped to 
increase the proportion of colonies with vectors containing 
insertions.
13. Bal 31 Exonuclease Digestion
20ug of linearized plasmid DNA was treated with 1 unit 
of the processive double-stranded exonuclease, Bal 31, in IX 
Bal 31 buffer at 31*^c for various lengths of time 
(0.5-10min). Exonuclease activity was stopped by quenching 
with an excess of 20mM EGTA/phenol (1:1). The extent of 
nuclease activity was determined by running samples from 
each time point on an agarose gel after cutting with a 
suitable restriction enzyme.
14. Preparation of Competent Bacteria
(i) For plasmid transformations
An overnight culture of bacteria was diluted into 100ml 
L-broth, and aerated vigorously until an OD550 of 0.3 had 
been reached. The bacteria were then chilled on ice for 
lOmin, and pelleted (Sorvall GSA rotor 6K rpm/ lOmin/ 4^C). 
The pellet was resuspended and left in 40ml ice-cold O.IM 
CaCl2 for 20 min. The bacteria were then re-pelleted, 
resuspended in 2ml O.IM CaCl2, and left on ice overnight. 
0.2vol sterile glycerol was mixed in with the competent 
bacteria, which were then rapidly frozen in 100-200ul 
aliquots and stored at -70^c.
(ii) For M13 transfections
For transfection by Ml3 vector DNA (replicative form — 
RF), 0.2ml of a JMlOl "overnight" culture was diluted into
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20ml 2YT broth and grown shaking for 2h (or until 
00650=0 .3). The cells were pelleted at 4°C and resuspended 
in 10ml ice-cold CT (50mMCaCl2, lOmMTris.HCl (pH7.5)). 
After leaving on ice for 20min, the cells were pelleted 
again, then taken up in 2ml ice-cold CT, and used within 
48h.
15. Transformation and Transfection of E.coli
(i) Transformation by plasmid DNA
1-lOul plasmid DNA solution was added to 100-200ul 
competent bacteria, and left on ice for about 20min. The 
bacteria were heat-shocked in a water-bath at 31'^c for Imin, 
and then incubated for 30min after the addition of SOOul of 
pre-warmed L-broth. The bacteria were then spread onto 
L-broth agar plates containing appropriate antibiotics, and 
incubated overnight at 37C>c.
(ii) Transfection by M13 phage vector
A colour test can help predict the successful insertion 
of DNA into the multiple cloning site (mes) of M13 RF DNA. 
The mes lies in a truncated ^>-galactosidase (P-gal) gene, 
whose encoded peptide complements the enzymatically inactive 
product of the lacZ MlS^el mutation in JMlOl. Thus, in the 
presence of the lacZ transcriptional inducer, IPTG, and the 
hydrolyzable substrate BCIG (or Xgal), activity of the M13 
encoded peptide can be assessed by the appearance of blue 
plaques when plated on a lawn of JMlOl; the blue colour
being due to the product of BCIG cleavage by ^-gal. A
"white" plaque potentially contains a phage with a fragment 
inserted into the mes, which has disrupted the coding 
sequences of the Ml3 portion of the 3-gal gene.
20ng of RF vector/ligation mix was added to lOOul of 
competent JMlOl and left on ice for 40min. The cells were 
then heat-shocked at 42°C for 5min, and added to 3ml molten 
top-agar containing 25ul BCIG (25mg/ml in
dimethylformamide), 25ul IPTG (25mg/ml in H 20), and 20ul of
an "overnight" JMlOl culture. The mixture was poured onto 
L-broth plates which were then incubated overnight at 37oc.
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16. DNA Sequencing
DNA sequencing by the chemical degradation method was 
employed to confirm the identity of plasmid constructions 
and determine deletion end-points. Dideoxynucleotide 
sequencing was used to analyse M13 DNAs used for the strand 
specific detection of RNA in nuclear run-on experiments. 
These methods are outlined below; the detailed procedures 
are described in the cited papers.
(i) Chemical method
The nucleotide sequences of 5'-end labelled DNA 
restriction fragments were determined by the methods of 
Maxam and Gilbert (1977, 1980). These methods are based on 
the specific modification of DNA bases followed by their 
removal and cleavage of the DNA backbone. In outline, the 
methods are as follows. The purine reaction was conducted 
by incubating about O.lpM of DNA in 15ul of depurination 
(DPU) mix (66% (v/v) formic acid, ImM EDTA, 2% (w/v) 
diphenylamine) for 2min at 250c. The reaction was stopped 
by ether extraction and lyophilization. Guanine residues 
alone are modified by dimethylsulphate (DMS ). The 
modification of cytosine residues reaction used hydrazine in 
the presence of 1.5M NaCl for 2min at 25°c (both C and T are 
modified in the absence of NaCl). This reaction was stopped 
by the addition of 0.3M NaCl and O.lmM EDTA and ethanol 
precipitation. In order to cleave the DNA at the modified 
bases, the lyophilized DNAs from the first reaction were 
resuspended in lOOul of freshly diluted IM piperidine, and 
incubated for 30min at 90°c. The cleaved DNAs were then 
ethanol precipitated and run on denaturing 8% polyacrylamide 
gels.
(ii) Dideoxynucleotide method
The M13 dideoxy sequencing method of Sanger et a l .
(1977, 1980) is based on the "random" termination at 
specific nucleotides of an elongating radiolabelled 
nucleotide chain. This is caused by the inclusion of a 
particular dideoxynucleotide (ddNTP) in a reaction to 
synthesize, using Klenow polymerase, the complementary DNA
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to a single-stranded Ml3 template from a primer 
complementary to sequences adjacent to the mes.
The sequencing primer was annealed to template DNA in 
lOmM Tris.HCl (pH 8.0), lOmM MgCl2 * Four reaction tubes 
were set up for each template; these contained all four 
dNTPs plus one ddNTP. Annealed template, 32p_d&TP and 
Klenow enzyme were then added to each reaction tube and 
incubated for 15min at RT. The reactions were completed by 
the addition of further dNTPs (0.25mM each) and either 
stored at -20Oq or run immediately on a denaturing 
polyacrylamide gel.
17. SI Mapping
5-20ug RNA was first denatured with 0.02pmol 32p end 
labelled probe DNA in 30ul of 40mM PIPES (pH6.5), ImM EDTA, 
400mM NaCl and 50% (v/v) formamide at 85°c for 5min, then 
allowed to hybridize at 42°c for 12-16h. Following 
hybridization, 60ul of 5X SI nuclease buffer, 210ul H 2O and 
5000 units of SI nuclease (Boehringer) (or 166 units, BRL) 
were added and the mixture incubated at 30°C for 3h.
Nuclease activity was stopped by the addition of lOOul 0.5M 
Tris.HCl (pH8.0), lOOmM EDTA. Nuclease protected hybrids 
were extracted with phenol/chloroform, and then ethanol 
precipitated. Protected hybrids were fractionated on an 8% 
denaturing polyacrylamide gel, and quantitated by 
densitometry.
18. Transfection of DNA into Tissue Culture Cells
Rapidly dividing cells were seeded at 30 to 40%
confluence on 90mm petri dishes 12-24h prior to 
transfection. TE(P) buffer was added to 10-20ug plasmid DNA 
to reach a final volume of 420ul. Then, 60ul of 2M CaCl2 
was added dropwise to the DNA-TE(P) whilst vortexing. The 
DNA-CaCl2 solution was then added dropwise to tubes 
containing 480ul 2X HBS, also whilst vortexing. The 
DNA-CaPO^ precipitate was allowed to form for 30min at RT, 
and was then applied dropwise to subconfluent cell 
monolayers, and swirled into the medium (15ml per 90mm 
dish). After 24h the cells were washed twice with 3ml
99
prewarmed medium, and were then usually incubated for 
another 24h, or infected with virus, prior to harvesting. 
Note that 50mm plates were used for CAT assays, so the 
quantity of DNA and volumes of solutions used for 
transfections were reduced by 3-fold.
19. Southern Transfer
Size fractionated DNA was blotted and immobilized on 
nitrocellulose membranes essentially by the procedure of 
Southern (1975). Following electrophoresis, an agarose gel 
was shaken for 45min in Gel Soak I (to denature the DNA), 
and then Gel Soak II (to neutralise the NaOH). The gel was 
placed on a large piece of Whatman 3mm paper (on a glass 
plate), which served as a wick to allow lOX SSC from a 
reservoir access to the gel. The gel was then overlaid with 
a similarly sized sheet of nitrocellulose (pre-treated with 
H 2O and lOX SSC), Whatman 3mm paper, and stack of paper 
towels, all under a 1kg weight. The transfer was left 
overnight. The following day, the nitrocellulose sheet was 
washed in lOX SSC, air-dried, and baked in a vacuum oven at 
80°c for 2h. Efficient transfer of DNA fragments from the 
gel was monitored by visualising blotted gels under 
uv-light.
20. DNA-DNA hybridization
Nitrocellose blots were pre-hybridized in 6X SSC, 5X 
PAF, 0.1% (w/v) SDS, 20ug/ml denatured calf-thymus DNA, at 
650c. Approximately 5 x 10^ cpm of probe DNA was hybridized 
to the blotted DNA in 20mM Tris.HCl (pH7.5), 6X SSC, lOX 
PAF, ImM EDTA, 0.5% (w/v) SDS, 50ug/ml denatured calf-thymus 
DNA, shaking at 65°c overnight. After hybridization, the 
blot was washed twice in 2X SSC plus 0.25% SDS, at 65°C for 
Ih, then rinsed in water at RT. The blot was then air-dried 
and autoradiographed.
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21 . CAT Assays
Chloramphenicol acetyl transferase activity was 
determined essentially as described (Gorman et a l ., 1982). 
Cells from 50mm transfection plates were washed in PBS, 
scraped into TEN, and resuspended in 75ul 0.25M Tris.HCl 
(pH7.8). The cells were lysed by sonication, and 
centrifuged (bench-top centrifuge, 12K rpm/ 2min) to remove 
debris. The cell extract supernatants were stored at -20^C.
Assay mixtures contained 25ul of supernatant, lul 50mM 
acetyl co—enzyme A, 14ul H 2O and 0.5ul ^^c chloramphenicol 
(45uCi/mM), and were incubated at 370c for Ih. The reaction 
was stopped by the extracting the chloramphenicol and 
acetylated products into 200ul ethyl acetate. The ethyl 
acetate was evaporated under vacuum, and the pellets were 
then disolved in a smaller volume (20ul) of ethyl acetate 
before spotting onto thin layer chromatography (TLC) plates. 
After running in 95% (v/v) chloroform, 5% (v/v) methanol, 
plates were air-dried and autoradiographed. The amount of 
radioactivity in the chloromphenicol and its 
3'-monoacetylated product (visualized by autoradiography) 
was determined by scintillation counting, enabling the 
percentage conversion of substrate to product to be 
calculated. The protein concentration of each extract was 
also determined, by the method of Lowry et a l . (1951) as 
outlined below, in order to calculate the percentage 
conversion of chloramphenicol per mg of protein in the 
extract.
Briefly, 20ul of extract in 0.25M Tris.HCl (pH7.8) was 
diluted with 80ul H 2O and mixed with 500ul of alkaline 
copper solution (2% (w/v) Na2C0 g in O.IM NaOH; 1% (w/v) 
CUSO4 .5H 2O; 2% sodium potassium tartrate; in a 100:1:1 
ratio), and left for lOmin at RT. Then, 50ul of H 20:Folin 
(3:1, freshly mixed) was added, and after 30min at RT the 
absorbance of the solution at 750nm was measured. The 
absorbance values were converted to milligrams of protein by 
comparison to a standard curve produced by using known 
quantities of BSA made up in 0.25M Tris.HCl (pH7.8).
101
22. Nuclear Run-On Assays
Run-on transcription in isolated nuclei was used as an 
assay to estimate the relative number of active RNA 
polymerase II molecules on a given gene, and thus give a 
direct indication of the rate of transcription. The method 
given below was adapted from Greenberg and Ziff (1984), 
Godowski and Knipe (1986), and Yager and Bachenheimer 
(1987).
(i) Labelling RNA
Cells on 90mm plates were washed twice in ice-cold PBS 
and scraped into STE. The harvested cells were lysed in RNA 
lysis buffer during a 5min incubation on ice. Nuclei were 
pelleted (MSE Coolspin, 2K rpm/ 3min/ 4°c), washed in lysis 
buffer, then resuspended in 50ul 50mM Tris.HCl (pH8.3), 5mM 
MgC12f O.lmM EDTA and 40% glycerol. Run-on transcripts were 
labelled by incubating the nuclei for 30min at 30^0 in an 
equal volume (50ul) of reaction buffer (lOmM Tris.HCl 
(pH8.0), 5mM MgCl2, 300mM KCl, O.SmM ATP, 0.5mM CTP, 0.5mM 
GTP) plus 60uCi 5'[^-32p]uTP and 50 units of human placental 
RNAase inhibitor (Amersham). The labelling reaction was 
stopped by the addition of 25ug RNAase-free DNAasel (Sigma) 
in 150ul DNAase buffer (50mM Tris.HCl (pH7.5), 500mM NaCl, 
5mM MgCl2, ImM CaCl2). Following DNAase treatment at 30°C 
for 5min, lOOul of 2X extraction buffer (200mM Tris.HCl 
(pH7.5), 300mM NaCl, 25mM EDTA, 2% (w/v) SDS) containing 
200ug/ml proteinase K was added, and the samples were 
further incubated at 37°c, for 15min. Samples were then 
extracted against phenol/chloroform (3 times), then 
chloroform, and precipitated with ethanol. The RNA was 
pelleted, then treated with DNAasel and proteinase K as 
above, and extracted against phenol and chloroform, and 
finally precipitated with ethanol. Following 
lyophilization, RNA pellets were resuspended in lOOul H 2O 
and stored at -20®c prior to hybridization.
(ii) RNA-DNA hybridization
Single-stranded DNA was immobilized on nitrocellulose 
membranes using a Schleicher and Schuell slot-blot
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apparatus. lOug of DNA was applied per slot, in 150ul 6X 
SSC. The filters were rinsed in 2X SSC, air-dried, and then 
baked in vacuo at 80°C for 2h. The filters were then 
pre-treated with hybridization solution (50% (v/v) 
formamide, 5X SSC, 5X PAF, 0.2% (w/v) SDS, 50ug/ml yeast 
tRNA) for 4-12h at 42^C. Hybridization was in the same 
solution, plus 25ug/ml polyadenylic acid (Sigma), and the 
labelled RNA sample (pre-treated with O.IM NaCl on ice for 
30min). The hybridization was at 42°c for 36-48h. Filters 
were then washed twice in 2X SSC, 0.1% (w/v) SDS, and twice 
in 2X SSC, at R T . They were then treated with 50ug/ml 
RNAaseA, before twice washing again in 2X SSC, 0.1% SDS, as 
above. The final two washes were in O.IX SSC, 0.1% SDS, for 
15min at 560c. Filters were air-dried and autoradiographed.
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RESULTS
SEXZTION H : Viral USll Gene Expression
The aim of the work presented in this thesis was to 
determine the basis of the regulation of a true late gene.
To this end, the initial part of the study involved the 
detailed characterization of a true late gene, USll, and 
comparison of its temporal regulation with that of a gene of 
an earlier temporal class. The time—course of appearance 
and accumulation of USll RNA was compared with that of US6, 
which encodes glycoprotein D (gD). The gD promoter is 
activated by IE gene products early in infection (Watson ejf 
al., 1983, Everett, 1984a,b), but since it requires DNA 
replication for maximal expression (Johnson and Spear, 1984) 
it has also been described as an EL gene. The positions of 
the USll and gD genes in the viral genome are shown in 
Figure 6a.
1. Location of the USll RNA cap sites
USll RNA was first identified and its approximate 5' 
terminus mapped against size standards by Rixon and McGeoch
(1984). The positions of the 5' ends of USll RNA have been 
analysed here in more detail by SI nuclease mapping. The 
probe used for mapping was the appropriate ^2p end-labelled 
single strand from a BamHI-TaqI fragment of pDG8 (Figure 
6b), isolated on a strand-separating 8% polyacrylamide gel. 
The correct strand was identified by DNA sequencing (not 
shown). The probe was hybridized to total cytoplasmic RNA 
made at 8h after HSV-1 adsorption (p.a.) to BHK cells, using
0.02pmol of probe and 5ug of RNA as described in Materials 
and Methods. After treatment with SI nuclease, Sl-resistant 
bands were identified on an 8% polyacrylamide sequencing 
gel, and their sizes were determined by comparison to an A+G 
DNA sequence ladder made from the same probe DNA, run in the 
adjacent lane (Figure 7). The 5' ends of USll RNA map at 
positions 121, 123, 124 and 127 nucleotides inside Ug
(coordinates 12859, 12857, 12856 and 12853 respectively of 
the published Ug sequence - McGeoch et a l ., 1985). These
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Figure 6 . The genome structure of HSV-1 and the location
of the USll and gP genes
a. Prototype viral genome indicating the short and long 
unique regions (Ug and U^), and the terminal and 
internal repeated regions (TR and IR). The locations 
and orientations of the five IE RNAs are shown, as are 
the positions of the USll and gD transcripts.
b. The 5' termini and coding sequences (open boxes) for 
the family of three 3' co-terminal genes located about 
the TRg/Ug junction. Numbering refers to bp from the 
TRg/Ug junction (coordinate 12979 of U g ; McGeoch ^
a l ., 1985). Also indicated are the TRg origin of DNA 
replication (hatched box; Stow and McMonagle, 1983), 
and the probe used for SI mapping of USll RNA. The 
probe was single-stranded, and labelled at the
indicated Taql site of pDG8 [pDG8 is a pBR322 based 
plasmid containing an HSV-1 insert (BamHI-Hindlll) as 
shown in the figure].
c. Detail of the gD terminus and coding region (open box), 
and the single stranded probe used for SI mapping gD 
RNA (32p labelled at the indicated BstNI site of 
pGX48). Numbering is as described by McGeoch et a l .
(1985), where 1 is the first base of Ug at the Ug/iRg 
junction.
d. DNA sequence around the USll 5' mRNA termini (Rixon and 
McGeoch, 1984), indicating cap site usage of the USll 
gene, as described in the text. A potential TATA box 
at -26 relative to the USll transcription start at +1 
(121bp inside Ug, or coordinate 12859, McGeoch et a l .,
1985), is underlined.
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Figure 7 . USll RNA cap sites
Lane 1, A+G sequence reaction of the 5 '-end labelled 
probe shown in Figure 7b; lane 2, protected hybrids from 81 
nuclease mapping of RNA produced 8h after infection of BHK 
cells with HSV-1. The nucleotide sequence of the 'sense' 
strand (complementary to the probe) around the cap sites is 
given. Interpretation of the data takes into account that 
the sequence track is displaced down the gel by one base 
compared to the Si hybrids, due to the chemistry of the 
sequencing reaction.
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results are in close agreement with previous data (Rixon and 
McGeoch, 1984), although "nibbling" by SI nuclease may be 
responsible for one or two of the apparent starts, or cause 
the exact positions of the 5' ends to be underestimated by 
about a single nucleotide. The major cap site employed by 
USll is taken to be at position 121 (as numbered in Figure 
6b), and is indicated on the nucleotide sequence in Figure 
6d as +1. The potential TATA box identified by McGeoch et 
al . (1985) is located between 21 and 26 nucleotides upstream 
from the major cap site, and is shown underlined in Figure 
6d.
2. Appearance of USll and gP transcripts during viral 
infection
The time of appearance and subsequent accumulation of 
gD and USll transcripts during a lytic viral infection of 
BHK cells was determined by quantitative SI mapping of total 
cytoplasmic RNA using the specific, 5' end-labelled probes 
described above and shown in Figures 6b and 6c. The gD 
promoter and cap sites have been described by Watson et a l . 
(1983) and Everett (1983, 1984b). A series of 90mm petri
dishes containing BHK cell monolayers, at 75% confluence, 
were infected with HSV-1 at a multiplicity of 20 pfu per 
cell for a Ih adsorption period, in a volume of 1.5ml of 
growth medium. Infected monolayers were then incubated 
further in 15ml of growth medium, and at various times 
post-adsorption the cells were harvested for the preparation 
of RNA for analysis.
USll transcripts could be consistently detected at very 
low levels by 2h p.a., then rose dramatically until between 
6 and lOh, and were maintained at a high level until 24h 
p.a. (Figures 8 and 9), despite considerable and increasing 
cytopathic effect from 16h p.a. onwards. In comparison, gD 
transcripts were first detected at Ih p.a., accumulated to a 
maximum level at 4-5h, and then gradually diminished 
(Figures 8 and 9). This result confirmed previous findings 
regarding transcription of the gD gene (Dr. R.D.Everett, 
personal communication). Thus, by the criteria of simple
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Figure 8 .
Time course of appearance (h post adsorption) and 
accumulation of USll (a,b) and gD (c,d) transcripts in the 
presence and absence of PAA. The SI resistant hybrids 
corresponding to the 5' starts of the USll and gD RNA are 
indicated. a,c; Without PAA. b,d; PAA included before, 
during and after the infection at 300 ug/ml, MI, 
mock-infected.
l6)(a)
1000
100
S 1000
100
Time after adsorption (h)
Figure 9 .
Time course of appearance, accumulation, and 
sensitivity to PAA of USll and gD transcripts (a and b 
respectively) and protein products (c and d respectively). 
PAA absent, open circles; PAA present, closed circles. 
Autoradiographs of the SI gels shown in Figure 8 and the 
protein gels shown in Johnson et a l . (1986), were scanned by
densitometry (see Materials and Methods) in order to 
quantitate the relative amounts of USll and gD gene 
products. Note that the vertical scale is logarithmic.
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kinetics of appearance, USll is of a later class than the gD 
gene. However, the definitive characteristic of a true late 
gene has been described as its dependence on DNA replication 
for expression (Wagner, 1985; Roizman and Batterson, 1985). 
Therefore, the effect of inhibition of DNA replication on 
USll transcription during viral infection was investigated.
Viral DNA synthesis was inhibited by maintaining cells 
in medium containing 300ug PAA per ml Ih before adsorption 
and throughout infection. In the presence of PAA, USll 
transcripts were again first detected at 2h p.a., but did 
not rise substantially above this level at later times 
(Figures 8B and 9). Accumulation of USll transcripts was 
inhibited by PAA between 50 to 100-fold (Figure 9). The 
level of USll transcripts made from mutant PAA^-l-infected 
cells at 16h was similar to unrestricted wild-type levels, 
and was unaffected by the presence of PAA (data not shown). 
This indicated that PAA at a concentration of 300ug/ml did 
not have any indirect effect on USll transcription other 
than by inhibiting the DNA replication of PAA-sensitive 
virus. In contrast, the time course of gD expression in the 
presence of PAA was unchanged, but the total level of gD 
transcripts was reduced by 5 to 10-fold (Figures 8D and 9). 
Thus there is a clear difference between the regulation of 
transcription of gD, an EL gene, and USll, a "true late" 
gene.
In one time-course experiment (not shown), RNA was 
isolated from the nucleus and cytoplasm of BHK cells which 
had been infected with HSV-1 in the presence and absence of 
PAA. The level of correctly initiated USll RNA in the 
nucleus corresponded with cytoplasmic levels at all times, 
both in the presence and absence of PAA. This experiment 
indicated that inhibition of DNA replication does not affect 
the transport of USll RNA to the cytoplasm. Regulation at 
the level of RNA transport to the cytoplasm appears to be 
involved in CMV late gene expression (Geballe et a l ., 1986).
3. Appearance of 21K polypeptide and glycoprotein D during 
viral infection
To confirm the difference in behaviour seen between gD
106
and USll RNAs, the appearance and accumulation of their 
protein products were simultaneously investigated under the 
above conditions by Christine MacLean (see Johnson et a l .,
1986). The product of USll, a 21kd protein (21K - see 
Section E(6c)), was detected by Western blotting using an 
oligopeptide-induced antiserum directed against the 
carboxy-termina1 seven amino acids of 21K, as predicted from 
the DNA sequence (McGeoch et a l ., 1985). Detection of gD 
was by immunoprécipitation of radiolabelled infected cell 
proteins using a gD-specific monoclonal antibody, kindly 
supplied by Ann Cross. The results are illustrated in 
Figure 9. Both 2IK and gD proteins were first detected at 
slightly later times than their respective RNAs. Continued 
accumulation of gD protein at late times during infection 
was observed, which contrasted with a decline in gD RNA 
accumulation during the corresponding period. This may 
reflect differences in the stability between gD RNA and 
protein products. The sensitivities of 2IK and gD protein 
synthesis to PAA were similar to those of their RNA 
synthesis. Therefore, the differences in regulation of the 
USll and gD genes observed by analysis of RNA are also 
observed by analysis of their protein products. Note that 2IK 
appears to be less stable than gD protein.
4. Accumulation of viral DNA in the presence and absence 
of PAA
For the purposes of this experiment, it was important 
to establish that the use of PAA had indeed inhibited viral 
DNA replication. Total DNA was extracted from the nuclei of 
the same cells used for the preparation of cytoplasmic RNA 
in the above experiment, and analysed for the presence of 
viral DNA sequences using a nick-translated probe, pGX156 
(Rixon and McGeoch, 1985), which contains the entire Ug 
sequence. Figure 10 shows that the amount of viral DNA 
detected began to increase between 2-3h p.a.. In the 
presence of PAA, there was no obvious increase in the level 
of virus DNA. The histogram in Figure 10 shows that the 
level of background hybridization of pGX156 to DNA from 
mock-infected cells was similar to that with DNA from 
PAA-treated cells. The histogram also confirms that PAA did
to
>-
ce
<
ce
CD
ce
<
1000
100
Ml PAA’-1
TIME P.A. (HOURS)
Figure 1 0 . Effect of PAA on viral DNA synthesis
Dot blets of infected cell DNA hybridized to nick 
translated pGX156 (which contains the entire Ug sequence) 
were aytoradiographed and quantified by densitometry. 
Results from cells either mock infected (MI) or infected 
with PAA^-1 at 16h post-adsorption are shown in the 
histogram. PAA absent, open symbols; PAA present, closed 
symbols.
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not inhibit DNA replication of the PAA resistant mutant, 
PAA^-1. Thus it can be concluded that under the conditions 
in which the addition of PAA led to an absence of detectable 
viral DNA synthesis, the expression of USll was decreased by 
50 to 100-fold
5. HSV-1 infection of HeLa cells
HSV-1 strain 17 syn+ is routinely grown on BHK cells. 
However, for studying the expression of a plasmid-borne USll 
promoter in subsequent experiments, HeLa cells were likely 
to be more useful than BHK cells due to their better 
transfection efficiency. Accordingly, the time course of 
USll and gD transcript accumulation was also examined during 
infection of HeLa cells. The graphs in Figures 11a and 11b 
are of a typical time course, and show that the appearance 
and accumulation of USll and gD transcripts in infected HeLa 
cells is delayed compared to infected BHK cells (Figure 9). 
The conditions of infection, RNA extraction and SI nuclease 
analysis were identical to those described above for 
experiments using BHK cells.
6 . The effect of delayed inhibition of DNA replication 
on USll RNA accumulation
The experiments described above indicate that DNA 
replication is required for maximum USll expression.
However, it is not clear if it is ongoing DNA replication 
that is required, or merely the presence of replicated 
template molecules. Accordingly,^in attempt to distinguish 
between these possibilities PAA was added to HeLa cell 
monolayers at 0 , B and liSn p.a. in order to investigate the 
effects of inhibiting DNA replication after its onset on the 
accumulation of USll and gD RNAs. Samples for RNA analysis 
were taken at various times up to 3Oh p.a. (Figure 11a).
The rationale for this experiment was that (i) a decline in 
RNA levels following the addition of PAA would indicate a 
requirement for continuous DNA synthesis, assuming that the 
RNA species is relatively unstable, or (ii) a rise in RNA 
levels would indicate that transcription is independent of 
the process of ongoing DNA replication, assuming in this
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Figure 11.
Time course of appearance and accumulation of USll (a) 
and gD (b) transcripts in HeLa cells. The effect on USll 
RNA accumulation of adding PAA at 8h (closed squares) and 
16h p.a. (closed circles), is also shown in a. Open circles 
indicated the absence of PAA.
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case that the RNA species is relatively stable. However, if 
the level of RNA remains unchanged, only limited information 
can be deduced from this experiment.
The results showed that the levels of USll transcripts 
detected after the inhibition of DNA synthesis remained at 
approximately the level found in the uninhibited control at 
the time of the addition of PAA (Figure 11a). Similar 
results were obtained for gD RNA, and also in infected BHK 
cells on a shorter time scale (data not shown). Since the 
stability of USll mRNA is unknown, it is not possible to 
distinguish from this experiment between (i) steady 
transcription from previously replicated templates matched 
by a steady turnover of transcripts, or (ii) persistence of 
stable mRNA in the cytoplasm in the absence of USll 
transe r ipt ion.
7. Conelusions
The above experiments describe the temporal regulation 
and sensitivity to inhibition of DNA replication of USll 
gene expression. The differences in the pattern of USll and 
gD gene expression during both a productive infection and in 
the presence of a DNA replication inhibitor indicate that 
USll is regulated as a later class of viral gene than gD.
Late genes have been occasionally defined as those 
which have a stringent dependence on viral DNA synthesis for 
their expression, unlike the earlier EL class whose 
expression is reduced, but not abolished, in the absence of 
DNA synthesis (Silver and Roizman, 1985; Roizman and 
Batterson, 1985). Having found that the appearance of USll 
gene expression is extremely sensitive to inhibition of DNA 
synthesis, it appears in this respect to be comparable to 
previously defined late genes. However, modern techniques 
have brought problems to the use of definitions based on 
older methodologies; at this point it is pertinent to 
re-examine the established definition of a true-late gene.
Using specific and sensitive probes to monitor the 
expression of USll RNA it has been shown here that as little 
as 1% of the observed maximum amount of gene product may be 
detected. The use of sensitive techniques, which have
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enabled the detection of USll gene products under conditions 
of DNA synthesis inhibition, brings into question the 
absolute requirement of DNA replication for late gene 
expression. However, it is not possible to conclude that 
absolutely no DNA replication has taken place in experiments 
using chemical inhibitors. Similarly, given the sensitivity 
of the techniques that have sometimes been used to detect 
late gene products, it is not possible to state that no 
product was present under the conditions used for DNA 
replication inhibition. Thus the available evidence does 
not allow any conclusion to be reached regarding the 
mechanistic relationship between DNA replication and late 
gene expression. An operational definition of late genes 
which is consistent with this study and others (Powell e_t 
a l ., 1975; Honess and Watson, 1977; Pederson et a l ., 1981; 
Godowski and Knipe, 1985, 1986; Yager and Bachenheimer,
1987) may be put as follows;
"Late genes are those whose expression is most severely 
reduced, compared to all other groups of genes, under 
conditions of severely inhibited DNA replication" (Johnson 
et a l ., 1986).
In the absence of a clear understanding of the 
mechanism of control of late gene expression, the 
classification of late genes remains subjective and cannot 
be defined using absolute statements. However, as a 
practical guide, on the term "most severely reduced", a 
figure of 95% inhibition could be used.
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SECTION I ; Plasmid-borne USll Gene Expression
The experiments described in this section were designed 
to determine whether DNA replication is obligatory for late 
gene expression, by studying transcription from a 
plasmid-borne USll promoter in the presence and absence of a 
functional HSV-1 origin of DNA replication. Prior to this, 
it was first necessary to establish whether a plasmid-borne 
USll promoter could mimic the regulated expression of its 
viral counterpart. The crucial method used in these 
experiments is the introduction of plasmid DNA into cultured 
HeLa cells by transfection, as described in Materials and 
Methods (Section G(18)). The transfected cells could then 
be infected with HSV-1 to provide all the viral factors 
required for DNA replication and trans-activation of 
transe r ipt ion.
1. Construction and structure of pPJ2
The initial cloning objective was to construct a 
plasmid which directs properly regulated synthesis of 
correctly initiated transcripts from the USll promoter. On 
the assumption that super infect ion with HSV would be 
necessary to activate the plasmid-borne promoter (and origin 
of DNA replication) in short-term transfection assays, it 
was necessary to be able to distinguish transcripts derived 
from the plasmid and the viral USll promoters. This was 
achieved by linking the USll promoter to the rabbit i^-globin 
coding region.
Plasmid pGX57 (Rixon and McGeoch, 1985) contains HSV-1 
DNA which extends from within the coding region of USll to 
over Ikb 5' to the USll transcription start site (see Figure
12). This plasmid also contains in the region upstream of 
the USll RNA start sites an origin of DNA replication and 
the regulatory sequences and transcription start sites of IE 
gene 5. Sequences which constitute the HSV-1 TRg/iRg origin 
of DNA replication (ORIg) are contained in the region -785 
to -825 relative to the USll transcription start site at +1 
(Stow and McMonagle, 1983). The IE gene 5 promoter is 
contained within a region extending 69bp upstream from its
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Figure 12. Map of pGX57
Plasmid pGX57 contains the larger EcoRI-BamHI 
subfragment from the BamHI x fragment of HSV-1 (double 
lines), in a pAT153 vector background (single lines).
The HSV-1 DNA is shown to scale, and numbering is in bp 
X  10-2 where "0" corresponds to the TRg end of BamHI x .  
Located below pGX57 are (i) the IE gene 5 promoter (PI) 
and far upstream regulatory element (P2); the TRg origin 
of DNA replication (ORI); (iii) the 5' starts of IE 5, 
USll and USIO RNAs (single lines) and their coding 
regions (solid boxes); and (iv) relevant restriction 
sites.
For cloning purposes, a new restriction site, SstI, was 
introduced into pGX57 such that it was downstream from 
the USll RNA start sites, but 5' to the Smal site at 
1417. This was achieved by cutting pGX57 with Xhol, 
treating with exonuclease as shown, and religating in 
the presence of SstI linker oligonucleotides. 
Recombinants were screened for the loss of the Smal site 
at 1417, and judged by the size of Sstl-BstNI fragments 
to have retained the USll transcription start site.
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transcription start site (-640 relative to +1 of USll). The 
far-upstream regulatory region of IE gene 5, which is 
required for an ~8 fold stimulation of the IE 5 promoter in 
response to the virion component (see Section E), is located 
on the far side of ORIg relative to the IE 5 promoter; that 
is 944 to 1007bp upstream from +1 of USll (Preston et a l ., 
1984; see Figure 12).
In order to isolate the DNA 5 '-flanking the USll 
transcription start sites, pGX57 was cut at its two Xhol 
sites (which lie over 200bp 3' to +1 of USll), treated with 
exonuclease, and religated in the presence of synthetic 
oligonucleotide SstI linkers. Recombinants were analysed 
for the presence of an SstI linker inserted 3' proximally to 
the USll transcription start sites. The location of the 
SstI linker was judged initially by restriction analysis, 
and a recombinant clone was chosen which had lost the Smal 
site lying 50bp downstream from +1 of USll in pGX57 (see 
Figure 12). The absence of this Smal site was desirable in 
order to facilitate the removal of ORIg and the IE gene 5 
regulatory sequences in later derivatives by usage of the 
five remaining Smal sites located in the far upstream region 
(see Figure 12).
The EcoRI site (at position -1233) in the 
pGX57-deletion construct was converted to a Xhol site using 
Xhol linker oligonucleotides, to give plasmid pdel57/X.S 
(Figure 13). This contains a XhoI-SstI HSV DNA fragment 
which includes the USll and IE 5 promoters and ORIg (Figure
13). The Hindlll site at the gD/globin junction of pRED122 
(Everett, 1983; see Figure 13) was converted to an SstI 
site using SstI linker oligonucleotides, and the Sstl-PstI 
fragment of the resulting plasmid, pl22/S (Figure 13), was 
used to provide the rabbit p-globin portion of pPJ2.
Lastly, pBR322 vector sequences were completed by insertion 
of the appropriate XhoI-PstI fragment from pRED4 (Everett, 
1983; see Figure 13), during the 3-way ligation shown in 
Figure 13. The USll/globin junction of pPJ2 was sequenced 
(from the probe shown in Figure 14b and its complementary 
strand, which were prepared as described below) to verify 
the final structure and ensure retention of the USll cap
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Figure 13. The construction of pPJ2
HSV-1 DNA (-1233 to +37 of USll, open box) containing 
ORIg, IE gene 5 regulatory sequences and the USll RNA start 
sites was derived from pGX57 by the indicated manipulations, 
via plasmid 5 7 / x S ;  rabbit P-globin DNA (from - 7  to 400bp 
beyond the globin gene polyadenylation site, hatched box) 
was derived from pRED122 via plasmid 122/S; the remaining 
pBR322 vector sequences (single lines) including the Tc gene 
were derived from pRED4. pREDl22 and pRED4 contain gD 
promoter DNA (stippled box) from -33 and -396 respectively, 
to +11. Cloning steps were as indicated. T c , tetracycline 
resistance gene; Ap, ampicillin resistance gene. Relevant 
restriction sites: e, EcoRI; x, Xhol; b, BamHI; h, Hindlll; 
s, SstI; p, Pstl.
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sites. The important features of pPJ2 are shown in Figure 
14b. The region 3' of +1 comprises 39bp of untranslated 
USll leader sequence, joined by an SstI linker to the entire 
rabbit ^-globin gene, from -7 to 400bp beyond the 
polyadenylation site. Therefore, activation of the USll 
promoter in pPJ2 will result in hybrid USll/f3-globin RNAs 
which can be detected by SI mapping using a single stranded 
end-labelled DNA probe, as shown in Figure 14b.
The probe for mapping USll hybrid transcripts was 
prepared as follows: lOOug of pPJ2 DNA (total size; 7320bp)
was digested with BamHI and Hindlll, which cut the plasmid 
at the single sites shown in Figure 14b. The 1778bp 
BamHI-HindlII fragment containing USll DNA was isolated by 
sucrose gradient centrifugation (see Materials and Methods), 
and the efficieny of recovery was estimated by running 
aliqqots of the isolated fragment against a known quantity 
of BamHI/HindiII-cut pPJ2 DNA. The fragment was then 
digested with BstNI (which cuts at the sites shown in Figure 
14b), treated with bacterial alkaline phosphatase (BAP), and 
Ipmol aliquots were 5'-end labelled with 32p, as described 
in Materials and Methods (Section G(10)). Labelled 
fragments were strand-separated on a non-denaturing 
polyacrylamide gel and the complementary strand to 
USll-initiated RNA was identified by DNA sequencing (not 
shown). The length of the probe was calculated to be 259 
nucleotides, and it is 5'-end labelled at the BstNI site, 
position +136 of the globin gene (see Everett, 1983), as 
shown in Figure 14b.
2. Internal control plasmid: pREDS
Quantitation and comparison of results obtained from 
independent transfection experiments using different plasmid 
constructions requires the ability to standardize 
transfection efficiencies. For this purpose pREDS was used 
as an internal control. This plasmid produces P-globin 
transcripts from the gD promoter under control of the SV40 
enhancer (Everett, 1984b; see Figure 14a). The single 
stranded DNA probe prepared from the BstNI fragment of pPJ2 
(Figure 14b) also detects RNAs derived from pREDS which span
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Figure 14. Detailed structures of pREDS, pPJ2 and 
pPJ-mutant plasmids
A. Internai control plasmid, pRED5. gD promoter DNA (-396 
to +11) is joined to the rabbit P-globin gene (from -7 
to 400bp beyond the polyadenylation site, hatched) by a 
Hindlll linker. SV40 DNA containing the 72 bp repeat 
enhancer region is located directly upstream from the 
HSV-1 gD DNA.
B. Structure of pPJ2. HSV-1 USll DNA (-1233 to +39) is
joined to the rabbit p-globin gene (hatched), shown
aligned with pRED5, via an SstI linker. Indicated
upstream from the USll transcription start site: IE
gene 5 transcription start site and promoter (PI); TRg 
origin of DNA replication (ORI); IE gene 5 
far-upstream regulatory sequence (P2). The positions 
of relevant restriction sites are shown, including 
BstNI sites (N) used for probe isolation, and 5 Smal 
sites (1-5) employed for pPJ-mutant construction. 
Coordinates refer to bp from the USll RNA start site at 
+1. Positioned above pPJ2 is the single stranded DNA 
probe used to detect USll initiated and pREDS RNA, 
which was ^^P 5'-end labelled at the BstNI site at +136 
of the P-globin gene.
C. Mutant test plasmids. Gaps represent deleted
sequences, whose end-points align to the numbered Smal 
sites or the Xhol site of pPJ2. The identities of the 
constructs are on the right. HeLa cells were 
transfected with test plasmids and pREDS. After 24h, 
the transfected cells were infected with HSV-1 for 16h, 
harvested, and RNA was made for SI analysis. The ratio 
of USll- and pREDS-derived RNAs was calculated for the 
individual transfections, and compared to the ratio 
from pPJ2 (taken to be 100%). The mean relative 
transcriptional activities of the various constructs 
(derived from at least four independent experiments and 
for more than one plasmid preparation), are given on 
the right, and the standard error of the mean (SEM).
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the break in homology between pPJ2 and pREDS. These RNAs, 
which include correctly initiated gD/globin RNA, varied in 
quantity during infection (Figure 15a), presumably in 
response to trans-acting viral factors which at early times 
increase gD expression from pRED5 above its cis-activated 
level mediated by the SV40 enhancer (Everett, 1984b). At 
late times, pREDS RNAs were readily detectable (Figure 15a) 
and gave a reliable standardization of the transfections in 
combination with all the test plasmids used (Figure 17).
Suitably exposed autoradiographs of SI gels were 
analysed by densitometry (see Materials and Methods). The 
ratio of correctly initiated RNA at the USll cap sites 
compared with bands from pRED5 corresponding to the homology 
break was calculated. The value of this ratio obtained with 
pPJ2 was taken to be 100, and the ratios obtained with the 
mutant plasmids were expressed as percentages of pPJ2. The 
activities given in Figure 14c were calculated from at least 
four independent experiments using two different plasmid 
préparât ions.
3. Time-course of appearance and accumulation of hybrid 
transcripts from the plasmid-borne USll promoter
The ability of the plasmid-borne USll promoter in pPJ2
to mimic its viral counterpart during transfection and 
infection experiments was investigated. Sub-confluent 
monolayers of HeLa cells in 90mm petri dishes were 
transfected with lOug of pPJ2 and lOug of pRED5 (except in 
the indicated controls - Figure 15), using the 
calcium-phosphate transfection procedure described in 
Materials and Methods. After 24h, transfected monolayers 
were infected with HSV-1 at a multiplicity of 20 pfu per 
cell. Cells were then harvested for the preparation of 
cytoplasmic RNA and nuclear DNA at various times p.a., as
indicated in Figure 15. Isolated RNA was analysed for USll
hybrid transcripts by SI mapping (see Materials and Methods) 
using the single-stranded 5 '-end labelled probe described 
above. The analysis of DNA isolated from the same cells is 
described below (part 4).
As shown in Figure 15a, the USll promoter in pPJ2 was
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Figure 15. Time course of plasmid-borne USll promoter 
expression and replication of pPJ2
A. Nuclease SI analysis of RNA isolated from HeLa cells
transfected with pPJ2 and pRED5, and probed for
USll/globin hybrid RNA, using the probe indicated in 
Figure 14b. Transfected cells were either uninfected 
(u/i), or infected with HSV-1 for the length of time 
indicated (hours p.a.), prior to harvesting. The 
indicated bands correspond to USll initiated hybrids 
and pRED5 RNAs which map to the pRED5/probe homology 
break.
B. Replication assay of pPJ2 plasmid DNA. Unlabelled DNA
was prepared from the same cells as in A., digested 
with Dpnl (which does not cut plasmid DNA which has 
replicated in eukaryotic cells and become 
unmethylated), and SstI and PvuII (to distinguish 
between pPJ2 and pRED5). The DNA was run on an 0.8% 
agarose gel following digestion, blotted onto 
nitrocellulose, and probed with 32p-labelled pBR322 
DNA. The first two tracks correspond to Ing of 
(E.coli-grown) pRED5 or pPJ2 DNA with Dpnl ommitted 
from the digest to provide quantitative and 
positional references. The final two tracks of A. and
B. are from single transfections of pPJ2 or pRED5.
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inactive in the absence of viral infection, which 
demonstrated that the plasmid-borne promoter was dependent 
on virus induced trans-acting factors involved in 
transcription and replication for its activity. After 
activation, the pattern and location of the 5 ' 
transcriptional starts from the plasmid-borne USll promoter 
(Figure 15a) were identical to the transcriptional starts 
from the viral USll promoter (Figures 7 and 8 ). This was 
confirmed by running SI- protected hybrids of pPJ2 RNAs 
alongside a sequence ladder derived from the same probe DNA 
(data not shown). The initial detection of hybrid gene 
transcripts in transfected HeLa cells occurred after 8h of 
super infection (Figure 15a). This is similar to the initial 
time of detection of viral USll transcripts in infected HeLa 
cells (Figure 11a). Thus in the same cell-type, the 
plasmid-borne and viral USll promoters are regulated with 
essentially the same kinetics of induction. The final two 
tracks in Figure 15a demonstrate the plasmid origin of the 
indicated USll or pRED5 bands; the bands at around 200nt are 
clearly derived from pPJ2 while those at around 155nt are 
produced from pRED5, the internal control.
4. Replication of pPJ2
Analysis of the regulation of USll in viral studies 
demonstrated the importance of viral DNA replication in 
achieving abundant gene expression (Section H ). To test 
whether the origin of replication in pPJ2 was functional in 
transfected cells, DNA was extracted from the same cells 
used in the time-course experiment described above, and the 
samples were analysed as follows: One-fifth of the total
DNA isolated for each time point was digested with SstI, 
PvuII and Dpnl. The Sstl/PvuII digestion allowed 
discrimination between bands arising from pRED5 and pPJ2. 
Dpnl cleaves the sequence GATC provided the A residue is 
methylated (by propagation of plasmids in dam+ strains of 
E.coli), but will not cleave the unmethylated DNA resulting 
from replication in a eukaryotic cell. Hence the Dpnl 
digestion provides the basis for a sensitive plasmid 
replication assay in eukaryotic cells (Stow, 1985). The
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digested DNA was analysed by Southern blot hybridization 
with pBR322 DNA ^^P-labelled in vitro. Ing each of pRED5 
and pPJ2 DNA were treated as the cellular extracts, but with 
the omission of Dpnl, to allow identification of bands 
corresponding to replicated pPJ2.
Figure 15b shows the time-course of pPJ2 replication 
following super infection with HSV-1. The appearance of Dpnl 
resistant bands corresponding to pPJ2 clearly shows that the 
plasmid is efficiently replicated after HSV-1 infection of 
transfected cells. At later times, concatemeric forms of 
pPJ2 become increasingly resistant to cleavage with SstI and 
PvuII which is probably due to partial digestion. There are 
no Dpnl resistant bands which correspond to pRED5, 
indicating that, as expected, this plasmid is not replicated 
during the course of the transient assay, and that the Dpnl 
digestion was complete in these samples.
5. Quantitation of USll hybrid transcripts and plasmid 
replication
The accumulation of USll hybrid transcripts correlates 
well with the replication of pPJ2 (Figure 15a,b), and is 
thus characteristic of normal late gene expression. Using 
the Southern blot shown in Figure 15b it was possible to 
estimate the number of plasmid molecules per cell during the 
time-course. The level of replicated plasmid molecules, 
which have necessarily spent some time in "active" areas of 
the nucleus, should give a guide to template availability 
for transcription. By comparing the relative rise in 
accumulated hybrid transcripts to replicated plasmid copy 
number, it was reasoned that information regarding the 
relationship between copy number and late gene expression 
could be derived. This is an important question, since as 
described above (Section H(6 )), one theory to account for 
the mechanism of true late gene expression proposes that the 
amount of transcription is simply proportional to the copy 
number of template DNA molecules.
Autoradiographs of the SI gel shown in Figure 15a and a 
shorter exposure of the blot shown in Figure 15b (to ensure 
comparability between lighter and darker tracks) were
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Figure 16. Accumulation of replicated pPJ2 DNA and USll 
hybrid transcripts
The graphs of USll RNA and pPJ2 DNA accumulation 
correspond to the 81 gel and blot in Figures 15A and 15B 
respectively. The copy number of pPJ2 was estimated by 
calculating the ng equivalents of replicated pPJ2 present at 
each time point (see insert). Since l/5th of the total DNA 
from 2x10^ cells was used for each analysis, and on the 
assumption that 50% of transfected HeLa cells take up 
calcium phosphate-precipitated DNA (based on 
immunoflourescence studies with the same cell line;
Dr.R.Everett, personal communication), Ing pPJ2 (1.3x10® 
copies) = 650 copies per cell. The level of of 
intracellular input pPJ2 was estimated from the Dpnl 
digested plasmid DNA from uninfected cells, taking into 
account the proportion of pRED5 DNA. The relative amount of 
USll-hybrid transcript accumulation takes the first detected 
level at 8h to be 1 .
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scanned and quantitated. The estimated level of plasmid 
copies per cell and the relative accumulation of USll hybrid 
transcripts are shown in Figure 16 and the method of 
calculation is described in the legend.
At 4h p.a. no replicated plasmid DNA was detectable, 
even on long exposures of the blot (the limit of sensitivity 
was estimated at approximately 4 copies/cell). Replicated 
pPJ2 DNA was first detected at 8h p.a., at a level of 530 
copies per cell, and doubled between 8 and 12h p.a., and 
then increased 6-fold during the following 4h (Figure 16). 
The input (unreplicated) level of plasmid DNA was estimated 
to be at 1100 copies of pPJ2 per cell (Figure 16), which is 
consistent with the data of Alwine (1985). Since DNA was 
extracted from the nuclei of transfected cells, it would 
seem reasonable to propose that most of the 1100 plasmid 
copies prior to infection were intranuclear and were 
available for transcription and replication.
It was notable that USll hybrid transcript accumulation 
increased dramatically (at least 10-fold) between 8 and 12h 
p.a., a period in which replicated plasmid DNA had barely 
doubled (Figure 16). Thereafter, transcript levels 
increased 1.3-fold between 12 and 16h, and in 2-fold steps 
up to 20 and 24h. Hybrid transcript accumulation from 12h 
onwards increased rapidly, and thus resembled the increase 
in replicated template from 8h onwards. This experiment 
suggests that the accumulation of transcripts had increased 
proportionally with the copy number of replicated template 
molecules, rather than the total copy number of plasmid 
molecules in the cell. The implication is that true late 
gene expression is not regulated simply by total copy 
number, but that the act of DNA replication of the template 
in some way allows the onset of efficient late gene 
expression.
6 . Role of DNA replication and IE gene 5 transcription 
through the USll promoter on USll promoter activity
In order to investigate the absolute role of DNA 
replication and possible effects caused by transcription 
from the IE 5 promoter on USll gene expression, a series of
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derivatives of pPJ2 were constructed which contained 
deletions in the region far upstream of the USll RNA start 
sites.
The construction of the pPJ2 derivatives, shown in 
Figure 14c, was as follows. As indicated in Figure 14b, 
there are five Smal sites in pPJ2 located in the region far 
upstream from 4-1 of USll. By utilizing these Smal sites, 
two series of deletions were made, by either (i) Xhol- 
partial Smal digestion, followed by filling-in and 
religation (which reproduces a Xhol site), to create the 
pPJXn series; or (ii) SstI- partial Smal digestion followed 
by, flushing of the overhanging 3' end of the cleaved SstI 
site with Klenow DNA polymerase, and ligation in the 
presence of Sail linker oligonucleotides, to create the 
pPJSn series (where n is the numbered Smal site shown in 
Figure 14b). Insertion of the appropriate Xhol-Sall 
fragments from pPJS3, pPJS2 and pPJSl into the Xhol site of 
pPJX5 gave rise to pPJ4, pPJ5 and pPJ8 , respectively. pPJ9 
was made simply by a partial Smal digestion of pPJ2 and 
religation. pPJ6 and pPJ7 were made by Smal or Smal-Xhol 
digestions respectively, of pPJ4, followed by religation.
The structures of all the plasmids shown in Figure 14c were 
checked extensively by restriction analysis.
The activity of the USll promoter in each of the 
constructs shown in Figure 14c was determined in short-term 
transfection assays by quantitative SI mapping of RNA 
prepared 16h after HSV-1 super infect ion. Typical results 
obtained by SI mapping are shown in Figure 17, and the 
averaged data from at least four independent experiments 
using more than one preparation of each plasmid was 
determined (see Figure 14c), using the method of calculation 
described above (part 2). The pPJ2 derivatives can be split 
into three groups, on the basis of a broad correlation 
between inducible promoter activity and far upstream 
structure:
(i) The activities of pPJ5, pPJ8 , pPJX4 and pPJX5 were 
consistently less than 10% of wild type pPJ2 activity, and 
their structures have in common the absence of ORIg. The
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Figure 17. Activation of pPJ-mutant plasmids
The transcriptional activation of pPJ2 and mutant test 
plasmids (shown in Figure 14) was compared after transfected 
cells had been super infected with HSV-1 for 16h. RNAs 
produced from the USll hybrid gene and pRED5 are marked. 
Transfections included lOug of indicated test plasmid and 
lOug of pREDS, except where indicated: S/l = RNA from only
super infected cells; RED5 only = no pPJ-test plasmid (shows 
that the background level of hybridization at the USll 
position is negligible). Size standards are Hpall cut 
pBR322 DNA.
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structure of pPJX4 differs from pPJX2 only by the absence of 
the origin containing sequence, yet the activity of the 
pPJX4-USll promoter was reduced to 3-4% of pPJX2. These 
results clearly show that deletion of ORIg results in a 
drastic decrease in USll promoter activity. Analysis of DNA 
from transfected cells using the Dpnl assay described 
earlier showed a consistent correlation between ORI^ 
plasmids and the appearance of replicated plasmid DNA, 
whilst no Dpnl resistant bands were observed in DNA samples 
where ORI” plasmids had been tested (data not shown).
(ii) Plasmids which contain ORIg but lack the IE 5 
promoter (pPJ4, pPJ6 and pPJ7) have reduced USll promoter 
activity compared to pPJ2, but substantially higher levels 
of expression compared to constructs lacking ORIg. Since 
the IE 5 promoter is absent in pPJ4, pPJ6 and pPJ7, 
correctly initiated IE 5 RNA cannot be transcribed through 
the USll promoter in these constructions. These data 
indicate that such through-transcription may play a positive 
role in USll transcription.
(iii) Plasmids which retain ORIg and the IE 5 promoter 
have similar levels of expression compared to pPJ2, as seen 
with pPJX2, or substantially higher, in the case of pPJ9.
The result with pPJ9 suggested that the presence of the IE 5 
far-upstream regulatory sequence may be acting negatively on 
USll promoter activity, but this hypothesis was inconsistent 
with the results obtained for pPJX2. Similar comparison 
between the activities and structures of pPJ4, pPJ6 and pPJ7 
yielded no obvious role for the far-upstream element of IE 
gene 5 in modulating USll promoter activity.
7. Conelusions
These experiments demonstrated that the regulation of a 
plasmid-borne USll promoter closely mimicked that of its 
viral counterpart during productive infection. In response 
to activation during HSV-1 infection, correctly initiated 
transcripts were produced from the plasmid copy of the USll 
promoter with the same kinetics as viral transcripts, and
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their appearance coincided with the onset of DNA 
replication. Hybrid transcripts were not detected in 
mock-infected cells, indicating that induction of the 
plasmid-borne promoter, like its viral counterpart, requires 
viral gene products.
An important question is the validity of extrapolating 
findings from the transient assay to the viral situation. 
Several lines of evidence suggest that promoter regulation 
in a transient assay is representative of viral gene 
regulation. The intact plasmid-borne USll (this study) and 
gD (Everett, 1983) promoters behaved in transient assays 
like their viral counterparts, and a series of mutations in 
the t_k promoter upstream of the mRNA cap site exerted 
qualitatively similar effects in both transient assays and 
reconstructed viral genomes (Eisenberg et a l ., 1985; Coen 
et a l ., 1986). In addition, both plasmid and viral DNA 
molecules are in open chromatin structure in the nucleus 
(Leinbach and Summers, 1980; Cereghini and Yaniv, 1984), 
suggesting that their physical state may be similar.
The greater than 90% reduction in USll initiated 
transcript accumulation from replication-inhibited viral 
genomes (Figure 9 - Section H ), and ORI” plasmids (Figure 
14c - with the exception of pPJ5), is strikingly similar. 
Allowing for a particle/pfu ratio of 20-50 in the HSV-1 
stock (determined by Mr. J.Aitkin), the number of viral 
genomes entering a cell at an moi of 20 pfu is unlikely to 
exceed the 500-1000 intracellular transfected plasmid copies 
estimated in these experiments. This comparison suggests 
that plasmid and viral templates are transcribed with 
similar poor efficiency in the absence of replication.
In contrast to the experiments using inhibitors of DNA 
replication (see Section H), it is possible to state with 
more confidence on the evidence of this transient assay 
system (using plasmids which lack a eukaryotic origin of 
replication), that USll can be expressed from unreplicated 
template DNA. However, it is important to stress that in 
both the transient assay system and the viral situation, DNA 
replication played a major role in achieving abundant 
expression. An obvious role for replication would be to
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increase the copy number of an intrinsically weak promoter, 
but it is also possible that template replication per se 
plays a role in increasing late promoter activity; this 
latter possibility is more consistent with the data 
described above than the former. The possible mechanisms 
involved in achieving abundant late gene expression through 
DNA replication are considered in more detail in the final 
Discussion.
SECTION J ; Sequence Requirements For Regulated
Activity of a Late Promoter
As discussed in Section E of the Introduction, the 
criteria which define an IE gene have been unambiguously 
defined. At the sequence level, IE genes are characterized 
by the presence of a far-upstream region which includes the 
consensus sequence, TAATGARATTC, in addition to a promoter 
region 5' flanking the IE RNA start sites (Mackem and 
Roizman, 1982a,b; Whitton et a l ., 1984; Preston et a l ., 
1984). The promoters of E and EL genes which have been 
characterized include a proximal TATA box (in the -25 
region) and an "upstream" region (usually between -35 to 
-100) (Everett, 1984b; Costa et a l ., 1985b; Eisenberg e^ 
a l ., 1985; Coen et a l ., 1986). The basis for the 
difference in the expression kinetics of early and late 
genes had not been discovered due to the lack of detailed 
molecular studies on late promoters. In this section, an 
investigation of the sequences which characterize a late 
promoter and which distinguish it from early promoters is 
described.
1. Construction of USll promoter deletion mutants
Efficient expression of a plasmid-borne USll promoter 
following HSV-1 infection of transfected cells requires the 
presence of ORIg (Section I). It was therefore decided to 
study the activity of USll promoter deletion mutants in
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plasmids which contain ORIg. The fragment containing ORIg 
used in most of these deletion constructs also contains the 
regulatory sequences of IE gene 5. This was intentional 
since transcription through the USll promoter from the IE 5 
promoter played a positive role in achieving high levels of 
USll promoter activity in the previous experiments (Section 
I )  .
Deletions extending towards the USll promoter were made 
by Bal31 exonuclease digestion of Xhol- cut pPJX5; this 
plasmid contains a single Xhol site at -444 relative to +1 
of USll (Figure 14c). The result of increasing exposure to 
exonuclease on the length of the XhoI-BamHI fragment of 
pPJXS is shown in Figure 18a. Following termination of the 
exonuclease reaction, plasmid DNA was recircularised by 
ligation in the presence of Sail linker oligonucleotides.
The Sail linker therefore defines the limit of the deletion. 
Plasmid pPJSS is a derivative of pPJ2, and contains a Sail 
linker at position -444 (Figure 18b). Thus fusion of the 
Sail site of a deletion plasmid to the Sail site of pPJSS, 
as outlined in Figure 18b, created the pPJO.n series of 
plasmids - where 'n ' refers to the number of nucleotides 5' 
to the USll start site. The various deletion constructs 
used in this study are shown diagrammatically in Figure 19c.
2. Transcriptional activation of the pPJO series
Plasmids were transfected into HeLa cells with the 
internal control plasmid pREDS (see Section 1(2)), to allow 
standardization of the transfection procedure. The cells 
were washed 24h after transfection, infected with HSV-1, and 
RNA isolated 16h after infection. Correctly initiated USll 
hybrid transcripts were detected by SI mapping, using the 
32p end-labelled single-stranded DNA probe shown in Figure 
19b. This probe is identical to that described in Section 
I. The level of correctly initiated USll RNA from the 
promoter deletion series of plasmids was compared to the 
level from pPJ2, after normalization of the individual 
transfections efficiencies (determined by comparison to the 
level of detected RNA corresponding to pRED5).
Preliminary experiments indicated that USll expression
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Figure IB. Construction of the pPJO.n series
pPJX5 DNA was cut with Xhol and treated with Bal31 
exonuclease for various lengths of time (c). Samples from 
each time point were digested with BamHI and run on a 1.5% 
agarose gel to determine the approximate extent of the 
deletions. pPJX5-deleted DNA was then recircularized in the 
presence of Sail linker oligonucleotides (pPJXSdel; d ) . In 
order to obtain finer control over the extent of the 
deletions, a pPJXSdel plasmid which had lost about 200bp of 
HSV DNA was cut with Sail and treated as above; the 
ethidium bromide-stained agarose gel in (a) shows the effect 
of Bal31 treatment for 0, 1, 2, 5 and 10 minutes (tracks 
1-5), size standards were provided by Alul cut pBR322 DNA. 
Appropriately deleted DNA was again recircularized by 
ligation in the presence of Sail linker oligonucleotides.
The 1439bp Sail fragment of pPJSS, which contains the ORIg 
and the IE 5 regulatory elements (b), was isolated from an 
agarose gel (Materials and Methods). Sall-cut pPJX5del DNA 
(e) was ligated in the presence of the 1439bp pPJS5 Sail 
fragment, and recombinants were selected in the presence of 
tetracycline; the exonuclease treatment of pPJX5 causes 
inactivation of the bacterial tetracycline resistence gene 
(Tc). The precise extent of the deletions were determined 
by DNA sequencing, and 'n ' refers to the number of 
nucleotides upstream from the USll RNA start sites (d,e). 
Abijfeviations and representations are as in Figures 13 and 14 
[sa = Sail, and may be lost (sa), in some pPJX5del 
plasmids].
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from pPJO plasmids with deletions extending to -70 was not 
impaired. Analysis was therefore concentrated on constructs 
with deletion end-points downstream from -70. The results 
of a typical transfection experiment are shown in Figure 20. 
A summary of the data derived from multiple transfections 
using pP J O .61,41,31 and 21 is given in Figure 19c.
Deletion of sequences upstream from the USll cap sites 
had no effect on inducible promoter activity until the 
deletion end-point had passed -31. The observation that 
sequences 3' of -32 are sufficient for abundant USll 
transcription was striking. Most of the TATA box (see 
Figure 19a) is lost in pPJ0.21, so the corresponding 
decrease in the level of correctly initiated transcripts 
from this construct was not surprising. Higher levels of 
expression were reproducibly observed from the pPJO series 
of plasmids (deletion end points -31 or upstream) compared 
to pPJ2 (Figure 19c). If DNA replication and 
through-transcription from the IE 5 promoter potentiate the 
USll promoter by opening up the template structure (Johnson 
and Everett, 1986a), then the increased transcription from 
pPJ0.61, 41 and 31 may be because the initiation of both 
replication and IE gene 5 transcription is closer to the 
USll promoter in these constructs than in pPJ2. However, 
the possibility of sequences required for a negative effect 
on USll transcription, contained within the region -444 to 
-61, cannot be ruled out.
Further constructs were made to investigate the 
possibility that the IE 5 promoter, or other sequences 
upstream of -444, might be providing surrogate promoter 
functions for the -31 USll promoter construct. The deletion 
of sequences 5' to the Sail linker, up to and including the 
IE gene 5 promoter (in plasmid pP0.31, Figure 19c), resulted 
in a promoter only slightly less efficient than pPJ2. 
Inversion of the Sail fragment in pP0.31 (see Figure 18b) 
puts prokaryotic sequences (encoding part of the 
tetracycline resistance gene) adjacent to the -31 deletion 
point. This plasmid, pP0'31 (not shown) gave similar levels 
of USll promoter activity compared to pP0.31 and pPJ2. The 
sequences adjacent to the USll TATA box in pPJ0.31, pP0.31,
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Figure 19. Structure of the USll/P-globin hybrid gene 
promoter region and activities of 
USll promoter-deletion mutants
A. DNA sequence of the USll promoter region, -70 to +39, 
in pPJ2. The positions of the RNA starts and the consensus 
TATA box are indicated.
B. Structure of pPJ2. HSV-1 DNA (-1233 to +39) is joined 
to rabbit ^-globin DNA at an SstI linker oligonucleotide.
The key for pPJ2 is contained in the legend to Figure 14.
C. Structures and activities of mutant test plasmids.
Gaps represent deleted sequences, whose 3' end-points align 
to the indicated Smal sites, and are joined by a Sail linker 
to 5' deletions (-21 to -61) of the USll promoter.- The 3' 
end-point of pP31 is the Sail site of pBR322 (see Figure 
18). The mean transcriptional activities (+/- standard 
error of the mean; SEM) of the transfected mutant constructs 
after 16h viral infection, are shown on the right.
2 4 2 t e
2 3 8 ^
217#*»
201 ^  
1 9 0 ^
180 ^
pPJ O. - 
61 41 39 33 31 21
CO
6
*  S s ■ ■ ## USll
160
147 REDS 
( internal 
control )
Figure 20. SI analaysis of transcriptional activation of 
the mutant USll promoter constructs after 16h superinfection 
of transfected cells with HSV-1. RNAs produced from the 
USll hybrid gene and pRED5 are marked. Transfections 
included lOug of test plasmid and/or lOug pREDS, as 
indicated. The band marked 'p ' corresponds to full length 
probe. Size standards are Hpall-cut pBR322 DNA. The ratio 
of USll initiated RNA compared to pRED5 RNA was determined 
by densitometry, and the averaged results from multiple 
experiments are given in Figure 19C. The poor detection of 
both USll and pREDS in the pPJ0.61 track demonstrates the 
importance of the internal control.
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pP0'.31 and pPJ2 are entirely different, which implies that 
they are not providing a distal upstream promoter region.
These results suggest that the USll promoter does not 
have an essential "upstream" promoter region analagous to 
those of the HSV-1 and gD promoters (Eisenberg et a l ., 
1985; Everett, 1984b): the TATA box and cap site region are 
necessary and sufficient to allow fully efficient regulated 
expression.
3. Effects of replication and transcription through the 
-31 USll promoter
Previous studies have indicated that transcription 
through the USll promoter has a positive effect on its 
activity (Section 1(6)). The effects of an absence of IE 
gene 5 transcription on the activity of the minimal (-31) 
USll promoter are illustrated by plasmid pP0.31. USll 
transcription from pP0.31 was only slightly reduced compared 
to pPJ2, but around 4-fold less compared to pPJ0.31 (Figures 
19c and 20). Inducibility of the USll promoter in the 
absence of the IE 5 promoter indicates that the latter does 
not provide an essential function for USll promoter 
activity, but does support the conclusion that transcription 
through the USll promoter increases its expression.
In the absence of ORIg or other HSV sequences upstream 
from -31, the USll promoter was poorly expressed (see pP.31, 
Figure 19c). The level of expression from pP.31 was similar 
to an undeleted USll promoter in an ORI” environment (for 
example, see plasmids pPJX4 and pPJX5 in Figure 14c, Section 
1(6) ) .
4. Does a TATA box constitute a functional late promoter ?
The experiments described above show that HSV-1 
sequences between -31 and +39 are sufficient for efficient 
expression of USll. This region includes a consensus TATA 
box homology beginning at position -26, as indicated in 
Figure 19a. If a TATA box alone is sufficient for late gene 
expression it should be possible to induce "late" expression 
from the TATA box of other promoters, which do not otherwise 
share homology with USll. T h i s__
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hypothesis was tested using a deletion mutant of the HSV-1 
gD promoter. During viral infection the gD gene is 
regulated with EL kinetics and is only moderately sensitive 
to inhibition of DNA replication (Section H ). The necessary 
proximal and distal promoter elements for normal gD 
expression lie within 83bp of the gD mRNA cap sites 
(Everett, 1983). A TATA box is located at position -25 to 
-20 (Figure 21a), and has been shown to be essential for 
accurate initiation of gD transcription (Everett, 1984b). 
Deletion of the distal promoter sequences upstream of the 
TATA box leads to a greater than 25-fold decrease in gD 
promoter activity in the absence of DNA replication 
{Everett, 1983).
5. Construction of a "late" gD promoter
It was decided to examine the transcriptional activity 
of a -33 deletion mutant of the gD promoter (which retains a 
TATA box), in an ORI+ environment. The IE gene 5 regulatory 
sequences and ORIg from the Sail fragment of pPJS5 (as 
described in part 1) were placed upstream from a -33 
deletion mutant of gD (pRED122 - see Everett,1983; 1984b), 
to give pOR33 (Figure 21c). Induction of pOR33 was compared 
with pERD130/33, which has gD sequences -2045 to -130 
incorporated upstream from the -33 deletion end-point 
(Figure 21c). pERD130/33 thus provides a negative control
for the induction of the -33 deleted gD promoter in an ORI” 
environment. To eliminate possible surrogate promoter 
effects by IE gene 5 in pOR33, an ORIg-containing fragment 
from pPJS3 (Section 1(1)), which lacks the IE 5 promoter, 
was placed upstream from the -33 deletion to create pR033 
(Figure 21c). For comparison with the -33 gD promoter, 
analagous constructs were made using a -83 promoter deletion 
(pERD130/83, pOR83 and pR083), which retains all the 
cis-acting DNA sequence elements for properly regulated 
expression of the gD promoter (Everett, 1983).
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6 . Transcriptional activation of a "late" gP promoter 
Transcriptional activation of the gD promoter 
constructs shown in Figure 21c was examined at early (4 h ) 
and late (16h) times after HSV-1 infection of transfected 
cells. The relative promoter activities were determined by 
quantitative SI mapping using the 5' end-labelled probe
indicated in Figure 21b. Standardization of the 
transfection procedure was by reference to the level of 
globin transcripts from a co-transfected internal control 
plasmid, pP(244+)j^ (Everett, 1983); bands corresponding to 
RNA from this plasmid are indicated in Figure 22. The 
activities of the various gD promoter constructs were 
compared to and expressed as percentages of the level of gD 
hybrid RNA from pERD130/83. Since both the level of 
accumulated globin (Figure 22, and data not shown) and gD 
transcripts decrease at late times (Section H - Figures 8 
and 9), the activités determined at the two time-points in 
Figure 21c are not directly comparable.
In an ORI” environment, induction of the -33 gD 
promoter in pERD130/33 is poor at both early and late times 
(Figures 21c and 22). This is consistent with previous 
findings (Everett, 1984b). The addition of ORIg to the -33 
gD promoter in pOR33 and pR033 produced a dramatic increase 
in gD initiated transcripts at late times (Figures 21c and 
22). This result demonstrated that the gD TATA box region 
alone can function as a late promoter in an ORI'*’ 
environment. Deletion of the IE 5 promoter in pR033 reduced 
gD promoter activity at late times compared to pOR33 - 
transcription through the gD 'TATA box promoter' thus has a 
similar effect as seen with the USll promoter (Figures 16c 
and 21c).
Some unexpected effects were observed with the 
introduction of ORIg to plasmids containing a complete or 
deleted gD promoter. At early times, pOR33 and pR033 were 
usually (but not always) moderately active (Figure 21c).
This early activity probably occurred in assays where DNA 
replication had commenced before cells were harvested. It 
was also noticed that at early times the presence of ORIg 
reduced expression from the -83 promoter (pR083) and this
ilIIIa
SZ O  
CD O
$ g
g
lO N0)
o « n
CM CM
00 N. O O)
<N CD CM
Q)XI0 
a1Q.
CM
CO I
à
i î .
 ^Io (0CM CD
ia
00
S
I
ü
î
Figure 21. Structure of the gP/P-globin hybrid promoter 
region and activities of mutant gP promoter 
constructs
A . DNA sequence of the gD/)3-globin promoter, from -90 to 
+11, in pRED4. The positions of the RNA starts and the 
consensus TATA box are shown.
B. HSV-1 DNA (-2045 to +11) is joined to rabbit ^-globin 
DNA at the Hindlll site beginning at +11. The probe 
derived from pRED4 for detecting gD- and globin- 
initiated RNA (labelled at +136) is shown above (kindly 
supplied as an unlabelled fragment by Dr.R.D.Everett). 
The structure of the HSV-1 ORIg-containing fragment 
from pPJSS is shown below pRED4.
C. Structures and activities of the mutant test plasmids.
Deletions into the gD promoter. S' delineated by a Xhol 
linker oligonucleotide, are joined to: (i) -2045 to 
-130 gD upstream DNA (3' Xhol) - pREDl30/n; (ii) -1233
to -444 USll upstream DNA (3' Sail) - pORn; or (iii)
-1233 to -714 USll upstream DNA (3'SalI) - pROn, where 
'n' is the -83 or -33 gD promoter deletion end-point. 
The mean relative transcriptional activities (+/- SEM) 
after 4 or 16h viral superinfection are shown on the 
right (pERD130/83 = 100%). Note that the results at 
the two time points are not directly comparable since 
between 4 and 16h super infection, the accumulation of 
plasmid-derived gD transcripts in HeLa cells is reduced 
by around 20%.
pERD. IpOR-lpERO.I pOR- 
130/83 83 |l30/3a 33
M 4 16 U  16l4  16 4 16
d.e.83
#  m m  « # #  d-e-33
180 «* S '  g
160 
147
0  0  go
globin
Figure 2 2 . SI analysis of transcriptional activation of 
mutant gD promoter test plasmids after 4 or 16h viral 
activation. Transcripts initiated from the gD test plasmids 
and the P-globin internal control plasmid, pP(244+)P, are 
marked. Full length probe (p) and bands corresponding to 
the break in homology at the -83 and -33 deletion end-points 
(d.e.), are indicated.
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reduction was more marked 'in the presence of the IE 5 
promoter (pOR83 - Figures 21c and 22). It is interesting 
that through-transcription and replication appear to have 
the converse effect on the fully functional gD promoter 
compared to that on USll and the -33 deleted gD promoters - 
they down regulate a functional EL promoter at early times. 
It could be argued that the effect of replication and the 
presence of the upstream IE 5 promoter is to increase 
competition for cellular factors, and thus cause a reduction 
in gD promoter activity. However, at late times ORIg is 
responsible for increased activity of the -83 gD promoter 
(Figure 21c), which suggests that cellular factors are not 
in short supply, unless gD is then activated by a different 
mechanism. It was shown in previous experiments that the 
presence ORI+ or ORI~ plasmids did not appear to influence 
the level of RNA derived from the co-transfected internal 
control plasmid, pRED5 (Figure 17 - Section H), which 
suggests that the negative effect of ORIg on gD promoter 
activity at early times is due to a cis-linked mechanism, 
i.e. replication.
Negative effects on transcription caused by replication 
and through-transcription have been documented in recent 
reports. Replication of SV40-based plasmids in 293 cells 
(which express the adenovirus Ela region and are proficient 
for SV40 DNA replication in the presence of T antigen) 
caused repression of transcription from the SV40 early 
promoter; expression was increased in the presence of 
inhibitors of DNA replication or with DNA" mutants of SV40 T 
antigen (Lewis and Manly, 1985; Lebkowski et a l ., 1985). 
Proudfoot (1986) studied the transcription of two tandemly 
duplicated <y-globin genes located either on a plasmid or 
integrated into the genome of biochemically transformed 
cells. Transcription of the downstream (X-globin gene was 
repressed by transcription of the upstream gene, unless 
separated by transcription termination signals. It is 
possible that DNA replication and through-transcription 
interfere with the activity of susceptible promoters in a 
similar way; they might reduce the ability of cellular 
transcription factors to bind to promoter DNA due to its
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altered, open structure.
7. Conclusions
Gene USll is regulated with "true-late" kinetics 
(Section H). A plasmid-borne promoter containing a 
functional HSV origin of DNA replication can mimic these 
kinetics in a transient assay (Section I). Here, the 
function of USll promoter deletions has been investigated in 
a transient assay system using plasmids which contain ORIg. 
It is shown that, in clear contrast to the requirements of 
early promoters, the DNA sequence elements required for 
fully efficient regulated expression of USll lie within 31bp 
of the RNA cap sites.
Visual comparison of the DNA sequences upstream from 
the USll cap sites with the well characterized and gD 
promoters yielded no obvious homology, with the exception of 
a proximal TATA box region (Eisenberg et a l ., 1985;
Everett, 1984b). Thus it seemed possible that an HSV late 
promoter might be characterized by the presence of a TATA 
box in the absence of distal regulatory sequences upstream. 
It was predicted that the EL regulation of the gD promoter 
might be converted to typical late gene kinetics, following
(i) removal of sequences upstream from its TATA box, and
(ii) linkage to the ORIg origin of DNA replication. This 
prediction was confirmed with constructs pOR33 and pRO33, 
both of which contain an upstream to -33 deletion of the gD 
promoter in an ORI+ environment, and are inducible at late 
times after infection with HSV-1 (Figure 21c). These 
results demonstrate that there is a clear difference in the 
sequence requirements for proper regulation of a model EL 
and a model L promoter.
Previous studies have shown that transcription through 
the USll promoter from the upstream IE gene 5 promoter plays 
a positive role in achieving abundant USll transcription 
(Section I). The results shown in this section suggest that 
transcription through either the minimal USll, or the 
'converted late' gD promoters, increases standard late 
promoter activity. In the pPJO series of constructs and 
pOR33 (Figures 19c and 21c) the IE gene 5 promoter (in the
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ORIs“Containing fragment) was placed immediately upstream 
from the USll and gD deletion end-points. Conceivably this 
might have enabled the IE gene 5 regulatory region to 
provide surrogate promoter functions on USll and gD. This 
possibility was dismissed by constructs pP0.31 and pR033, in 
which the IE gene 5 promoter had been deleted. Despite the 
complete change of sequences upstream of their TATA box 
regions, both promoter constructs exhibited substantial 
activities at late times (Figures 19c and 21c).
Furthermore, inversion of the ORIg-vector fragment in pP0.31 
and pR033 (which places pBR322 vector sequences immediately 
upstream of the USll and gD TATA box regions) did not alter 
the level of induced expression (data not shown). This 
indicated that the position or nature of the DNA sequences 
upstream of the deleted promoters made no essential 
contribution to their inducible expression at late times 
after infection.
Thus, features that distinguish an HSV late promoter 
and account for its characteristic late induction kinetics 
have been identified. If USll is typical of HSV true late 
promoters [the HSV-1 late gene, gC , has been shown to have 
similar sequence requirements (Homa et a l ., 1986)], then the 
relationship between the three temporal classes of HSV 
promoters may be summarised as shown in Figure 23. This 
illustrates that as infection proceeds and after DNA 
replication occurs, fewer regulatory signals are required 
for efficient transcription from promoters of different 
temporal classes.
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Figure 2 3 . Regulatory signals required in cis for the 
efficient expression of HSV-1 genes 
(from Johnson and Everett, 1986b)
The far-upstream element of IE genes, required for 
activation by the virion component, Vmw65, includes the 
consensus sequence T A A T G A R A T T C ,  in addition to flanking 
modulatory sequences. The distal promoter elements of IE 
and E genes contain one or more copies of at least one of 
the following: (i) GC-rich motifs, (ii), GA-rich motifs,
(iii) a CAAT box. Late promoters, which contain only a TATA 
box-cap site region (CAP), require an active origin of DNA 
replication (ORI) in cis for their efficient expression.
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SECTION K ; Trans-activat ion of USll
The aim of the experiments described in this section 
was to identify viral gene products involved in 
trans-activation of the USll promoter. This was first 
attempted in an ORI+ environment by use of a replication 
system that does not require HSV gene products (part 1). 
However, this approach did not meet with success, for the 
reasons mentioned below. The second approach (parts 2-6) 
was to use the sensitive chloramphenicol acetyltransferase 
assay (CAT) to facilitate the detection of USll promoter 
activation in the absence of template replication. This led 
to the identification of at least two IE gene products 
involved in USll promoter activation.
1. Replicative Conditions; Incorporation of the SV40 origin 
of replication into pPJ2
Plasmids containing the SV40 origin of replication 
(ORIgy) are replicated in COS cells due to the presence of 
SV40 T antigen. It was reasoned that the addition of GRIgv 
to plasmid pPJ2 would enable USll promoter activation to be 
studied on replicated template without a requirement for HSV 
replication functions. The effect of individual HSV gene 
products on USll promoter activity might then be determined 
by co-transfection of COS cells with plasmids bearing 
isolated HSV genes.
The construction of pPJSV2 is outlined in Figure 24. 
This plasmid contains a 200bp Sphl-Hindlll fragment from the 
control region of SV40 (including ORIgy, but not the SV40 
enhancer), inserted into the Hindlll site of pPJ2.
Unfortunately, USll hybrid RNA was not detectable in 
pPJSV2 or pPJ2 transfected COS cells which had been mock- or 
super-infected with HSV-1. Only very low levels of 
replicated pPJSV2 could be detected in DNA isolated from 
transfected COS cells, suggesting that the failure to 
observe USll expression was due to an inadequate 
transfection efficiency (data not shown). It might have 
been possible to improve the transfection efficiency by 
either (i) using different COS cell lines, or (ii) trying
SphI
HindlllSail
Hindlll
Sal
USll
( p P J 2 )
p S V S V
P P J S V 2
Figure 24. Construction of pPJSV2
pPSVSV contains the indicated 200bp Sphl-Hindlll 
fragment from the SV40 control region (coordinates 128-5171, 
BBB numbering system; Tooze, 1980) cloned between the SphI 
and Hindlll sites of pRED4 (Everett, 1987). The SV40 DNA 
contains the extreme 3' end of the 72bp repeat region 
(hatched box), the 21bp repeats (open boxes), and the origin 
of DNA replication (ORIgv, stippled box). This region also 
contains the EE and LE RNA start sites (see Figure 5). The 
thick line represents SV40 DNA, the thin line represents 
vector DNA.
The Sall-Hindlll fragment of pSVSV was cloned between 
the Sail and Hindlll sites of pPJ2 (see Figure 14 for key to 
pPJ2), to create pPJSV2, as shown.
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other transfection procedures. However, due to pressure of 
time it was felt more worthwhile to pursue the experiments 
described below. Also, the presence of T antigen in COS 
cells may have created difficulties in the interpretation of 
results using this approach.
2. Non-replicative conditions; Construction of a USll 
promoter/CAT fusion gene - pPSlC
Since USll promoter activity in an ORI- environment is 
rather poor (Section I), it was decided to link the USll 
promoter to the bacterial CAT gene. The advantages of 
making such a construct are that CAT assays are very 
sensitive (more so than SI mapping), and the background of 
CAT activity in untransfected cells is zero.
The USll promoter DNA used in the construction of the 
CAT fusion gene was the Sall-SstI fragment from pP.31, which 
contains the defined minimal USll promoter region (Section J 
- Figure 19c). This fragment was inserted into the 
Sall/SstI sites of the multiple cloning site region of the 
CAT vector plasmid, pSCAT (derived from pLW2 - Gaffney e_t 
a l ., 1985), as shown in Figure 25. pSCAT contains the CAT 
gene with an HSV-2 polyadenylation signal at its 3' end, and 
several convenient restriction sites at its 5* end, cloned 
into pUCB.
3. CAT-assay protocol
CAT assays (Gorman et a l ., 1982) are now routinely used 
to obtain an indirect measure of the amount of transcription 
produced from a promoter. Increased levels of CAT activity 
have correlated well with increased levels of cytoplasmic 
RNA in studies using the HSV-2 IE 4/5 promoter (McLaughlan 
et a l ., 1985; Gaffney et a l ., 1985) and the HSV-1 gD 
promoter (Everett, 1984a, 1986). Everett (1986) has shown 
that stimulation of transfected Ut and gD promoter/CAT 
fusion genes can be mediated by the HSV-1 IE gene products, 
Vmwl75 and VmwllO, in agreement with the results of O'Hare 
and Hayward (1985a); and in combination these two IE gene 
products produced very high levels of activation. In 
contrast, activation of the VP 5 promoter brought about by
SstI
Sai l + 1
+ 39-31
USll
S st IS a i l
( p S C A T  )
p P 3 1
pP31C
Figure 25. Construction of pP31C
The Sall-SstI fragment of pP31, containing USll promoter
DNA from -31 to +39, was cloned between the Sail and SstI 
sites of pSCAT to create pP31C. The USll promoter in pP31 
is linked to globin DNA (hatched box; see Figure 19). The 
pSCAT vector plasmid contains the bacterial chloramphenicol 
acetyltransferase gene (CAT) inserted into pUC8 . 
Transcription termination signals (T) are provided by a 
10 0bp Smal-Xbal fragment from the 3' terminus of HSV-2 IE
gene 5. pSCAT was derived from pLW2 (Gaffney et a l ., 1985),
by removal of a BamHI fragment (containing the HSV-2 IE 4/5 
promoter) lying 5' to the CAT gene, and conversion of the 
resulting BamHI site to an SstI site (R.Everett, personal 
commun i cation),
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the combination of Vmwl75 and VmwllO was relatively slight, 
but was increased further (by about 4 to 5-fold) when 
plasmids encoding Vmw63 were included in the transfection 
(Everett, 1986). Using a similar approach, the ability of 
cloned IE genes to activate the USll promoter in 
pP3lC-transfected HeLa cells has been examined.
IE gene products were provided by the following 
plasmids; (i) pill, which encodes VmwllO (Perry et a l ., 
1986); (ii) pl75, which contains the coding sequences of 
Vmwl75 under control of the SV40 early promoter and enhancer 
(Perry et a l ., 1986); (iii) p63 contains the BamHI-SstI 
subfragment of HSV-1 fragment EcoRI b, which encodes Vmw63.
(iv) pSV63, which contains the Vmw63 coding sequences from 
p63, with the SV40 enhancer region inserted upstream of IE 
gene 2; and (v) p63dell, which differs from p63 by the
presence of a frameshift mutation at the Sail site located
in the Vmw63 coding sequences (L.Perry and D.McGeoch, 
personal communication).
Combinations of 'activator' plasmids which express IE 
gene products were transfected into HeLa cells with either
(i) pP3lC; (ii) pSCAT - for a negative control; or (iii) 
pgDCAT (Everett, 1986), which contains the HSV-1 gD promoter 
linked to CAT, for a positive control. The cells were grown 
in 50mm petri dishes and were transfected with 4ug of each
plasmid DNA. After 24h, transfected mono^yers were washed
and then incubated in fresh medium for a further 24h. The 
cells were then harvested for the extraction of proteins 
which were assayed for (i) CAT activity (Gorman et a l ., 
1982), and (ii) protein concentration (Lowry et al , 1951), 
as described in Materials and Methods. The level of CAT 
activity present in individual extracts was calculated by 
the percentage conversion of substrate to 3 monoacetylated 
product (see Figure 26), determined by scintillation 
counting. If the conversion was greater than 50% the 
extract was diluted and assayed again. The percentage 
conversion was then standardized to the amount of protein in 
the assayed extract, and expressed relative to the value 
(adjusted to 1), obtained with pP3lC in the absence of 
activator plasmids.
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4. Interpretation of data
Interpretation of the CAT expression data presented in 
Table 1 requires consideration of the following. The CAT 
activities have been normalized to the level of activity 
obtained with pP3lC in the absence of co-transfected 
activator plasmids. This basal level of activity is very 
low (essentially the same as that for the CAT vector 
plasmid, pSCAT), and could lead to relatively high levels of 
variation in the standardization of more active extracts. 
Also, since there is no internal control in the CAT 
transfections, the individual transfection efficiencies 
cannot be standardized (unlike in SI RNA assays). As a 
result, the calculated level of CAT expression for a 
particular experimental condition may vary widely, although 
falling within a normal distribution for that condition. 
Quantitative comparisons should therefore only be made with 
caut ion.
This limitation may be partially overcome by repeating 
the individual experiments many times. However, the data in 
Table 1 shows individual and averaged activities from a 
limited number of repeated experiments, and a significant 
difference in the level of activation should only be 
considered where the averaged CAT activities differ by at 
least 5-fold.
5. Trans-activation of the USll promoter
The results of a typical CAT assay are shown in Figure 
26; the individual and averaged data from six transfection 
experiments are given in Table 1.
It is clear that Vmwl75 and VmwllO in combination can 
activate the USll promoter. In the positive control, 
activation of pgDCAT by Vmwl75 and VmwllO is about an order 
of magnitude higher than pP31C. However, it is not clear 
from these results whether Vmw63 has any effect on the USll 
promoter in combination with Vmwl75 and VmwllO. Certainly 
its effect is not as obvious as on the VP 5 promoter (about 4 
to 5-fold; Everett, 1986), and nor does it have any effect 
on its own. However, as reported by Sacks et a 1 . (1985),
Vmw63 is important for the production of normal levels of
i
Figure 26. Activation of the USll promoter-CAT
fusion qene
Plasmids containing the CAT gene with either no promoter 
(pSCAT), or linked to the gD promoter (pgDCAT) or USll 
promoter (pP3lC), were transfected into HeLa cells with the 
following combinations of activator plasmids bearing IE 
genes :
o no activator plasmids
a pl75
b pill
c pl75 + pill
d pl75 + pill + p63
e pl75 + pill + pSV63
Cells were harvested after 48h, and cell extracts were 
assayed for CAT activity. The products of the CAT reaction 
were separated by thin-layer chromatography and identified 
by autoradiography of the resulting chromatogram.
Cm chloramphenicol (substrate)
Cm-l-Ac chloramphenicol-l-acetate
Cm-3-Ac chloramphenicol-3-acetate
In track "c" of pgDCAT, a third, diacetylated product of 
chloramphenicol (Cm-1,3-Ac) can be seen above the Cm-3-Ac 
form. Spots corresponding to Cm and Cm-3-Ac were removed 
from the TLC plate for liquid scintillation counting (see 
Table 1 ) .
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Table 2. Activation of the USll promoter by IE gene
products or super infection with HSV-1.
Test Plasmid Mode of 
Activation
Amount of 
USll 5' RNA
pBR322 pl75 + pill undectable
pPJ2 HSV-1 1733
pPJ2 pl75 + pill 25
pPJX2 pl75 + pill 14
pPJ4 pl75 + pill 22
pPJXS pl75 + pill 163
pP31 pl75 + pill 4
pPJO.31 pl75 + pill 212
pPO.31 pl75. + pill 55
The structures of the test plasmids are outlined in 
Figures 14 and 19. HeLa cells were either transfected with 
the indicated test plasmid and either pl75 and pill for 48h, 
or infected with HSV-1 for 16h, as indicated. The level of 
correctly initiated USll hybrid RNA (arbitrary units) was 
determined by quantitative SI mapping, using the same probe 
as described in Sections I and J.
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the USll gene product, 21K, during virus infection.
It is important that trans-activation of pP3lC can be 
attributed directly to the presence of the USll promoter as 
this result may have significant implications for the 
mechanism of trans-activation by HSV IE gene products (see 
Discussion). Since the level of USll trans-activation was 
low, it may have resulted from spuriously initiated RNAs.
For instance. Langer et a l . (1986) have shown that in 293 or 
HeLa cells. Ad Ela causes trans—activation of a CAT vector 
plasmid which lacks a eukaryotic promoter (pSVO-CAT; Gorman 
et a l ., 1982). By mapping pSVO-CAT-specific RNAs, it was 
shown that pSVO-CAT activity was mediated by prokaryotic 
promoter-like sequences in the pBR322 section of this 
construct (Langer et a l ., 1986).
However, it is unlikely that prokayotic sequences 
mediate the HSV IE trans-activation response in pP3lC, since 
the control vector plasmid pSCAT, which only differs from 
pP31C by the lack of the minimal USll promoter, is not 
activated. To check whether the trans-activated USll 
promoter produced correctly initiated RNA, in one 
co-transfection experiment plasmids containing the 
USll/^-globin gene were used for the analysis of RNA by SI 
mapping (Table 2). This also enabled a comparison between 
the level of USll-initiated transcripts from a replicating 
template in response to HSV-1 infection, and from a 
non-replicating template in response to HSV-1 IE gene 
products. Low levels of correctly initiated RNA were 
detected from the USll promoter in pP.31 and related 
constructs in response to co-transfections with Vmwl75 and 
VmwllO. Therefore, sequences within the minimal USll 
promoter appear to respond to trans—activation by IE gene 
products. It is possible these sequences correspond to the 
TATA box.
The data in Table 2 also shows that, as expected, the 
level of USll promoter activation in an ORI+ environment 
(pPJ2) in response to infection with HSV-1 is very 
substantially higher to that produced in an ORI- 
environment, by c o — transfection with Vmwl75 and VmwllO. 
Therefore, the transient assay system using co—transfected
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IE genes with a late promoter appears to be a valid system 
to investigate late promoter activation in the absence of 
DNA replication, in contrast to the conclusions of 
Mavromara—Nazos et a l . (1986) (see Discussion),
6 • MethyIdeoxyadenosine residues do not affect activation 
of the USll promoter
Méthylation of CpG dinucleotides in the DNA 5 '-flanking 
eukaryotic promoters has been associated with promoter 
inactivation (Bird, 1986). Although méthylation is unlikely 
to play a normal role in the regulation of animal virus gene 
expression during a productive infection, there have been 
reports where méthylation in vitro has caused inhibition of 
gene expression. In vitro méthylation of the HSV-1 gene 
at CpG sites results in the maintenance of this méthylation 
pattern in biochemically transformed cells, and the 
subsequent inhibition of gene expression (Keshet et a l ., 
198fir) . Méthylation of the adenosine residue at -78 of the 
tk gene, using EcoRI methylase, also inhibited expression 
in microinjected tk~ cells (Waechter and Baerga, 1982). 
Knebel and Doerfler (1985) have reported that deoxyadenosine 
méthylation at certain specific sites in the vicinity of the 
Adl2 Ela promoter caused reduced expression of a linked CAT 
gene in transfected cells. Although there is no evidence 
that N^-methyldeoxyadenosine normally occurs at detectable 
levels in eukaryotic DNA, this "unnatural" modification can 
evidently inactivate a eukaryotic promoter.
The USll promoter contains the dam methlyase target 
sequence, 5'-GATC-3', at -30 to -27 (McGeoch et a l ., 1985; 
see Figure 19c). The adenosine residue of this sequence is 
methylated by propqgation in the routinely used dam+ strains 
of E.coli (strains C600 and HBlOl, see Materials and 
Methods). It was conceivable that méthylation at this site 
reduced the activation of USll by HSV gene products, and 
that plasmid replication in eukaryotic cells increased USll 
expression due to de—méthylation. Unreplicated viral DNA 
might have reduced late gene expression compared to 
replicated template for entirely different reasons, such as 
the presence of nicks in parental DNA.
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Therefore, pP3lC was grown up in a dam" strain of 
E.coli (strain GM48, see Materials and Methods; kindly 
provided by D r .R .Thompson) to examine the effect of 
méthylation at residue —29. Restriction with Dpnl confirmed 
that stocks of pP3lC (dam" ) DNA were not methylated, whereas 
other stocks of pP3lC were dam-methylated (not shown). The 
activation of pP3lC (dam~ ) is shown in Table 1. There was 
no clear difference in the activation of methylated (pP3lC) 
and non-methylated plasmids [pP31C (dam-)]. indicating that 
the methylated adenosine residue at —29 of the USll promoter 
did not inhibit USll gene expression. In addition, the 
behaviour of pPJ2 grown in dam- E.coli was similar to 
methylated pPJ2 DNA in terms of USll gene expression in 
response to viral super infect ion (data not shown).
SECTION L ; Transcription of USll in Isolated Nuclei
The aim of experiments described in this section was to 
investigate how DNA replication increases late gene 
expression. It is likely that either copy number, 
replicated template, or ongoing replication are important 
for abundant late gene expression. These three mechanisms 
might be distinguished by measuring the actual rate of USll 
transcription after DNA replication has been inhibited at 
various times during infection. Rates of RNA synthesis were 
therefore determined in isolated nuclei (nuclear run-on 
assays), which measure primarily elongation of nascent 
transcripts (Hoffer and Darnell, 1981; Greenberg and Ziff, 
1984).
Measurement of USll transcription by run-on assays is 
complicated by two factors. Firstly, following the onset of 
DNA replication, transcription of both strands of HSV genes 
may occur (Jaquemont and Roizman, 1975; Godowski and Knipe, 
1986; Yager and Bachenheimer, 1987). This necessitates the
measurement of strand—specific RNAs. Secondly, USll is the
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internal member of a family of three, 3 ' co—terminal 
overlapping genes. Therefore, it is necessary to take 
account of the synthesis IE gene 5 transcripts, which 
completely overlap USll transcripts. The results described 
here should be considered as preliminary.
1. Production of single-stranded DNAs
HSV-1 DNA sequences (Figure 27) were cloned into the 
double-stranded replicative form (RF) of the M13 phage 
vectors, mpl8 or mpl9, either directly or via pUC9, as 
described below. The multiple cloning sites (mes) in mpl8 
and mpl9 are identical but present in opposite orientations, 
and contain all the restriction sites present in the mes of 
pUC9. Fragments were inserted into M13 vectors in both 
relative orientations, such that complementary and 
anti-complentary DNAs could be produced. Dideoxy sequencing 
was employed to confirm the identity and orientation of 
inserts (see Materials and Methods).
(i) USll; A 348bp BstNI-HindlII fragment from pDG8 
(Figure 6b) was isolated and its overhanging ends were 
filled in. This fragment was inserted into Smal-cleaved 
pUC9. The HSV DNA insert was then re-isolated by a 
BamHl/EcoRI double restriction digest, and inserted by a 
sticky-end ligation into the BamHl/EcoRI sites of mpl8 and 
mpl9.
(ii) IE-5 (US12); A 534bp XhoI-TaqI fragment from 
pPJX4 (Figure 14c) was isolated from an agarose gel, 
filled-in, and blunt-end ligated into Smal-cleaved pUC9.
The fragment was then re-isolated by BamHl/EcoRI digestion 
and inserted into the BamHl/EcoRI sites of mpl8 and mpl9.
(iii) tk ; An 840bp PstI fragment from pTKl (Wilkie et 
al., 1979) was inserted directly into the PstI site of mpl9. 
Recombinant phage were obtained with the insert in both
or ientat ions.
g I j^ g 3_0 — s t r anded phage containing both complementary
(cUSll, cUS12, c ^ )  and anti-complementary (aUSll, aUS12, 
atk) DNA inserts were propagated for the isolation of 
recombinant phage DNA, as described in Material and Methods 
(Section G(5)). Single-stranded DNA was applied in lOug
BamHI x 
0 2 10 12 14 10 18 201 I I I 1--1--1--1-- 1-- 1--1-- r bp X 10-2
O R I
I E 5 -»
Xhol
(Smal) TaqI
U S 1 0
(pPJX4) IE6 B s t N l Hindlll
534
(473) USn d ( p D G 8 )
348
(290)
P a l l PstI
840
t k <pTK1)
tk
Figure 27. DNA sequences used for the detection of USll, 
IE 5 and tk RNA synthesis
a. The coding potential of HSV-1 BamHI x fragment (see 
Figure 12 legend for key). In the lower part of the figure, 
the subfragments from pPJX4 and pDG8 which were used for the 
detection of IE 5 and USll RNA by hybridization, are 
indicated. The size of the subfragments and length of 
hybrids (in brackets) are given (bp).
b . The 840bp PstI subfragment from pTKl used for 
hybridization to RNA. The RNA start site lies 
approximately lObp 5' to the right—most indicated PstI site.
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aliquots to nitrocellulose strips using a Schleicher and 
Schuell slot-blot apparatus.
2. USll transcription
Nuclei were isolated from BHK cells on 90mm plates,
0-8h after adsorption with HSV-1. PAA was added to two 
additional plates, at Oh or 7h p.a,, and at 8h p.a. nuclei 
were isolated from these plates. The nuclei were incubated 
with exogenous nucleotide triphosphates and [ -32p] UTP.
RNA was then isolated and hydridized to filters which had 
been blotted with single-stranded DNAs (using a "slot-blot" 
apparatus) as described in Section G(22). This experiment 
was repeated twice (Exp.l and Exp.2). An autoradiograph 
corresponding to the slot-blot from the Exp.2 is shown in 
Figure 28. It can be seen that there is a high
level of background hybridization from uninfected cellular 
RNA to the cUSll and cUS12 ssDNAs, although this is 
over-represented in the autoradiograph as the incorporation 
of radioactivity was highest in the uninfected cells in 
Exp.2. The relative levels of hybridization were measured 
by densitometry, and normalized for input cpm and length of 
hybrids. Standardized results for the two experiments are 
given in Table 3 (note that DNA was not available for
Exp.1 ) .
The calculated level of US 11-initiated transcription at 
various times during infection is given in Table 3 (see 
cUSll-cUS12 column). These values have been determined from 
the level of hybridization to corresponding to US12 (cUS12) 
subtracted from that to USll plus US12 (cUSll). In both 
experiments, the rate of USll transcription increased during 
infection. Interestingly, the rate of IE 5 transcription 
was high at late times in Exp.2, although in both 
experiments it was less than the amount of USll 
transcription at 4 and 8h. The level of anti-complementary 
transcripts remained low in all cases, in contrast to 
previous reports (Godowski and Knipe, 1986; Yager and 
Bachenheimer, 1987). In Exp.2, the detected level of Uc
transcription was poor; the reason for this was unknown, but 
might simply be due to a poor infection.
ml3- 
CUSI2 -  
cUSII -  
cUc - 
aUSI2 -  
aUSIl -
atk —
i
Figure 28. Transcription of USll, IE 5, and tk 
in isolated nuclei
Nuclei were isolated from BHK cells which were 
uninfected (track 1), or had been infected with HSV-1 for Ih 
(track 2), 2h (track 3), 4h (track 4) or 8h (tracks 5,6,7). 
In two cases, PAA had been added to cells, at Oh (track 6 ) 
and 7h p.a. (Track 7). Radioactively labelled run-on 
transcripts synthesized in isolated nuclei were hybridized 
to ss Ml3 DNAs that had been blotted onto nitrocellulaose 
filters. The ss DNAs contained either no insert (M13) or 
HSV-1 sequences complementary (c) or anti-complementary (a) 
to RNAs for US12 (IE 5), USll, and (see Figure 27). The 
relative levels of hybridization from the autoradiograph 
were quantified by densitometry, and standardized for the 
lengths of hybrids and the total CPM used in each 
hybridization (Table 3).
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The results of the experiments with PAA are also shown 
in Table 3. In Exp.l, PAA at Oh severely diminished USll 
and IE 5 transcription, but not in Exp.2. In both 
experiments, the addition of PAA at 7h appeared to reduce, 
although not abolish, USll transcription one hour later.
Due to the variability of these results, the uncertain 
contribution of transcription from IE gene 5, and the lack 
of a control for the effect of PAA, it is unwise to draw any 
conclusions from these experiments concerning the role of 
DNA replication on USll promoter activity.
3. Conclusions
The results shown here indicate that the nuclear run-on 
assay would be useful in investigating the role of DNA 
replication on late promoter activity. At the moment, it is 
unclear whether copy number, past-replication, or ongoing 
replication is the dominant controlling factor for abundant 
late gene expression. To distinguish between these 
possibilities it will be essential to measure actual rates 
of RNA synthesis under varying conditions of DNA synthesis 
inhibition. However, the choice of USll as a late gene 
promoter appeared unfortunate in these experiments due to 
the substantial level of overlapping transcripts which arose 
from the IE 5 promoter at late times in infection. A late 
gene such as gC, which is not overlapped by other 
transcription units, would be more suitable for this type of 
investigation. In future experiments, the effect of PAA on 
DNA relication should be controlled for (perhaps by 
measuring the incorporation of ^H into HSV DNA), and the 
effects of PAA on both late and early (or EL) transcription 
should be compared. Note that gD was not used in this study 
as it too is overlapped by another transcription unit (see 
Figure 3; Rixon and McGeoch, 1985).
A nuclear run-on assay would also enable the effect of 
specific gene products on late gene transcription to be 
investigated. For example, temperature shift-up experiments 
could be used to see if Vmwl75 (from the temperature- 
sensitive tsK virus) is essential later in infection for 
late gene transcription.
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DISCUSSION
The experiments described in this thesis were designed 
to investigate the molecular basis for the temporal 
regulation of HSV-1 late genes. The gene chosen for study 
was USll (McGeoch et a l ., 1985), which was shown to be 
regulated with "true-late" kinetics during viral infection 
(Section H ). A plasmid-borne USll promoter can mimic these 
kinetics in a transient assay system, where it was shown 
that DNA replication is not an absolute requirement for 
promoter activation, but is important for abundant 
expression (Section I). The activities of deletion mutants 
of the USll promoter were studied in plasmids containing the 
HSV-1 TRg/iRg origin of replication (ORIg). The sequences 
required for fully efficient regulated expression of USll 
are contained within the region -31 to +39 relative to the 
RNA cap sites (Section J). Thus, by the absence of an 
upstream region, the structure of the USll promoter appears 
to differ significantly from that of characterized HSV IE, E 
and EL promoters (see Section E) . Co-transfection 
experiments indicated that the USll promoter may be 
activated by the HSV IE gene products, Vmwl75 and VmwllO, at 
least in the absence of DNA replication (Section K ) . The 
mechanism of late promoter activation may therefore share 
some similarity to the activation of E promoters, but 
differs by its requirement of DNA replication for abundant 
expression.
1. Late Promoter Sequence Requirements
Deletion analysis indicated that the sequences required 
for USll promoter activity lie within -31 to +39 of the USll 
RNA start sites. In the region upstream from +1 of USll 
there is no sequence homology to either of the well 
characterized and gD promoters, except for the presence 
in all three promoters of a consensus TATA box sequence in 
the -25 region (see Figure 29). Since a deletion mutant of 
the gD promoter, with sequences -33 to +17 linked to the
ORIg origin of DNA replication, is regulated with late
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kinetics (Section J), it is possible that an HSV late gene 
might be characterized simply by the presence of a TATA box, 
in the absence of distal regulatory signals upstream.
How typical is USll of other HSV true late promoters? 
The HSV-1 glycoprotein C (g C ) gene is also regulated with 
true late kinetics during viral infection, and is dependent 
on DNA replication for efficient expression (Hall et a l ., 
1982; Yager and Bachenheimer, 1987). Homa et a l . (1986) 
have studied the expression of deletion mutants of the gC 
gene reinserted into the gC locus of recombinant viruses.
The sequences required for proper regulation of gC 
transcription during viral infection were found to lie 
within -34 to +124 of the gC cap sites. Moreover, the -34 
to +124 region of gC functioned as a late promoter when 
placed 5' to the structural gene. The gC promoter 
contains a TATA box at -30 and therefore resembles USll with 
regard to its minimum sequence requirements, and lack of a 
functional "upstream" region.
Homa et a l . (1986) suggested that sequences downstream 
of -35 of g C , although containing signals responsive to 
trans-activation, also contain signals which prevent the 
expression of gC prior to the onset of viral DNA 
replication. They argue that when linked to the t_k 
structural gene, these sequences prevented expression 
prior to DNA replication. However, it seems unlikely that 
late promoters contain specific signals for their negative 
regulation in the absence of DNA replication, since a -33 
deletion mutant of the gD promoter is poorly active in a 
transient assay (Everett, 1983), but can be converted to a 
late promoter capable of efficient expression, simply by 
linkage to ORIg (Section J).
The role of sequences within the TATA box-cap site 
regions of USll (Section J) and gC (Homa et a l ., 1986), have 
not been specifically investigated. The TATA box itself is 
likely to be critical for promoter function, since its 
deletion (by removal of sequences between -31 to -21) 
reduced USll promoter activity by nearly 100-fold (see 
Figure 19). But it is possible that sequences other than 
the TATA box are involved in the activation of the USll and
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gC promoters. Although there is no obvious conservation at 
the sequence level in the tract of DNA between the TATA box 
and cap site regions of USll and gC (Figure 29), both 
regions are notably purine-rich (80% and 70% respectively). 
The degree of purine richness in the same region of other 
HSV promoters is variable; e.g. gD- 73%; tk- 55%; VP5- 50% 
(see Figure 29); and the significance (if any) of a 
purine-rich tract in the region -20 to - 1, is not known.
The TATA box sequences of the five promoters shown in Figure 
29 all match reasonably well the consensus sequence of 
Breathnach and Chambon (1981), although this is not 
universally true for all HSV promoters (Wagner, 1985). It 
would be of interest to determine the effect of individual 
base mutations in the TATA box-cap site region of, say USll. 
Since the deletion or mutation of sequences in the cap site 
regions of gD (Everett, 1984b) and (Coen et a l ., 1986) 
affected their expression, it is possible that similar 
mutations might also affect USll promoter activity.
The relationship between the three temporal classes of 
HSV promoters may be summarised as shown in Figure 23. This 
illustrates that as infection proceeds, and after DNA 
replication occurs, fewer regulatory signals are required 
for efficient transcription from a promoter. In the case of 
USll, an active origin of DNA replication appears to 
substitute for a distal ("upstream") promoter region during 
the later stages of the lytic cycle. Thus late promoters 
may not require certain cellular transcription factors such 
as Spl, that IE and E genes have been shown to require 
(Jones et a l ., 1985; Jones and Tjian, 1985); these cellular 
factors may become scarce or diluted out at the later stages 
of the lytic cycle, due to HSV mediated shut-off of host 
mRNA and polypeptide synthesis (Fenwick and Morse, 1979;
Read and Frenkel, 1983). It is interesting to speculate 
that a relaxation in the requirements for cis-acting DNA 
sequences for transcription initiation may lead to an 
increase in apparently randomly initiated RNA molecules, 
which may account for at least/^proportion of the "symmetric" 
transcription observed at late times and which is associated 
with DNA replication (Jaquemont and Roizman, 1975; Godowski
g
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and Knipe, 1986; Yager and Bachenheimer, 1987).
Although the expression of some early genes (the EL 
class) is increased by DNA replication (perhaps simply due 
to an increase in copy number), at late times their 
expression is decreased (Honess and Roizman, 1974; Johnson 
6t a l ., 1986). The difference between the late and early 
promoters at the sequence level suggests a mechanism to turn 
down early transcription without affecting late gene 
expression: Factors that bind to distal upstream elements
may be inhibited, or their function altered causing 
inhibition of early promoter activity. Thus the mechanisms 
for both activation (in conjunction with IE gene products) 
and repression of early gene expression may be mediated by 
cellular transcription factors without recourse to 
virus-specific sequences.
Two very different viruses share a similar brevity in 
DNA sequence requirement for replication-associated late 
gene expression. Bacteriophage T4, which has a large double 
stranded DNA genome of about 166kb, replicates in the 
bacterium, E.coli. A comparison of nucleotide sequences 
around the 5' starts of five T4 late genes revealed the 
presence of a conserved "-10" region (consensus 
5'-TATAAATA-3'), but no common sequences in the "-35" 
consensus region of T4 early and E.coli promoters 
(Christensen and Young, 1983). The minimal DNA sequence 
requirements for the function of a T4 late promoter, P23# 
are contined within a 35bp segment of T4 DNA (from -18 to 
+17 of P 23)/ which includes the "-10" homology (Elliott and 
Geiduschek, 1984). Vaccinia virus, which also has a large 
double-stranded DNA genome (about 190kb), replicates in the 
cytoplasm of mammalian cells, and is thought to use 
exclusively virus-encoded enzymes for the expression of its 
genes (Moss, 1985). Although there is currently little 
information on the structure of vaccinia virus early genes, 
two groups have recently published similar results regarding 
the sequences required for late promoter activity, using 
recombinant viruses (Bertholet et a l ., 1986; Hanggi et a l ., 
1986). Only 15bp of 5' flanking DNA is required for
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properly regulated expression of a vaccinia virus late gene.
The respective biologies of HSV, T4 and vaccinia virus 
could hardly seem more disparate, yet these large DNA 
viruses which undergo rapid lytic cycles may have come to a 
similar solution regarding the control of expression of 
their late genes; namely linkage (in some way) to DNA 
replication, and a minimalisation of promoter DNA sequences. 
Whereas the functions involved in HSV DNA replication and 
late promoter activation are only just beginning to be 
defined, the wealth of knowledge concerning bacteriophage T4 
genetics means that the understanding of T4 late promoter 
activation is well advanced by comparison (Geiduschek e_t 
al., 1983). Thus, T4 might provide useful insights into the 
possible mechanisms of HSV late promoter function, and is 
discussed further below (part 4).
2. Trans-activat ion
a . Trans-activation of late genes
The activity of a plasmid-borne USll promoter was 
studied in response to activation by HSV-1 IE gene products 
by linking the minimally defined USll promoter DNA to the 
bacterial CAT gene, and assaying for CAT activity in 
co-transfected HeLa cells (Section K ) . Co-transfection of 
USll-CAT with either Vmwl75 or VmwllO gave low but 
detectable levels of CAT activity. An approximate 10-fold 
increase in CAT activity was produced by Vmwl75 and VmwllO 
in combination, thus their synergistic effect appears to 
apply to a late promoter as well as to early promoters 
(Everett, 1984a; Quinlan and Knipe, 1985; Gelman and 
Silverstein, 1986). Vmw63 did not cause a detectable 
increase in CAT activity from USll-CAT, either alone or in 
combination with Vmwl75 and VmwllO (Section K ) . This 
contrasts with the observation that late gene products are 
underproduced during infection with a virus bearing a 
lesion in Vmw63, at NPT (Sacks et a l ., 1985). Since the 
USll-CAT construct was not replicated in the co-transfection 
experiments, it is not possible to rule out that Vmw63 might 
only be required following the onset of replication.
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Two groups have investigated trans-activation of the 
L42 late promoter (Hall et a l ., 1982), also in 
co-transfection experiments. DeLuca and Schaffer (1985) 
found that CAT activity was induced from an L42-CAT fusion 
gene by co-transfection with a plasmid bearing IE genes 
1,2,3 and 5, but not by IE gene 3 alone. In contrast, 
Mavromara-Nazos et a 1 . ( 1986) reported that similar levels 
of ^  activity were induced by Vmwl75 from an L42-tk 
construct, as from a plasmid bearing the natural tk gene. 
Co-transfection of L42-t_k with VmwllO also stimulated tb 
activity, whereas Vmw63, Vmw68, and Vmwl2 did not, but no 
combinations of IE genes were tested.
It is clear that late promoters can be activated by 
HSV-1 IE gene products in co-transfection experiments, but 
between different groups there appear to be differences in 
the level of stimulation and the requirement for one or more 
IE gene products. This is reminiscent of the differences 
found in the activation of E promoters, as discussed in 
Section E. Essentially the results in Section K are 
compatible with those of DeLuca and Schaffer (1985), which 
indicate Vmwl75 does not activate L promoters very well on 
its own. The major apparent discrepency is that 
Mavromara-Nazos et a l . (1986) found that a similar level of 
tk activity was induced by Vmwl75 from the L42 promoter as 
from the promoter. Mavromara-Nazos et a l . (1986) argue
this result shows that late promters are regulated as early 
promoters in transient assays. This need not be the case;
Firstly, the level of stimulation of activity was 
quite low, only 5-fold above background. Trans-activation 
of the USll promoter by Vmwl75 or VmwllO also increased CAT 
activity by about 5-fold, and in combination Vmwl75 and 
VmwllO further increased CAT activity by 5 to 10-fold (Table 
2). It was possible to detect USl1-initiated RNA from pPJ2 
in response to co-transfection with plasmids encoding Vmwl75 
and VmwllO (Table 3). However, the level of USll-initiated 
RNA from plasmid pPJ2 was increased much more efficiently 
(over 25-fold) by super infection with HSV-1 (Table 3). 
Although it is not strictly valid to make a direct 
comparison, this result indicates that the level of
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stimulation by Vmwl75 and VmwllO is of the order of
magnitude that might be expected, since super infect ion of
pPJ2 induces replication of pPJ2 DNA whereas a
co-trans feetion does not. Therefore, the level of late
promoter activation in co-transfection experiments is not
sufficiently high to suggest that it involves a novel
mechanism.
Secondly, Mavromara-Nazos et a 1 . (1986) did not show 
that the stimulation of tic activity from L42-tk correlated 
at the RNA level with the stimulation of the natural tjc 
gene. The probe used for SI mapping L42-tk hybrid 
transcripts was labelled at +138 of the ^  gene, and would 
not have detected any RNA initiated at +200 from a 
downstream pseudo-promoter, which is also capable of 
producing enzymatically active (Dennis and Smiley, 1984; 
Halpern and Smiley, 1984). Thus the overall level of 
activity induced from L42-tJ^, although not especially high, 
might not have arisen solely from L42-initiated transcripts.
b. Trans-activation in general
Since a late promoter can be activated by cloned HSV-1 
IE gene products, the sequences required for 
trans-activation probably lie within the TATA box-cap site 
region rather than, for instance, the upstream promoter 
region. Everett (1987) constructed a hybrid promoter 
consisting of the SV40 early promoter upstream region and 
the HSV gD TATA box region. This hybrid promoter was 
activated well in response to HSV-1 infection, whereas the 
natural SV40 early promoter is poorly responsive (O'Hare and 
Hayward, 1984). The TATA box itself may therefore be a 
critical promoter element for the mechanism of action of 
HSV-1 IE gene products. In support of this conclusion, 
Tackney et a l . (1984) observed that the Chinese hamster aprt 
gene, which in common with many other housekeeping genes 
lacks a TATA box (Dush et a l ., 1985; Kim et a l ., 1986), was 
not activated during infection with an HSV-1 recombinant 
virus that contained the aprt gene and promoter. In 
contrast, the rabbit P-globin gene, which does possess a 
TATA box, is activated during infection with an
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HSV-l/P-globin recombinant virus {J.R.Smiley, C.Smibert,
R.D.Everett, submitted).
Trans-activation mediated by the adenovirus Ela 
proteins requires the presence of an AG-rich element in the 
upstream region of responsive promoters (see Section D). 
There is evidence that at least one mechanism of action of 
Ela occurs through a direct or indirect interaction with a 
cellular factor that recognises this sequence (Kovesdi et
1986; SivaRamen et a l ., 1986). Experiments by Loeken 
et a 1 . (1986) indicate that Ela and SV40 T antigen stimulate 
the adenovirus E2 promoter by different mechanisms, and it 
is clearly possible that HSV IE gene products may also have 
different mechanisms for trans-activation, especially since 
different sequences are implicated in trans-activation 
mediated by Ela and HSV IE products. A complexity in 
proposing how HSV IE proteins might operate is the observed 
synergism between Vmwl75 and VmwllO. It is possible that 
both IE products might operate through the TATA box, if for 
example, VmwllO were to increase the availability of a TATA 
box binding factor and Vmwl75 were to increase the activity 
of this factor. Possible mechanisms of action of Vmwl75 are 
considered below, however, there is currently insufficient 
data on the properties of VmwllO to enable a reasoned 
proposal of how it might operate.
Some of the reported properties of Vmwl75 include; (i)
Partially purified Vmwl75 failed to bind to DNA except in
the presence of uninfected cell extracts (Freeman and 
Powell, 1982); (ii) In a DNA binding immumoassay, 
antibodies to Vmwl75 immunoprecipitated DNA fragments, 
including gD promoter DNA (Faber and Wilcox, 1986; Beard e^
al., 1986); (iii) Vmwl75 stimulated gD transcription i^
vitro (Beard et a l ., 1986). With the assumption that the 
TATA box is critical for the action of Vmwl75, a mechanism 
of action that is consistent with the above observations 
would involve a direct interaction of Vmwl75 with a TATA box 
binding factor, and for this interaction to occur in a 
nucleoprotein complex (see Echols, 1986). Three alternative 
mechanisms which seem less likely are (i) Vmwl75 transiently 
interacts with unbound TATA box factor, and alters its
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activity, (ii) Vmwl75 increases the availibility of TATA 
boxbinding factors, or (iii) Vmwl75 binds directly to the 
TATA box. The first two alternatives are inconsistent with 
the observation that the related herpes virus IE protein,
PRV IE180, is required in functional form to stimulate 
transcription in vitro (Abmayr et a l ., 1985). However, the 
third possibility, that Vmwl75 might bind directly to DNA, 
cannot be ruled out completely on currently available 
evidence.
A general mechanism of promoter activation for RNA 
polymerase Il-mediated transcription may involve the 
formation of a stable complex of DNA-bound transcription 
factors (see Section D). It is attractive to postulate that 
trans-activating proteins are able to take part in the 
formation of such a complex. This may explain how in some 
cases trans-activating proteins are able to substitute for 
enhancer function: If one of the functions of enhancer
DNA-bound transcription factors is to interact with promoter 
DNA-bound transcription factors in the formation of a stable 
complex, then the enhancer factors might be replaced by 
trans-activating proteins if these are able to interact 
directly with promoter DNA-bound transcription factors.
3. The Role of DNA Replication in Late Gene Expression
It is well established in the literature that HSV-1 
late gene expression is hard to detect under conditions of 
DNA replication inhibition or using t^ DNA" mutants at NPT 
(see Section E ). How dependent is late gene expression on 
DNA replication? During HSV-1 infection in the presence of 
300ug/ml of PAA, USll gene expression was reduced 50 to 
100-fold, whilst the expression of an EL gene, gD, was 
reduced 5 to 10-fold (Section H ). This result indicated 
that late gene expression was more dependent on DNA 
replication than EL expression, by about an order of 
magnitude. Although low levels of USll gene products were 
detected in the presence of PAA, it cannot be assumed using 
chemical inhibitors that absolutely no DNA replication had 
taken place. To investigate the absolute requirement for
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DNA replication, the activity of plasmid-borne USll promoter 
was studied using plasmids which contained or lacked a 
functional HSV-1 origin of DNA replication (ORIg). In 
response to HSV-1 infection, the USll promoter was activated 
on ORI“ plasmids, but expression was reduced by about 
25-fold compared to an ORI+ plasmid (Section I). This 
indicates that DNA replication is not an absolute 
requirement for late gene expression. Late gene expression 
under non-replicating conditions has also been reported for 
gC, using wild-type virus and a ^  MDBP (DNA") mutant at 
NPT, both in the presence of PAA (Godowski and Knipe, 1985). 
Transcription of gC in isolated nuclei is strongly inhibited 
but not completely abolished by the presence of PAA 
(Godowski and Knipe, 1986; Yager and Bachenheimer, 1987). 
Activation of the L42 promoter in transient assays has also 
been shown to take place in the absence of DNA replication 
functions (DeLuca and Schaffer, 1985; Mavromara-Nazos,
1986). Although DNA replication is not an absolute 
requirement for late gene expression, it clearly is 
important for achieving abundant expression.
How does DNA replication increase late gene expression? 
An obvious role for replication would be to increase the 
copy number of an intrinsically weak promoter, i.e. the 
"amplification model". The absence of an upstream region 
would suggest why a late promoter might have poor activity. 
The ability to trans-activate late promoter function in the
UjiH a
absence of DNA replication is consistent^the amplification 
model, in that replication is only needed to increase copy 
number, not late promoter activity. However, evidence 
described below suggests that the role of replication in 
late gene transcription may be more complex than merely to 
increase copy number.
A frequent observation is the coincidence of the 
detection of late gene expression with the onset of DNA 
replication (Swanstrom et a l ., 1975; Powell et a l ., 1975; 
Pedersen et a l ., 1981; Johnson et a l ., 1986). In the 
time-course experiment described in Section I, transcription 
from the plasmid-borne USll promoter was not detectable 
prior to the onset of DNA replication, yet up to 1000 copies
149
per cell of plasmid DNA were isolated from transfected cell 
nuclei (Figure 16). USll transcripts became detectable when 
there were 500 copies per cell of replicated plasmid DNA.
The similarity in the times of appearance of USll hybrid 
transcripts and pPJ2 plasmid DNA replication is striking.
It was notable too that USll hybrid transcript accumulation 
dramatically increased (at least 10-fold) between 8 and 1 Oh 
p.a., a period in which the copy number of replicated 
plasmid DNA had barely doubled (Figure 16). These 
observations suggest that replication may provide a switch 
which increases late promoter activity, independent of the 
changes in template copy number.
If DNA replication per se is important, does a lasting 
change in template structure or the transient act of 
replication itself affect late promoter activity? The 
experiments in Sections I and J indicated that transcription 
through a late promoter (from the upstream IE gene 5 
promoter) increased its expression. Replication of and 
transcription through a late promoter may indicate a common 
mechanism by which both processes operate positively on late 
gene expression; both would lead to an opening up of the 
template structure to improve access to the transcription 
machinery. However, the presence of the IE 5 promoter 
upstream from the USll promoter had no affect on USll 
promoter activity in the absence of ORIg (Figure 14). It 
would seem that replication is required to potentiate the 
effect of 'through-transcription', therefore their 
mechanisms of action on late gene expression are likely to 
be different. For instance, if replication prepares a 
'competent' template for late transcription, the effect of 
the IE 5 promoter might be to increase the concentration of 
RNA polymerase molecules in the vicinity of the USll 
promoter.
Two experiments were designed to test whether the 
effect of DNA replication on late gene transcription was 
transient or lasting. The effect of inhibiting DNA 
replication late during infection was measured in terms of 
USll RNA accumulation (Section H ) and USll transcription in 
isolated nuclei (Section L ). Although the addition of PAA
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checked the normal rise in USll RNA accumulation (Figure 
11), it is uncertain whether the measured decrease in USll 
transcription in isolated nuclei was significant (Table 3). 
Ideally this experiment should be repeated using a late gene 
(such as g C ) which is not overlapped by other transcription 
units, as is the case for USll. However, if DNA replication 
has multiple roles in increasing late promoter activity (see 
discussion below, on T4), then the overall effect of 
inhibiting replication late in infection might be difficult 
to interpret, and the method of inhibition may also be 
important.
A view held by some is that late genes are regulated 
with early kinetics, and bypass a requirement for DNA 
replication, when they are integrated into the cellular 
genome (Silver and Roizman, 1985), or resident on a plasmid 
in transient assays (Mavromara-Nazos et a l ., 1986). As 
such, the regulation of late genes as early genes in the 
"environment of the host" (Mavromara-Nazos et a l ., 1986), 
has been taken into account to construct two further models 
for the role of DNA replication. As discussed in part 2 
above, there is no reason to assume that the ability to 
trans-activate a late promoter in a transient assay is proof 
that it is being regulated by a different mechanism to its 
counterpart in the viral genome under non-replicative 
conditions. Silver and Roizman (1985) have shown that an 
L 4 2 - ^  fusion gene was active in the absence of both a
cis-linked HSV DNA replication origin, and HSV gene
products, when integrated into the cellular genome of 
biochemically transformed cells. Infection of L42-tk 
transformed cells with HSV-1 increased ^  activity by 
16-fold. However, it is not known whether the early
gene-like activity of the L42 promoter was due to an effect
of the host genome, or the nature of cellular sequences 
surrounding the multiple, randomly integrated fusion genes. 
Aspects of the two models described below are influenced by 
whether or not viral genes are regulated differently outside 
the viral genome because of differences in DNA structure.
In simple terms, the "repressor model" supposes that 
viral or cellular factors prevent the activation of late
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genes by IE gene products until these factors are displaced 
by viral DNA replication. Mavromara-Nazos et a l . (1986) 
suggest that the putative "late-repressor" binds to viral 
late promoter DNA which is not part of a replication 
complex, but that the repressor cannot bind to cellular or 
plasmid DNA. Homa et a 1 . (1986) suggest that there are 
specific sequences within a late promoter which are a target 
for a repressor; but this is difficult to reconcile with the 
ability to convert an EL promoter to a late promoter 
(Section J). There is evidence that prior to DNA 
replication MDBP represses transcription of HSV-1 genes 
belonging to all temporal classes (Godowski and Knipe, 1985, 
1986), and therefore the repressor model is at least partly 
valid. However, a defect in MDBP permits only low levels of 
late gene transcription, so it is unlikely that MDBP plays a 
major role in the regulation of late gene expression. The 
repressor model is also unattractive for the following 
reason; it predicts that in the absence of repression late 
promoters can be activated by IE gene products as well as 
early promoters. However, the absence of an upstream region 
would suggest that late promoters need a positive mechanism 
to increase their expression, rather than the relief of 
repression.
The second model is the "sequestered factor" 
hypothesis, put forward by Mavromara-Nazos et a l . (1986).
This model predicts that host factors necessary for the 
induction of late genes are contained within host chromatin, 
and are released by an effect of the viral DNA polymerase. 
The main support for this model is that the expression of a 
late gene integrated into the cellular genome appeared to be 
unlinked from DNA replication (Silver and Roizman, 1985). 
However, it is difficult to imagine how the viral DNA 
polymerase could cause a release of factors from cellular 
chromatin.
4. Comparison of HSV-1 and Bacteriophage T4 Regulation of 
Late Gene Transcription
Although HSV-1 replicates in eukaryotic cells and 
bacteriophage T4 replicates in prokaryotic cells, these
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viruses appear to share a similarity regarding late promoter 
structure and the association of late transcription with DNA 
replication (see part 1 above). Unlike HSV-1, the majority 
of the ~15ü gene functions of T4 have been characterized, 
facilitated by the ease with which phage containing 
mutations in individual genes can be isolated (for review, 
see Mathews et a l ., 1983). It is known that three T4-coded 
proteins, gp33, gp55, and gp45, are normally required for 
late gene expression. Two of these, gp33 and gpSS, are 
subunits of the modified E .coli RNA polymerase, and are 
required for selective transcription from late promoters.
The third gene product, gp45, is a component of the T4 DNA 
replication complex (the 'replisome'), but is also directly 
required for late transcription and is thought to interact 
with gp55 and RNA polymerase (Geiduschek et a l ., 1983). The 
components of T4 late gene transcription are therefore 
better defined than those of HSV. From this knowledge it 
would seem important that the intrinsic effects of DNA 
replication on HSV late gene transcription are able to be 
distinguished from the effects of individual HSV DNA 
replication proteins.
T4 late transcription is not dependent on a lasting 
covalent modification of replicated DNA, nor does it have an 
absolute requirement for DNA replication, as with HSV (Riva 
et a l ., 1970a). Blocking ongoing replication causes an 
approximate 10-fold decrease in the rate of T4 late RNA 
synthesis (Riva et a l ., 1970a), although metabolic 
inhibitors generate a less extreme effect on late 
transcription than inactivation of the T4 DNA polymerase 
(Rabussay and Geiduschek, 1979). This is reminiscent of the 
moderate reduction in the rate of HSV-1 USll RNA synthesis 
in isolated nuclei following inhibition of DNA replication 
with PAA (Section L ). Geiduschek et a l . (1983) suggest that 
the 10-fold effect of ongoing DNA replication in T4 is 
divided between the effects of individual replication 
proteins (such as gp45), and the effects of DNA structure.
An insight into the DNA structure that is important for late 
transcription has been gained by studying ^  mutants in 
temperature shift-up experiments (Riva et a l ., 1970b). It
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is possible to uncouple late transcription from DNA 
replication in a T4 multiple mutant bearing lesions in 
DNA polymerase, DNA ligase, and gene 46 exonuclease 
function. At NPT, the t_£ lesion in ligase prevents the 
repair of single-stranded nicks and gaps, many of which are 
likely to be generated at the replication fork. The 
mutation in DNA polymerase blocks DNA replication, and the 
mutation in gene 46 inhibits degradation of phage DNA. A 
role for DNA replication may therefore be the transient 
generation of a nicked template. Uncoupled late 
transcription has been shown to be correctly initiated, and 
absolutely dependent on gp55 and gp45 (Christensen and 
Young, 1982). Since it was attractive to propose that gp45 
might link RNA polymerase to the replisome, and thus aid the 
initiation of late transcription in newly made DNA 
(Geiduschek et al ., 1983), it was suprising to find that 
uncoupled late transcription was still dependent on gp45 
function. The ability to express cloned T4 genes in plasmid 
DNA, following infection with T4 helper phage, has also 
presented problems in the interpretation of T4 late gene 
regulation (Geiduschek et a l ., 1983). However, the genetic 
background of the helper phage is critical for the induction 
of correctly initiated late RNA. The infecting phage must 
contain a mutation that allows transcription of 
cytosine-containing DNA (since T4 DNA normally contains 
hydroxymethylcytosine), and from the literature it seems 
controversial whether or not a recombination/nuclease 
function is involved in creating an independence from DNA 
replication for plasmid-borne late promoters (Christensen 
and Young, 1983; Geiduschek et a l ., 1983; Elliott and 
Geiduschek, 1984).
A major difference between HSV and T4 late 
transcription is that a T4-modified RNA polymerase appears 
to select T4 late promoters. There is no evidence that 
different factors are required in HSV infected cells for the 
recognition early and late promoters, with the possible 
exception of Vmw63 (Sacks et a l ., 1985). Promoter 
selectivity in T4 might be based on (i) a slight difference 
in the highly conserved "-10" region of T4 late promoters
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(5'-TATAAATA-3') compared to the E.coli "-10" homology 
(5'-TATAAT-3') present in T4 early promoters, and (ii) a 
less conserved 3-4bp sequence located 3' to the late "-10" 
region (Christensen and Young, 1983). In HSV, selection of 
specific sequences within the TATA box-cap site regions of E 
and L genes is unlikely, since it has been shown that the 
TATA box of the EL gD promoter can function as a late 
promoter (Section J), and in general, the TATA box sequences 
of HSV early and late promoters do not appear to be very 
highly conserved (Wagner, 1985).
5. Future Prospects
Future work directed at improving the understanding of 
the control of HSV late gene transcription falls into three 
main areas; (i) precise definition of the late promoter 
sequence requirements; (ii) complete identification of the 
proteins involved in late transcription; and (iii) 
determining the exact role of DNA replication. Since the 
sequences required for late transcription are relatively 
short, the use of synthetic oligonucleotides to introduce 
specific mutations into the TATA box-cap site region would 
be quite easy. It would be possible to ask if the TATA box 
alone constitutes a late promoter, and determine the 
importance of individual nucleotides within the TATA box 
sequence.
The experiments which have shown that VmwlVS and VmwllO 
can activate late promoters have been done in the absence of 
DNA replication, and the level of activation was quite low. 
It would be interesting to see if the DNA structure 
conferred by replication is sufficient to increase the level 
of activation mediated by Vmwl75 and VmwllO, or if different 
IE or E gene products (such as Vmw63 replication functions) 
are involved. Plasmids bearing the USll promoter could be 
replicated in the absence or presence of HSV replication 
functions, by (i) transfection into COS cells (which provide 
SV40 T antigen), using a USll promoter linked to the SV40 
origin of DNA replication (as in Section K(l)), or by (ii) 
reconstitution of isolated HSV-1 replication functions in a 
multiple co-transfection (using the approach of Challberg,
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1986). The effect of isolated HSV genes, such as Vmwl75, 
VmwllO and Vmw63, could then be tested, on the expression of 
the USll promoter contained on a replicating template.
To investigate the role of DNA replication in late gene 
expression, a sensitive assay is needed to measure the 
effects of various perturbations on late RNA synthesis. The 
nuclear run-on assay described in Section L appeared 
promising, although USll was not a particularly suitable 
gene to study using this technique, as it was difficult to 
distinguish USll RNA synthesis from that of IE gene 5, and 
due to the high level of background hybridization of 
cellular RNA to the USll region. A more suitable late gene 
would be g C . It would be possible to determine the effect 
on gC transcription of, e.g. inhibition of DNA replication 
late in infection, temperature shift-up of ^  DNA" mutants, 
and of ^  mutants in other genes, such as Vmwl75, which 
might be involved in late transcription.
Finally, does the control of HSV-1 late gene 
transcription have any revelance to the regulation of 
cellular genes? It seems reasonable to suggest that 
coupling transcription to DNA replication would be an 
appropriate way to achieve cell-cycle specific gene 
expression. However, the needs of a virus at the later 
stages of the lytic cycle are vastly different to those of a 
dividing cell. HSV-1 employs a method of achieving abundant 
late gene expression that appears to require less control 
than viral early genes or cellular genes; the absence of 
upstream promoter elements is likely to correlate with a 
reduced requirement for cellular transcription factors. 
Following the onset of HSV DNA replication, there appears to 
be an increase in the transcription of non-coding RNA 
molecules, which accumulate in the infected-cell nucleus; 
this may be a consequence of the relaxation of cis-acting 
control. If DNA replication is used as a trigger for 
cell-cycle specific gene expression, it is likely that the 
cellular mechanisms of control would differ from that of 
HSV-1 late gene expression, especially because the dividing 
cell replicates its DNA only once.
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